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 II 
Summary 
 
A million copies of short interspersed nuclear elements (SINEs) comprise 11% of 
the human genome, but despite this abundance, they are expressed at a very 
low level. Alu elements are estimated to harbour 33% of CpG sites in the human 
genome and DNA methylation of these sites is believed to silence their 
transcription. However, this study shows the presence of RNA polymerase III (Pol 
III) transcription machinery on methylated SINEs alongside methylated DNA-
binding proteins. Methylation of A- and B-block elements on the Pol III promoter 
is unable to inhibit Pol III loading at SINEs. Loss of DNA methylation in DNA 
methyl transferase1-null fibroblasts or following 5-azacytidine treatment neither 
changes expression levels nor the occupancy of the Pol III machinery on SINEs. 
H3K9-trimethylation, along with SUV39H1 and associated heterochromatin 
protein 1 (HP1), is found to be enriched at SINEs. Treatment with chaetocin, a 
SUV39H1 H3K9-methyltransferase inhibitor, elevates Pol III loading and 
expression of SINEs. Thus, H3K9 methylation, and not DNA methylation, is 
responsible for SINE transcriptional inhibition. 
This suggests an alternative role for DNA methylation on these repetitive 
sequences. Homologous recombination events between Alu elements are 
implicated in several human diseases, including some cancers. Reduction in DNA 
methylation causes a two-fold increase in the rate of Alu-driven inter-
chromosomal translocation events. Hence, DNA methylation serves not to inhibit 
transcription of SINEs but instead it plays a role in inhibiting homologous 
recombination between these elements. 
Chromatin can pose a physical barrier to transcription by limiting polymerase 
accessibility to DNA. Studies showing effects of chromatin modifications caused 
by c-MYC and of remodeling by various complexes, clearly highlight the 
significance of chromatin in the regulation of Pol III transcription. Recently 
published ChIP-sequencing data also indicate that tRNA genes may be subject to 
the same chromatin-mediated transcriptional control as is seen for Pol II-
transcribed genes. SWI/SNF is an evolutionarily conserved ATP-dependent 
chromatin remodeling complex. SNF5, a core SWI/SNF subunit, is a bona fide 
tumour suppressor and is commonly lost or mutated in malignant rhabdoid 
tumours. 
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SNF5, along with SWI/SNF ATP-hydrolysis subunits, BRG1 and BRM, is found to 
occupy Pol III-transcribed loci. SNF5 knockdown or a BRG1/BRM dual-knockdown 
leads to a significant increase in tRNA expression. However, a corresponding 
increase in Pol III transcription apparatus occupancy at tRNA genes is not 
observed. c-Myc null rat fibroblasts have elevated levels of SWI/SNF enrichment 
at tRNA genes compared to c-Myc wild-type cells, suggesting that Pol III 
induction by c-MYC evicts the SWI/SNF complex.  Thus, SWI/SNF chromatin 
remodeling complex represses Pol III transcription and this repression may have 
to be overcome in order to increase Pol III transcriptional output. SWI/SNF 
subunits are lost and Pol III transcription is elevated in many human cancers, 
suggesting that these findings may be of clinical significance. 
The mechanistic details of this repression are still unclear. SWI/SNF subunits co-
immunoprecipitate with TFIIIC subunits, suggesting that Pol III transcriptional 
machinery is responsible for its recruitment. However, SWI/SNF occupancy at 
tRNA genes is highly correlated with Pol III enrichment, indicating that the mode 
of repression is not through inhibition of polymerase loading. SNF5 knockdown 
leads to higher levels of Pol III enrichment downstream of a tRNA locus. Thus, 
SWI/SNF may spatially limit the area available to Pol III transcriptional apparatus 
and, therefore, inhibit transcriptional elongation, termination or facilitated 
recycling. 
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Chapter 1 Introduction 
 2 
1.1 Transcription by RNA polymerase III 
The central dogma of molecular biology was first articulated by Francis Crick, 
where he described how the hereditary DNA information within a cell is 
recognised by RNA polymerases and transcribed into complementary RNA 
molecules. These RNA molecules are further recognised by the cellular apparatus 
that translates them to produce proteins. Thus the transcription of DNA to RNA 
is an essential part of the central dogma (Crick, 1970). In eukaryotes, the task of 
transcribing nuclear genes is divided between three highly-related enzymes, RNA 
polymerase I, II and III (hereon referred to as Pol I, Pol II and Pol III) (Roeder and 
Rutter, 1969). Derivatives of Pol II that transcribe short interfering RNAs (Pol IV) 
or of noncoding RNAs (Pol V) have also been identified in Arabidopsis (Ream et 
al., 2009). An RNA polymerase of the mitochondrial origin, named snRNAP-IV, 
has also been found to transcribe mRNA of certain mammalian protein coding 
genes in the nucleus (Kravchenko et al., 2005). 
Each of the three classical RNA polymerases is devoted to the transcription of 
specific genes. Pol I distinctively transcribes only one type of gene, the large 
tandemly repeated, ribosomal RNA (rRNA) genes. The untranslated RNA products 
of Pol I transcription are essential components of the cellular translation 
apparatus [reviewed in (McStay and Grummt, 2008; Russell and Zomerdijk, 
2006)]. Pol II transcribes genes encoding messenger RNAs (mRNAs) that are used 
as templates for protein synthesis. Pol II is also responsible for transcription of 
most small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and micro 
RNAs [reviewed in (Baumann et al., 2010)]. The genes transcribed by Pol III are 
classified as class III genes. These encode a diverse group of small untranslated 
RNAs that are involved in various cellular processes like transcription, RNA 
splicing and translation. Pol III-transcribed genes include the 5S rRNA and tRNA 
genes (White, 2001).  
Gene transcription is subject to a high degree of regulation that allows the cell 
to constantly adjust its RNA and protein content in response to environmental 
changes and metabolic requirements (White, 2001). Pol III-transcribed RNAs are 
important contributors to cellular protein synthesis and are thus considered 
crucial for the regulation of cell growth and proliferation. The deregulation of 
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Pol III transcription is observed in human diseases like cancer and is, therefore, 
an area of active research (White, 2004). 
1.1.1 Class III genes 
With 17 subunits, Pol III is the largest eukaryotic nuclear RNA polymerase, and is 
responsible for 10% of all nuclear transcription. Pol III transcription gives rise to 
small untranslated RNAs, which are usually shorter than 400nt in length (White, 
2002). Some of the Pol III-transcribed RNAs are described below. 
1.1.1.1 5S ribosomal RNA (rRNA) 
Eukaryotic ribosomes are composed of two unequal subunits, which are made up 
of four RNA molecules (28S, 5.8S, 5S and 18S) and approximately 80 protein 
subunits. The four rRNAs are required in equal stoichiometry, one molecule of 
each per ribosome (Phillips and McConkey, 1976). 5S rRNA is produced by Pol III, 
whereas the other rRNAs are transcribed by Pol I. 5S rRNA is approximately 120nt 
long and is found associated with the large ribosomal subunit. Eukaryotes 
contain multiple copies of the 5S rRNA genes, for example the human genome 
contains 200 to 300 5S genes, many of which are found arranged in tandem 
arrays (Lander et al., 2001). 
1.1.1.2 Transfer RNAs (tRNAs) 
Transfer RNAs are 70-90nt long adaptor molecules, which facilitate the 
translation of mRNA molecules. Each tRNA recognises a specific three nucleotide 
codon on the mRNA and translates that codon to a specific amino acid (Crick, 
1968). Pol III transcribes pre-tRNA molecules which, when processed, adopt an L-
shaped secondary structure. The 3' end of the tRNA comprises the amino acid 
attachment region, whereas the opposite end contains a three nucleotide 
anticodon that recognises and binds to the appropriate triplet codon on the 
mRNA (Hopper and Phizicky, 2003). There are 506 tRNA genes and 110 predicted 
pseudogenes annotated in the hg19 human genome database (Chan and Lowe, 
2009). Different tRNAs recognising the same amino acid but varying triplet 
codons are termed ‘isoacceptors’ and each isoacceptor group is named after the 
amino acid it recognises. The distribution of tRNA genes is mainly random 
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throughout the genome; however some clustering is observed (Lander et al., 
2001). 
1.1.1.3  U6 small nuclear RNA (snRNA) 
Small nuclear riboproteins (snRNPs) are structurally-related RNA-protein 
complexes found within eukaryotic nuclei. U6 snRNA, together with the Pol II-
transcribed U1, U2, U4 and U5 snRNAs, is an essential part of the most abundant 
snRNP called the spliceosome. This multisubunit ribonucleoprotein is essential 
for pre-mRNA splicing. There are multiple copies of U6 snRNA genes in the 
human genome, which show a high degree of evolutionary conservation 
(Valadkhan, 2005). 
1.1.1.4 7SL RNA and short interspersed nuclear elements  
The 7SL RNA forms the structural backbone of the signal recognition particle 
(SRP) and provides the scaffold for its six protein components. SRP is responsible 
for the transport of nascent polypeptide chains to the endoplasmic reticulum. In 
eukaryotes, 7SL RNA contains a small Alu domain and a large S-domain, which 
are separated by a long linker region (Batey et al., 2000). The Alu domain, which 
binds SRP9/14, retards the ribosomal elongation of the peptide before its 
association with the endoplasmic reticulum. The S-domain binds the signal 
peptide and targets it to the ER membrane-bound SRP receptor (Mason et al., 
2000). The 7SL RNA is ~300nt long and is highly conserved through evolution. 
Some SINEs are 7SL derived repeat elements found within mammalian genomes 
and will be discussed in section 1.5. 
1.1.1.5 Other class III genes encoding ribonucleoprotein components 
Various ribonucleoproteins (RNPs) contain Pol III-transcribed RNAs as their RNA 
components, for example 7SK, H1 and mitochondrial RNA processing (MRP) RNA. 
7SK is an abundant 330nt long Pol III-transcribed RNA that has only been 
identified in vertebrates to date. 7SK functions as a negative regulator of Pol II 
transcription by binding to the elongation factor P-TEFb and repressing the 
phosphorylation of Pol II CTD (Yang et al., 2001). H1 RNA is a component of 
RNase P endoribonuclease that processes the 5' termini of pre-tRNAs 
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(Bartkiewicz et al., 1989), whereas the structurally related MRP RNase is mainly 
involved in pre-RNA processing (Gold et al., 1989).  
Thus, RNA Pol III transcribes multiple RNA species, which together contribute to 
the regulation of global protein synthesis. In addition to the above mentioned 
RNAs, Pol III is also found to transcribe less well known RNAs such as vault RNAs 
(van Zon et al., 2003), Y RNAs (Deutscher et al., 1988) and the neural specific 
BC1/BC200 RNAs (Cao et al., 2006). Pol III transcription is also involved in 
production of various viral RNAs such as the adenoviral VA and Epstein-Barr viral 
EBER RNAs (Rosa et al., 1981). The size of the Pol III transcriptome has expanded 
considerably in recent years and it now also includes snoRNAs, microRNAs, stem-
bulge RNAs and other unclassified non-coding RNAs (Dieci et al., 2007). 
1.1.2 Class III gene promoters and assembly of the transcription 
complex 
The selective transcription of genes by Pol I, Pol II and Pol III is dictated by the 
identification of distinct promoters by their specific transcription factors.  
1.1.2.1 Class III gene promoters 
The majority of class III gene promoters comprise of regulatory elements that 
are within the transcribed region, downstream of the transcription start site 
(TSS). These promoter elements, known as internal control regions (ICRs), were 
identified by mutation analysis in yeast and are found to be present as 
discontinuous conserved sequences separated by non-essential regions (Koski et 
al., 1980; Kurjan and Hall, 1982). Three different types of promoters are 
identified by Pol III transcription apparatus, type I and type II promoters that are 
found within the gene, and type III promoters that are located entirely upstream 
of the TSS [reviewed in (Schramm and Hernandez, 2002)](See Figure 1.1). 
Type I promoters are unique to 5S rRNA genes and consist of three internal 
elements; an A-block (+50 to +64), an intermediate element (+67 to +72) and a 
C-block (+80 to +92). These promoter sequences are highly conserved between 
different species and mutations within the A- and C-block sequences are 
detrimental to transcription (Pieler et al., 1985). A change in the spacing 
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between these elements also leads to diminished transcription (Pieler et al., 
1987).  
 
Figure 1.1 Schematic diagram of general types of Pol III-transcribed promoters 
The TSS is indicated by +1 and the site of transcription termination is indicated by Tn. The 
approximate positions of various promoter elements are depicted including the intermediate 
element (IE), proximal sequence element (PSE) and distal sequence element (DSE). The known 
consensus sequences for A-block and B-block elements are also shown (Galli et al., 1981) 
[adapted from (Schramm and Hernandez, 2002)] 
 
The most common Pol III promoters are found within tRNA genes and are termed 
type II promoters. This promoter class consists of two highly conserved A-block 
and B-block sequences that are separated by a variable distance. Interblock 
separation of ~30 to 60bp is thought to be optimal for transcription, however a 
distance as great as 365bp can be tolerated (Baker et al., 1987; Fabrizio et al., 
1987). The A-block sequences of the type I and II promoters are homologous, but 
in the latter case they are much closer to the TSS (Ciliberto et al., 1983). 
In contrast to type I and II promoters, type III promoters are external and lie 
upstream of the transcribed region. The best characterised type III promoter 
belongs to the human U6 gene where the regulatory sequences include a TATA 
box (-30 to -25), a proximal sequence element (PSE, -66 to -47) and a distal 
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sequence element (DSE, -244 to -214) (Das et al., 1988). The U6 PSE and DSE are 
homologous and interchangeable with elements found upstream of the Pol II-
transcribed U2 gene. Surprisingly, it is the presence of the TATA box (generally a 
feature of Pol II-transcribed genes) that defines U6 as a Pol III-transcribed locus 
(Lobo and Hernandez, 1989). Other genes containing type III promoters include 
the 7SK RNA, H1 RNA and MRP RNA genes (White, 2002). 
Some promoters recognised by the Pol III machinery cannot be classified as any 
of the conventional promoter types. For instance, the EBER2 gene requires all 
the elements of a type II promoter as well as those of a type III promoter for its 
transcription by Pol III (Howe and Shu, 1989). The optimal transcription of the 
7SL gene requires the internal A- and B-box elements alongside a 37bp sequence 
found upstream of the TSS (Ullu and Weiner, 1985).  
1.1.2.2 Preinitiation complex formation 
Transcription by an RNA polymerase is preceded by the formation of a 
preinitiation complex (PIC). Different Pol III promoter types require a different 
cocktail of transcription factors for PIC formation [reviewed in (Schramm and 
Hernandez, 2002) and (White, 2002)]. The core transcription apparatus required 
for Pol III transcription is conserved from yeast to mammals, however certain 
transcription factor subunits in mammals have diverged considerably from their 
yeast counterparts (Huang and Maraia, 2001). The PIC formation of various 
promoter types is discussed below and depicted in Figure 1.2. 
Type II promoters found at tRNA genes require a large multi-subunit 
transcription factor complex called TFIIIC. Human TFIIIC, with an aggregate mass 
of more than 500kDa (Geiduschek and Kassavetis, 2001), comprises of TFIIIC220, 
TFIIIC110, TFIIIC102, TFIIIC90, TFIIIC63 subunits (Kovelman and Roeder, 1992; 
Yoshinaga et al., 1989) and the recently identified TFIIIC35 subunit (Dumay-
Odelot et al., 2007). The primary binding affinity of TFIIIC to the Pol III promoter 
is determined by the binding of TFIIIC220 to the B-block element. However, this 
alone is not sufficient for the recruitment of TFIIIC, which also requires IIIC220 
to interact with TFIIIC110 (Shen et al., 1996; Yoshinaga et al., 1987).  
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TFIIIC63 recognises the A-block sequence and contributes to the recruitment of 
TFIIIC (Hsieh et al., 1999b), however the B-block binding is the major 
determinant of promoter efficiency (Baker et al., 1986). TFIIIC90 forms a 
flexible linker between the two TFIIIC sub-complexes (TFIIIC63/102 and 
TFIIIC110/220) and forms what appears as a dumbbell shaped transcription 
factor under the electron microscope (Schultz et al., 1989). This structure and 
the flexible central linker allow the recruitment of TFIIIC to promoters with 
variable distances between the A- and B-blocks. On promoters with large inter-
block separation, the intervening DNA can be looped out to allow TFIIIC binding 
(Baker et al., 1987). Six TFIIIC subunits have been identified in yeast and five of 
them were found to be conserved in humans. The human homologue to the sixth 
yeast TFIIIC subunit, TFIIIC35, has been recently identified. Even though TFIIIC35 
shows considerable sequence divergence from its yeast conterpart (Tfc7), the 
interactions with other TFIIIC subunits are conserved from yeast to man. TFIIIC35 
is found to interact with TFIIIC63 and, to a lesser extent, with TFIIIC90 in vitro. 
TFIIIC35 also localises within active transcription complexes (Dumay-Odelot et 
al., 2007). 
Once recruited, TFIIIC further recruits another transcription factor TFIIIB, which 
comprises of the TATA-binding protein (TBP), TFIIB-related factor 1 (BRF1) and B 
double prime 1 (Bdp1) (Schramm and Hernandez, 2002). BRF1 forms a stable 
complex with TBP (Kassavetis et al., 1991; Khoo et al., 1994), whereas Bdp1 
interacts very weakly with this complex in the absence of a DNA template (Huet 
et al., 1994). An N-terminal TFIIB-like domain of BRF1 interacts with TBP, 
although the primary binding site was recognised to lie within the C-terminal 
part of BRF1 (Khoo et al., 1994). In addition, BRF1 is also found to interact with 
TFIIIC102 (Kassavetis et al., 1992b), which is thought to be the primary point of 
contact of TFIIIB and TFIIIC (Schramm and Hernandez, 2002). Further 
interactions of BRF1 with TFIIIC63 and TFIIIC90, alongside the binding of TBP to 
TFIIIC63 and TFIIIC102 contribute to the recruitment of TFIIIB to the TFIIIC-bound 
promoters (Hsieh et al., 1999a; Hsieh et al., 1999b).  
The recruitment of TFIIIB is followed by the recruitment of Pol III via protein-
protein interactions. TBP and BRF1 interact with multiple Pol III subunits and 
these interactions are crucial for the recruitment of the polymerase. The role of 
Bdp1 in the recruitment of Pol III is less defined, however it contains a SANT 
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domain which is essential for TFIIIC-dependent, but not for TFIIIC-independent 
Pol III transcription on type III promoters (Schramm et al., 2000). Moreover, 
TFIIIC subunits are also capable of interacting with the polymerase, which 
contributes to the polymerase recruitment and stabilises the PIC (Schramm and 
Hernandez, 2002).  
 
Figure 1.2: Transcription complex assembly on class III gene promoters 
The promoter elements are recognised by the transcription factors shown associated with them. All 
TFIIIC subunits are depicted in blue, TFIIIB subunits in green and Pol III subunits in yellow. [Figue 
adapted from (Dumay-Odelot et al., 2010)) 
 
5S rRNA genes lack the B-block sequence and, therefore, cannot be recognised 
by TFIIIC. TFIIIC recruitment on type I promoters is dependent on a 40kDa 
adapter transcription factor called TFIIIA, which was the first transcription 
factor to be purified to homogeneity (Engelke et al., 1980). This single 
polypeptide contains nine zinc finger domains which bind to the A-block, IE and 
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the C-block promoter elements (Miller et al., 1985). Similar to B-block binding 
by TFIIIC on type II promoters, the C-block binding by TFIIIA on type I promoters 
determines the overall binding affinity (Hanas et al., 1983). It is not completely 
clear how TFIIIC binds TFIIIA, but together they form a complex that recruits 
TFIIIB and consequently Pol III to the 5S rRNA gene promoters (Bieker et al., 
1985). 
The PIC formation at type III promoters requires a different set of transcription 
factors. The PSE is identified by snRNA activator protein complex (SNAPc) and 
the TATA box is recognised by TBP (Schramm et al., 2000). Both SNAPc and TBP 
can bind weakly to these promoter elements; however co-operative binding 
greatly enhances their promoter affinity (Mittal and Hernandez, 1997). TBP 
bound to the TATA box is found within an alternative form of TFIIIB that contains 
BRF2 instead of BRF1 (Schramm et al., 2000). The DSE is recognised by Oct-1, 
which also binds and promotes SNAPc promoter occupancy, thereby stimulating 
transcription (Mittal et al., 1996). However, Oct-1 is not essential for basal in 
vitro transcription (Hu et al., 2003). Given the distance between the two 
elements, a positioned nucleosome may be required to juxtapose PSE and DSE in 
order to facilitate Oct-1 and SNAPc interaction (Stunkel et al., 1997). The PIC 
formation is completed by the recruitment of Pol III to the promoter by SNAPc 
and TFIIIB (Schramm and Hernandez, 2002). 
1.1.3 Pol III: transcription initiation, elongation and termination 
With an aggregate mass of 600-700 kDa, Pol III is the largest eukaryotic RNA 
polymerase. Pol III consists of 17 subunits in humans and yeast, all of which are 
found to be essential for its function and for cell viability (Geiduschek and 
Kassavetis, 2001). Five of the subunits are shared by all three classical RNA 
polymerases, whereas an additional two are shared between Pol I and Pol III. 
Ten of the seventeen subunits are unique to Pol III (Breant et al., 1983; Buhler 
et al., 1980). The Pol III-specific subunits are thought to be responsible for its 
nuclear localisation and binding specificity for Pol III-specific transcription 
factors, as well as for its elongation and termination properties. 
Following the successful formation of PIC, the DNA at the transcription initiation 
site is melted by Pol III, forming a transcription bubble. TFIIIB is responsible for 
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correctly positioning the polymerase at the TSS (Kassavetis et al., 1990). 
Moreover, mutations of specific domains in BRF1 and Bdp1 can impair the 
transcription initiation, even though the polymerase recruitment is unaffected. 
This suggests that TFIIIB may also be involved in transcription bubble formation. 
The presence of A/T rich sequences found around the TSS is thought to promote 
the formation of the transcription bubble, due to the lower thermodynamic 
stability of A:T bonds (Kassavetis et al., 1992a). The recruitment of Pol III and 
the formation of the transcription bubble are the rate-limiting steps for Pol III 
transcription, whereas the synthesis of an initial 17bp transcript takes mere 
seconds (White, 2002). 
Once transcription is initiated, the 14bp long transcription bubble moves along 
the gene as transcription proceeds. Pol III dissociates from TFIIIB without a 
considerable delay in elongation (Kassavetis et al., 1992a). Moreover, the 
presence of TFIIIC does not seem to significantly delay the progress of Pol III 
either. It is presently unclear how Pol III passes through DNA that is bound by 
TFIIIC; however some experiments propose the transient dissociation of TFIIIC to 
allow the polymerase to pass (Bardeleben et al., 1994). Unlike the other 
polymerases, Pol III does not require specific elongation factors, possibly due to 
the small size of the Pol III-transcribed genes (White, 2002). Pol III transcription 
proceeds until it reaches a stretch of four thymidine residues, where the 
transcription terminates (Galli et al., 1981). It has been proposed that the La 
autoantigen and NF1 polypeptides are required for efficient termination of Pol III 
transcription (Maraia, 2001). 
Once transcription is terminated, Pol III does not dissociate from the template, 
but is recycled to the TSS. The repeat rounds of transcription by the recycled 
polymerase occur much more rapidly than the initial round (Dieci and Sentenac, 
1996). The La protein is also thought to promote polymerase recycling (Maraia et 
al., 1994). Thus once assembled, the Pol III transcription complexes can produce 
multiple transcripts with remarkable efficiency due to polymerase recycling. 
1.1.4 Regulation of Pol III transcription 
The synthesis of rRNA (including 5S rRNA) is an important step in ribosome 
production and consequently protein translation. Moreover, the cellular tRNA 
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levels also affect the rate of protein translation. Thus, Pol III transcriptional 
products are vital for cellular protein synthesis and, thus, cell growth. 
Therefore, Pol III transcription within a cell is subject to tight regulation (White, 
2002).  
The first evidence for the regulation of Pol III transcription in eukaryotic cells 
came from the 5S rRNA genes in Xenopus oocytes. 5S rRNA is highly expressed in 
the oocyte, whereas its expression is greatly diminished following oogenesis. The 
Xenopus laevis genome contains 21300 copies of oocyte-specific 5S rRNA genes 
and 400 copies of somatic 5S rRNA genes. The oocyte genes are only expressed 
during oogenesis, whereas the somatic genes are expressed both before and 
after oogenesis. This differential regulation of these two gene types is in part 
due to their different affinities to TFIIIA. Following oogenesis, a considerable 
drop in the TFIIIA protein levels is observed, and the limited amount of TFIIIA 
binds the high affinity somatic 5S genes (Ginsberg et al., 1984; White, 2002). 
Initial studies also found Pol III transcription to be regulated by various viral 
proteins including the adenoviral E1A protein (Berger and Folk, 1985) and the 
SV40 small τ antigen (Loeken et al., 1988). 
The regulation of Pol III transcription is now known to occur in three primary 
ways: i) changes in transcription factor availability (Figure 1.3a), ii) post-
translational modification (primarily phosphorylation) of transcription factors 
(Figure 1.3b), and iii) regulation by chromatin. The first two modes of regulation 
are discussed briefly below, whereas the third mode of regulation is discussed in 
chapter 6. 
1.1.4.1 Changes in transcription factor levels 
The first example for this mode of transcriptional regulation was obtained from 
studies investigating the E1A viral protein. The infection of cells by E1A was 
found to upregulate the cellular TFIIIC110 protein levels and cause increased Pol 
III transcription (Sinn et al., 1995). The hepatitis B virus X protein was also 
shown to upregulate Pol III transcription by causing an increase in TBP protein 
levels (Wang et al., 1995). Cell lines transformed by either SV40 or Py were 
shown to overexpress Bdp1, whereas the human papillomavirus 16 was found to 
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cause elevated BRF1 levels in cervical carcinomas (Daly et al., 2005; Felton-
Edkins and White, 2002; Larminie et al., 1999).  
JNK1 and JNK2 can modulate the levels of ELK1 occupancy on BRF1 and TBP 
promoters, thereby inducing or suppressing their expression respectively. The 
levels of Bdp1 respond similarly to JNK1 and JNK2 protein levels due to 
alterations in TBP occupancy at the Bdp1 gene promoter. Thus JNKs regulate Pol 
III transcription by altering the levels of all three TFIIIB subunits (Zhong and 
Johnson, 2009).  c-MYC is also seen to bind E-boxes within the BRF1 gene 
promoter and upregulate its expression levels (Unpublished Data, Lynne 
Marshall). Thus, multiple proteins are capable of elevating levels of Pol III TFs 
and thereby induce Pol III transcription. 
The levels of Pol III transcription can also be limited by reducing the availability 
of its TFs. Rb and p53 proteins were found to target BRF1 and TBP respectively, 
and sequester them away from the transcription complexes, thereby reducing 
Pol III transcriptional output (Crighton et al., 2003; Larminie et al., 1997). Rb-
family proteins p107 and p130 have been shown to have similar properties 
(Sutcliffe et al., 1999). Recently, BRCA1 has been shown to cause reduced BRF1 
and BRF2 proteins levels and repress Pol III transcription, however it still remains 
to be resolved whether this is a direct or indirect effect (Veras et al., 2009).  
1.1.4.2 Post translational modification of transcription factors 
Over the past decade Pol III transcriptional regulation has been shown to be a 
battle ground for kinases. Both activating and inhibitory phosphorylation events 
on Pol III transcription factors contribute to determining the overall 
transcriptional output of Pol III. CK2 (Johnston et al., 2002) and ERK (Felton-
Edkins et al., 2003a) can directly interact with and phosphorylate BRF1, thereby 
facilitating its recruitment to promoters. Contrary to this, the phosphorylation 
of BRF1 by cyclin-dependent kinases (Cdks) can lead to transcriptional inhibition. 
Cdc2-cyclin B kinase was found to be sufficient for repressing transcription from 
Xenopus 5S rRNA genes (Gottesfeld et al., 1994).  BRF1 was also shown to be 
hyperphosphorylated by kinases other than cdc2-cyclin B during mitosis, which 
leads to dissociation of Bdp1 from the gene promoters and subsequent repression 
of transcription (Fairley et al., 2003). Recent findings attribute this mitotic 
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repression of Pol III transcription to Polo-like kinase 1 (Plk1) [(Fairley et al., 
2011), submitted]. 
Maf1 is a target for multiple signalling cascades including the PI3K/AKT, TORC1 
and PP2A pathways. Maf1 was found to associate with Pol III-transcribed genes 
and interacts with TFIIIC, TFIIIB and Pol III. Repression by MAF1 leads to reduced 
PIC formation at Pol III transcribed promoters (Desai et al., 2005; Goodfellow et 
al., 2008). However, phosphorylated Maf1 is unable to repress Pol III 
transcription, which makes Pol III transcription sensitive to Maf1 phosphorylation 
by TORC1 or PKA and dephosphorylation by PP2A (Kantidakis et al., 2010; Moir et 
al., 2006; Oficjalska-Pham et al., 2006). The regulation of Pol III transcription by 
all these phosphorylation events makes it highly sensitive to the metabolic state 
of the cell.    
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Figure 1.3: Schematic for the regulation of Pol III transcription 
a) Mechanisms that influence cellular transcription factor availability. b) Kinases and 
phosphorylation events that influence Pol III transcriptional output. The arrows do not indicate 
direct protein-protein interactions.      indicates a phosphorylation event. P 
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1.1.5 Pol III and cancer 
It is clear that the control of Pol III transcription is of vital importance for the 
correct regulation of cell growth and metabolism. Therefore, in order to 
upregulate its growth and proliferation, a cell must elevate the Pol III 
transcriptional output. Indeed, many studies have reported the overexpression 
of Pol III-transcribed RNAs in various tumour types [reviewed in (White, 2004; 
White, 2008)]. The levels of various Pol III transcription factors are also found to 
be upregulated in multiple cancers (White, 2004). TFIIIC is overexpressed in 
ovarian carcinomas (Winter et al., 2000), whereas BRF2 is found to be 
overexpressed in human breast, bladder and lung cancers (Lockwood et al., 
2010; Melchor et al., 2007). Recent analysis of tissue microarrays has found 
elevated levels of BRF1 in prostate tumours (Noor Nam, unpublished data).  
Thus, elevated Pol III transcription seems to be a feature of tumours; however 
this may simply be the outcome of deregulation of multiple oncoproteins and 
tumour suppressors. The question whether elevated Pol III transcription could 
cause cancer was answered recently by Marshall et al, where the authors 
demonstrate that a modest increase in BRF1 protein levels and a consequent 
increase in Pol III transcriptional output is sufficient for oncogenic 
transformation. Surprisingly, a small increase in initiator tRNA (tRNAiMet) was 
sufficient to reproduce these effects. An increase in c-MYC and cyclin D1 protein 
translation was observed as a result of elevated Pol III transcription. It is still 
unclear whether the observed oncogenic effects of BRF1 and tRNAiMet are 
dependent on upregulation of c-MYC and cyclin D1 (Marshall et al., 2008). But it 
is clear that an elevation in Pol III transcriptional output can cause cellular 
transformation. 
1.1.6 Recent insights 
Recently, multiple studies have analysed Pol III and its transcriptional targets by 
ChIP-sequencing (Barski et al., 2010; Canella et al., 2010; Moqtaderi et al., 
2010; Oler et al., 2010; Raha et al., 2010). These have revealed many aspects of 
Pol III transcription that were previously unknown and have shed light on the 
complexity of its regulation in mammalian cells (White, 2011). The first 
unexpected finding was the presence of Pol II 200bp upstream of Pol III-bound 
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loci, which in most cases does not correspond to the presence of a Pol II 
transcription unit (Barski et al., 2010; Oler et al., 2010; Raha et al., 2010). Basal 
Pol II transcription factors, such as TFIIB, are also present (Barski et al., 2010). It 
is not known what brings Pol II to these loci; however one can hypothesise that it 
may be the common transcription factor TBP or common transcriptional 
regulators like Myc, which are found to be associated with both Pol II and Pol III 
transcription complexes. Further biochemical and genetic analyses are required 
in order to understand if Pol II-enrichment at Pol III-transcribed loci is of 
functional relevance. It was also observed that active tRNA genes, i.e. those 
highly enriched for Pol III, often reside within or close to annotated Pol II 
promoters (Moqtaderi et al., 2010; Oler et al., 2010). This may reflect a 
preference for the open chromatin environment associated with Pol II genes.  
Another unexpected finding was the presence of TFIIIC on its own at multiple 
intergenic loci (Moqtaderi et al., 2010; Oler et al., 2010). These loci were first 
identified in yeast and were named ETC (extra TFIIIC) loci (Moqtaderi and Struhl, 
2004). ETC loci are often found near binding sites for the CCCTC-binding factor 
(CTCF) and, thus, may have a role in genome organisation. ETC sites are also 
often found in intergenic sequences between evenly spaced, but divergently 
transcribed Pol II genes (Moqtaderi et al., 2010). Since TFIIIC-binding sites have 
been shown to have barrier or insulator activities, these ETC sites may serve a 
similar purpose and regulate the differential transcription of neighbouring genes 
(Simms et al., 2008; Valenzuela et al., 2009). 
The ChIP-seq data also show remarkable differences in Pol III-loading at tRNA 
genes between different cell lines. Despite having similar promoters and using 
the same core transcription apparatus, 26% of tRNA loci showed cell-type 
specific differences in Pol III occupancy (Barski et al., 2010). However, recent 
ChIP-seq. analysis in 6 different species has revealed that despite differences at 
individual tRNA genes, the additive Pol III-loading at all tRNA genes coding for a 
particular isotype is highly conserved (Kutter et al., 2011). These data suggest 
that the regulation of Pol III transcription is not as simple as it has been thought 
to be. 
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1.2 Chromatin 
The average diameter of the human nucleus is only about 5 microns and 2 
metres of DNA has to be contained within this small space. This is achieved by 
wrapping 146bp of the negatively charged DNA around an octamer of positively 
charged histone proteins. This forms the basic monomer of the chromatin, a 
nucleosome. These monomers are held together by linker DNA to form the 
classic ‘beads on a string’ conformation as viewed by X-ray crystallography 
(Thoma et al., 1979). Linker histone (H1/H5) binding organises a further 20bp of 
DNA into the nucleosome and also defines the geometry of the DNA entering and 
exiting the nucleosome. The angles of entry and exit further organise the 
nucleosomes into a 30-nm fibre which is then tethered onto an axial scaffold 
protein core to form higher order structures (Moser and Swedlow, 2011). 
Depending on the extent of chromatin compaction, the eukaryotic genome can 
be categorised into two distinct environments. The regions with relatively 
relaxed environment which permit gene transcription are classed as 
‘euchromatin’. In contrast, the more tightly packaged non-permissive regions 
with inactive genes are classed as ‘heterochromatin’ (Kouzarides, 2007). 
The nucleosome core comprises of dimers of core histone proteins H2A, H2B, H3 
and H4. These histone proteins have highly basic N-terminal tails which protrude 
from the core nucleosome and can make contacts with the nearby nucleosomes 
and other proteins. Histone tails are known to be targets of post-translational 
modifications such as acetylation, phosphorylation, ubiquitilation, methylation, 
deamination, ADP ribosylation, ß-N-acetylglucosamination, sumoylation and 
proline isomerisation. These histone tail modifications can directly influence the 
structure of the chromatin by altering the binding affinity of the nucleosome to 
the DNA. Moreover, they also act as signals for the recruitment of effector 
protein complexes (Bannister and Kouzarides, 2011). Only the post-translational 
histone modifications considered during this study will be discussed in detail. 
1.2.1 Histone Acetylation 
Histone acetylation is the characteristic euchromatic mark and, since its 
discovery, is almost invariably associated with transcriptional activation (Allfrey 
et al., 1964). Acetylation reduces the overall positive charge of histones, thus 
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reducing the affinity of the nucleosome to the negatively charged DNA. This in 
turn enables easier access by transcription factors to their target sequences. 
Acetylation occurs at numerous lysine residues on histone tails, including H3K9, 
H3K14, H3K18, H4K5, H4K8 and H4K12. Multiple lysine residues can get 
acetylated at the same time giving rise to hyper-acetylated regions of the 
genome. The genomic histone acetylation levels are highly dynamic and are 
regulated by opposing activity of the histone acetyl-transferases (HATs) and 
histone deacetylases (HDACs) (Kouzarides, 2007).  
HATs catalyse the transfer of the acetyl group from acetyl-CoA to an amino 
group in the lysine side chain. HATs can be divided into three main families 
based on their acetyltransferase domains, GNAT superfamily (Gcn5-related N-
acetyltransferase), MYST family (named for its founding members MOZ, 
Ybf2/Sas3, Sas2, and Tip60) and p300/CBP (CREB-binding protein) family 
(Sterner and Berger, 2000). In addition, multiple other proteins including (Hsieh 
et al., 1999a) and circadian rhythm protein CLOCK (Doi et al., 2006) have been 
shown to have HAT activity. To complicate the picture, HATs have also been 
shown to acetylate numerous non-histone proteins (Lee and Workman, 2007).  
HATs are found to exist as multisubunit complexes in yeast, like the SAGA (spt-
Ada-Gcn5) complex, the ADA complex (contains Ada but none of the other SAGA 
subunits), the NuA4 and the NuA3 complexes. The primary HAT complexes in 
humans are the GCN5/PCAF complex and Tip60 complex (Sterner and Berger, 
2000). Other human HAT complexes like STAGA and TFTC have also been 
identified. The unique individual subunit compositions of these complexes define 
their targeting and specific acetylation activity. For example, the SAGA complex 
preferentially acetylates H3K9 and to a lesser extent H3K14, whereas the NuA3 
complex prefers to acetylate H3K14. The Elongator complex (another GNAT 
family complex in yeast) prefers to acetylate H3K9, just like the SAGA complex. 
But unlike SAGA, which is targeted to gene promoters, the Elongator is targeted 
to gene bodies. The targeting of HAT complexes to active genes is also mediated 
by transcriptional regulators like c-MYC and TRRAP (Lee and Workman, 2007). 
Lysine acetylation is recognised by proteins containing a recognition domain 
called a bromodomain. For example, Pol II transcription factor TFIID subunit1 
contains a bromodomain, thus directly linking histone acetylation to 
transcriptional activation. Certain HATs themselves contain bromodomains and 
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this maintains their occupancy at acetylated regions of the genome (Kouzarides, 
2007). 
Counteracting the activity of the HAT complexes, are the HDAC complexes which 
deacetylate histone tail lysines and repress transcription. Four different classes 
of HDACs have been identified: Class I (containing scRpd3 histone deacetylase-
like proteins including HDAC1 and HDAC2), class II (containing scHda1 histone 
deacetylase-like proteins), class III (are homologous to scSir2 and referred to as 
Sirtuins) and class IV (with only one member HDAC11). Sertuins are different 
from the other classes because they require NAD+ as a cofactor (Cress and Seto, 
2000). HDACs recognise an acetylated aminoalkyl group and catalyse the removal 
of the acetyl group by cleaving an amide bond (Leipe and Landsman, 1997). 
HDACs on their own show little substrate specificity, but their presence within 
co-repressor complexes like NuRD, Sin3a or Co-REST provides specificity to their 
activity. HDAC-containing complexes can be recruited by DNA-binding proteins 
such as MBDs and p53 (Cress and Seto, 2000). 
1.2.2 Histone methylation 
Histones can be methylated at lysine and arginine residues. Unlike lysine 
acetylation, its methylation does not alter the charge of the residue, but 
changes its hydrophobic and steric properties. Lysines can be mono-, di- or tri- 
methylated depending on the functional properties of the histone lysine 
methyltransferase (HKMT) responsible. Each histone can be methylated at 
multiple sites and, depending on the location of the methylation, this has a 
positive or negative influence on transcription. In general, H3K4, H3K36 and 
H3K79 methylation are associated with transcriptionally active chromatin, 
whereas H3K9, H3K27 and H3K20 methylation marks inactive chromatin 
(Upadhyay and Cheng, 2011). 
The majority of HKMTs, contain a highly conserved, 130 amino acid SET domain 
that uses S-adenosylmethionine (Adomet) as a methyl donor. HKMT are relatively 
specific with respect to the lysine side chain they can methylate and how many 
methyl moieties they can place upon that particular side chain. Well-studied 
human HKMTs include SUV39H1, G9a, SETDB1 (H3K9 methylases), EZH2 (H3K27 
methylase), MLL1-5, SET1A, SET1B (H3K4 methylases), SET2, NSD1 (H3K36 
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methylases), SpSet9, SUV420H1, SUV420H2 (H3K20 methylases) and DOT1 (H3K79 
methylase) (Kouzarides, 2007).  
Depending on its position, histone lysine methylation is recognised by specific 
proteins. For example, Heterochromatin Protein 1 (HP1) chromodomain 
recognises H3K9 methylation and promotes the formation of repressive 
chromatin (Bannister et al., 2001). On the other hand, H3K4 methylation is 
recognised by bromodomain-PHD-transcription-factors (Li et al., 2006), CHD1 (an 
ATP-dependent chromatin remodelling enzyme) (Sims et al., 2005), as well as 
HAT complexes (Saksouk et al., 2009), thus associating this modification with 
active chromatin. H3K27 methylation is recognised by the polycomb group 
proteins (PCG), which are known to be global epigenetic transcriptional 
repressors. PRC1 (Polycomb Repressive Complex 1), once recruited in a H3K27-
dependent or -independent manner, can in turn interact with EZH2 and 
propagate this repressive mark further (Margueron et al., 2009). Thus, the 
overall effect of a histone lysine methylation mark is defined by the effector 
proteins it recruits. 
Histone methylation was considered to be an irreversible modification until the 
discovery of lysine-specific demethylase 1 (LSD1) (Shi et al., 2004). Multiple 
members of the jumonji C (jmjC)-domain-family, like JHDM1, JHDM2, JHDM3 and 
JMJD2 have also been shown to have histone demethylase activity. LSD1 and 
jmjC enzymes also demonstrate a level of substrate-specificity, where LSD1 
primarily demethylates H3K4, JHDM1 demethylates H3K36, whereas JHDM2 and 
JHDM3 demethylate H3K9 and H3K36 residues (Kouzarides, 2007). 
1.2.3 Chromatin remodelers 
In addition to the effects of post-translational histone modification, the 
chromatin fibre is also actively reorganised by ATP-dependent remodelling 
complexes. The hydrolysis of ATP to ADP provides the energy required to move a 
nucleosome along the DNA in cis or completely reposition the nucleosome in 
trans. Thus chromatin remodelers make DNA/chromatin available to proteins 
that need to access DNA or histones directly for their function. Moreover, 
chromatin remodelling can also lead to nucleosome positioning and make 
specific regions of the DNA inaccessible (Hargreaves and Crabtree, 2011). 
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1.3 SWI/SNF chromatin remodelling complex 
A screen for sucrose non-fermenting (SNF) yeast mutants identified the first 
components of the SWI/SNF complex, which were later characterised as 
chromatin remodelling proteins (Carlson et al., 1984). The SWI genes were later 
identified from mutants defective in mating type switching (Peterson and 
Herskowitz, 1992). Strains containing mutations in histone H2A and H2B failed to 
show the effects of SNF gene deletions. Moreover, swi2/snf2 and snf5 mutants 
showed altered sensitivity of the suc2 gene to nuclease digestion, suggesting 
that these proteins altered the nucleosome occupancy at their target loci 
(Hirschhorn et al., 1992). 
Brahma (BRM) was identified as an activator of homeotic genes in Drosophila and 
was found to be a homolog of the yeast swi2/snf2 gene (Tamkun et al., 1992). 
BRG1 was identified by a cDNA screen as the human BRM homolog and was later 
found to be involved in regulation of murine Hox genes (Khavari et al., 1993; 
Randazzo et al., 1994). INI1 (integrase interactor 1), the human homolog of 
yeast snf5, was first identified in a yeast two hybrid screen as a binding partner 
of human immunodeficiency virus-type 1 (HIV1) integrase (Kalpana et al., 1994).  
Swi2/snf2, a highly conserved member of the SWI/SNF family, was found to 
exhibit DNA-stimulated ATPase activity. Mutations in the nucleoside-binding site 
impaired snf2 activity, indicating that ATP hydrolysis by snf2 was necessary for 
transcriptional activation by SWI/SNF (Laurent et al., 1993). Purified yeast 
SWI/SNF complex was shown to exhibit ATPase activity, which was required to 
drive transcription from a nucleosomal GAL4 template (Cote et al., 1994). 
Partially-purified human homolog of the yeast SWI/SNF complex was also shown 
to mediate ATP-dependent nucleosome disruption and the binding of 
transcription factors to nucleosomal templates (Kwon et al., 1994). Thus, it was 
proposed that the primary role of the SWI/SNF complex was to promote 
transcriptional activation via nucleosomal eviction driven by ATP hydrolysis. 
Microarray data analysis on snf2Δ or swi1Δ yeast strains revealed that 5% of yeast 
genes are regulated by the SWI/SNF complex. Moreover, the data also 
demonstrated that SWI/SNF represses more genes than it activates (Sudarsanam 
et al., 2000). Microarray data from SNF5 null mouse embryonic fibroblasts (MEFs) 
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also suggested a repressive role of SWI/SNF complex. The number of genes 
repressed by SWI/SNF is three-fold higher than the number of activated genes 
(Isakoff et al., 2005). Deletion of BRG1 in mouse ES cells followed by 
transcription analysis also revealed that BRG1 represses most of its direct targets 
(Ho et al., 2009a). Thus, despite its original identification as a transcriptional 
activator, a genome-wide repressive role is now attributed to the SWI/SNF 
chromatin remodelling complex. 
A novel 15-subunit complex with the capacity to remodel the structure of 
chromatin (RSC) was later identified in yeast. The Sth1, Rsc6 and Rsc8 
components of RSC were found to be significantly similar to the swi2/snf2, 
Swp73 and Swi3p components of the SWI/SNF complex respectively. It was 
observed that unlike the SWI/SNF complex, RSC is abundant in a yeast cell and is 
essential for cell viability (Cairns et al., 1996). Sth1 was later recognised as the 
ATPase essential for RSC activity (Du et al., 1998). The human homolog of the 
yeast RSC, the SWI/SNF-B complex, was termed the PBAF complex, since it 
contains a unique factor called BAF180 that shows homology to the chicken 
polybromo gene (Xue et al., 2000). RSC has been shown to have roles in DNA 
repair, sister chromatid cohesion, chromosome segregation and ploidy 
maintenance (Hargreaves and Crabtree, 2011).  
1.3.1 Composition of the SWI/SNF complex 
Purified yeast SWI/SNF complex, with an estimated molecular mass of ~1MDa, 
was shown to be composed of 10 subunits including swi1, swi2/swi2, swi3, snf5 
and snf6 (Cote et al., 1994; Smith et al., 2003). However, its mammalian 
counterpart is twice as large in size and shows considerable heterogeneity in its 
subunit composition between different cell lines and tissues (Wang et al., 1996a; 
Wang et al., 1996b). Mammalian SWI/SNF complex normally consists of 9-12 
subunits. Only four of these, called the core subunits, are required for 
remodelling activity in vitro. Reconstitution experiments showed that BRG1 or 
BRM can promote nucleosome remodelling independently in vitro. However, the 
addition of BRM-associated factors, BAF155 and BAF170, along with SNF5 (also 
known as BAF47) increases this basal activity to levels similar to that of 
immunoprecipitated SWI/SNF complexes (Phelan et al., 1999).  
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An individual SWI/SNF complex can only contain one of the two ATPases, such 
that BRM/BAF complexes are structurally distinct from BRG1/BAF complexes 
(Wang et al., 1996a; Wang et al., 1996b). The functional differences between 
these two complex types are still unclear and are an area of active investigation. 
A subset of SWI/SNF subunits, including BRG1 and BRM, can also be found as part 
of alternative chromatin remodelling complexes, such as the WINAC nucleosome 
assembly complex, the nucleosomal methylation activated complex (NUMAC) and 
the nuclear receptor corepressor-1 (NCoR-1) complex [for review see (Trotter 
and Archer, 2008)] 
SNF5 is present in all the SWI/SNF complex variants and is thought to be 
essential for SWI/SNF function. SNF5 contains a highly-conserved central 
functional domain, which comprises of acidic repeat sequences. Mutations within 
this functional domain were found to influence the complex assembly step or the 
post-recruitment catalytic remodelling step (Geng et al., 2001). The mechanistic 
role of SNF5 in the remodelling step is still unclear, but it may be required for 
binding of SWI/SNF to a nucleosome (Dechassa et al., 2008). Homozygous loss of 
SNF5 has been shown to cause preimplantation embryonic lethality in mice 
(Guidi et al., 2001). Core subunits, BAF155 and BAF170, are thought to provide 
the protein scaffold that is important for complex assembly (Tang et al., 2010). 
In yeast, inactivation of any single subunit leads to dissolution and subsequent 
inactivation of the complex (Hargreaves and Crabtree, 2011). 
Other known components of the mammalian SWI/SNF complex include 
BAF250a/b, BAF200, BAF180, BAF60a/b/c, BAF57, and BAF53A/B (Reisman et 
al., 2009). Unlike yeast SWI/SNF, the mammalian complex also contains actin or 
actin-related proteins (ARPs). Actin forms a tight complex with BRG1 via the 
conserved N-terminal HAS domain, however its precise function within the 
complex is still unclear (Szerlong et al., 2008). Actin can bind to myosin and act 
as an ADP-exchange factor, thus increase the rate of ATP-hydrolysis by myosin 
(Lymn and Taylor, 1971). Actin and ARPs may serve a similar role within the 
SWI/SNF complex. 
The subunit composition of the human SWI/SNF complex varies dramatically in a 
tissue-specific manner (Wang et al., 1996a). Moreover, using low stringency 
immunoprecipitations and sequential chromatin immunoprecipitations, a recent 
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study has shown that SWI/SNF subunit composition can vary to a great degree 
even within the same cell type. Five different promoters regulated by the 
SWI/SNF complex showed varying subunit occupancy, leading to the proposition 
that each complex may be tailored to specific target requirements (Ryme et al., 
2009). 
 This variability is thought to contribute significantly to the regulation of 
transcriptional programs during development. For example, pluripotent ES cells 
contain the esBAF version of the SWI/SNF complex, which comprises of BRG1, 
BAF155 and BAF53a, but not BRM, BAF170 or BAF53b. This complex is a part of 
the core pluripotency transcriptional network and is essential for ES cell self-
renewal and pluripotency (Ho et al., 2009a; Ho et al., 2009b). Since BRG1 plays 
an essential role in the ES cell compartment, its deletion causes early embryonic 
lethality (Bultman et al., 2000). In contrast, BRM null mice are viable, however 
they show significant elevation in the levels of BRG1, indicating that BRG1 may 
compensate for the loss of BRM (Reyes et al., 1998). 
Differentiation of ES cells into neuronal precursors is associated with an 
activation of BRM and BAF170 and the repression of BAF60b. In post mitotic 
neurons, repression of BAF53a and the activation of BAF53b, BAF45b and BAF45c 
is observed. Preventing this subunit switch impairs neuronal differentiation. 
Thus, varying the subunit composition of SWI/SNF complexes can lead to specific 
alterations in the transcriptional program which is essential for cellular 
differentiation (Lessard et al., 2007). 
1.3.2 ATP-hydrolysis, structure of SWI/SNF and mechanisms of 
remodelling 
Human BRG1 is approximately 74% identical to human BRM, 52% identical to 
Drosophila BRM and 33% identical to yeast swi2/snf2 (Khavari et al., 1993; 
Reisman et al., 2009). All snf2-family proteins contain a DNA-dependent ATPase 
domain. Early experiments showed that the addition of dsDNA causes more than 
a five-fold increase in the ATPase activity of recombinant swi2/snf2 (Laurent et 
al., 1993). The snf2 gene family is homologous to many helicases of the DEAD/H 
family and all its members contain seven conserved helicase-related motifs 
within the ATPase domain. These motifs enable snf2 proteins to specifically 
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recognise regions of double-stranded to single-stranded DNA transition, thus 
allowing SWI/SNF to localise to regions of active replication, repair and 
transcription (Muthuswami et al., 2000). A recent study has shown that the 
ATPase domain is capable of binding independently to DNA or ATP. However, 
only the ATPase domains which bind DNA first are capable of ATP hydrolysis 
(Nongkhlaw et al., 2009). 
 
Figure 1.4: Schematic depicting the domains in the BRG1 and BRM ATPases. 
Human BRG1 and BRM show 74% sequence identity. Multiple minigenes occur within both ORFs, 
however the functions of the resulting proteins are unclear. Both BRG1 and BRM also have an 
alternatively spliced exon [Figure adapted from (Reisman et al., 2009)] 
 
In addition to the ATPase domain, snf2 family members also contain a C-terminal 
bromodomain that binds acetylated lysines on histone tails. However, the 
presence of this bromodomain is not essential for function, since its deletion 
does not affect BRM-mediated transcriptional activation (Muchardt and Yaniv, 
1993; Trouche et al., 1997). Furthermore, a BRM mutant lacking the 
bromodomain was able to fully rescue the BRM knockout phenotype in flies 
(Elfring et al., 1998). BRG1 and BRM also contain a QLQ domain and an Rb-
binding (LxCxE) domain, both of which are involved in protein-protein 
interactions. BRM also contains a polyQ expansion repeat domain, which is not 
found in BRG1. The functional properties of this domain are still unknown 
(Reisman et al., 2009).  
Multiple attempts have been made to determine the structure of the SWI/SNF 
and RSC complexes. The yeast and human RSC complexes are shown to have a 
large central cavity surrounded by four regions of high density. The central 
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cavity is large enough to accommodate an entire nucleosome (Tang et al., 2010). 
However, the yeast SWI/SNF seems to be structurally different, as it contains an 
asymmetric shallow surface trough with dimensions matching the contour of a 
nucleosome. DNA footprinting and protein crosslinking experiments revealed 
that SWI/SNF subunits within and around the surface trough make extensive 
contacts with the DNA and the histone octamer. The catalytic Swi2/snf2 subunit 
contacts the nucleosomal DNA two helical turns from the dyad axis and also 
interacts with the histone octamer. SNF5 binds the DNA only weakly, but makes 
multiple contacts with the histone core (Dechassa et al., 2008; Tang et al., 
2010).  
Based on the structural and interaction data, a model for the remodelling 
activity of the SWI/SNF complex was proposed (Figure 1.5). The remodelling 
begins with a ~20bp translocation of SWI/SNF along the nucleosomal DNA 
towards the dyad axis. The DNA between the translocation site and an anchor 
point on the other side of the trough is displaced from the nucleosome, forming 
a loop. The translocation and the loop formation steps are thought to require 
ATP hydrolysis. This loop then propagates through the nucleosomal DNA causing 
the nucleosome to slide along the DNA (Dechassa et al., 2008). In addition to 
this, the extensive contacts made by the SWI/SNF complex with the nucleosome 
may also cause large disruptions in the nucleosome-DNA interactions and may 
facilitate the complete dissociation of the nucleosome by histone chaperones 
(Tang et al., 2010).  
1.3.3 Transcriptional regulation by SWI/SNF 
SWI/SNF has been linked to the activities of a large number of transcriptional 
regulators including Rb, c-MYC, p53, AP-1, EKLF, TGFβ, Myo-D, Sox2, Utf1 and 
Oct4. SWI/SNF has also been functionally linked to transcriptional regulation by 
various steroid receptors (Reisman et al., 2009). The best characterised 
interaction of SWI/SNF is with the retinoblastoma protein (Rb). As previously 
mentioned, the ATPases BRG1 and BRM both contain an Rb-binding (LxCxE) 
domain. BRG1 was shown to bind directly and specifically to hypo-
phosphorylated Rb in a yeast two-hybrid screen and by co-immunoprecipitation 
experiments (Dunaief et al., 1994).  
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Figure 1.5: Schematic model for the chromatin remodelling activity of the SWI/SNF complex. 
The SWI/SNF complex contains a central trough that makes multiple contacts with the 
nucleosome. The left arm of the complex depicts the higher wall of the trough (a). A 20bp 
translocation of the left arm leads to disruptions in the DNA-histone contacts causing the formation 
of a loop (b). This step is thought to require ATP hydrolysis and is necessary for the remodelling 
activity. The loop propagates around through the nucleosome and exits through the lower wall of 
the trough depicted by the right arm (c-d). This causes a unidirectional displacement of the 
nucleosome along the DNA (e)(Dunaief et al., 1994). 
 29 
The interaction with BRG1/BRM is required for Rb induced cell cycle arrest. 
Constitutively active Rb is unable to cause cell cycle arrest in BRG1- and BRM-
deficient cells. This defect can be rescued by co-expressing BRG1, but not an 
LxCxE mutant form of BRG1 (Zhang et al., 2000). Moreover, SNF5-induced G1 
arrest in SNF5-deficient cells was also found to depend upon the presence of 
functional Rb (Versteege et al., 2002). Rb co-operates with SWI/SNF to repress 
the activity of E2F1 transcription factors (Trouche et al., 1997). Conditional 
inactivation of SNF5 was shown to alter expression of various Rb-E2F-regulated 
genes (Guidi et al., 2006). The Rb repressor complex is found to contain HDACs 
and SWI/SNF, which together repress the transcription of cyclins-E and -A. 
Hyper-phosphorylation of Rb by cyclin-D-CDK4 causes the disruption of the Rb 
repressor complex, allowing E2F1 to induce cyclin-E, which enables S-phase 
entry (Zhang et al., 2000). 
Despite this, direct interaction with Rb may not be necessary for SWI/SNF to 
regulate the cell cycle. Re-expression of BRG1 and SNF5 in deficient cells was 
found to induce p21 and p16 respectively, both of which inhibit Rb 
phosphorylation by CDKs (Kang et al., 2004; Oruetxebarria et al., 2004). There is 
also functional interaction between SWI/SNF and p53. BAF53 binds p53, and 
SWI/SNF activity is required for p53-mediated cell cycle control (Wang et al., 
2007). Knockdown of SNF5 was found to cause cell cycle arrest and apoptosis in 
a p53-dependent manner (Kato et al., 2007).  
SWI/SNF is also required for transcriptional transactivation by c-MYC. A repeat 
domain of SNF5 was found to directly interact with the C-terminal region of c-
MYC. Mutations in either SNF5 or BRG1 abrogate the ability of c-MYC to 
transactivate its target loci (Cheng et al., 1999). Moreover, BAF53 also binds c-
MYC and is critical for c-MYC oncogenic activity (Park et al., 2002). Thus, 
SWI/SNF complex is involved in genome-wide transcriptional regulation and has a 
critical role in cell growth and proliferation. 
ChIP-sequencing analysis has shown that SWI/SNF localises near transcription 
regulatory elements, including enhancer sequences and regions critical for 
chromosome organisation, for example CTCF binding sites and replication 
origins. Gene-specific analysis and genome-wide assays suggest the involvement 
of SWI/SNF complex in cell cycle control and chromosomal organisation 
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(Euskirchen et al., 2011). Taken together, the available data suggests that the 
SWI/SNF complex is a master regulator of gene expression. 
1.3.4 SWI/SNF and cancer 
Many components of the SWI/SNF complex are lost, mutated or silenced in 
multiple cancers. SNF5 is a bona fide tumour suppressor, the homozygous loss of 
which leads to highly aggressive paediatric rhabdoid tumours (Versteege et al., 
1998). SNF5 is also found deleted in both chronic and acute phase CML (Grand et 
al., 1999). Heterozygous knockout of SNF5 causes tumours in mice that are 
similar to human malignant rhabdoid tumours (MRT). Conditional deletion of 
SNF5 in mice leads to lymphomas or rhabdoid tumours with 100% penetrance 
within 10 weeks (Roberts et al., 2002).  
Relative to SNF5, the ATPase subunits of SWI/SNF are lost in a greater number of 
human tumours. BRG1 and BRM expression is lost in lung, bladder, colon, breast, 
melanoma, esophageal, head/neck, pancreas and ovarian cancers [reviewed in 
(Reisman et al., 2009)]. Consistent with these data, BRG1+/- mice acquire 
mammary tumours within one year (Bultman et al., 2008). However, the tumour 
phenotype observed is significantly different from that in the SNF5+/- mice, 
indicating that these two proteins are not functionally equivalent. Loss of BRM, 
although non-transforming in mice, was found to cause distinct abnormalities in 
cell cycle control. Moreover, BRM heterozygote and null mice showed a 
significant increase in the number of lung tumours when treated with the 
carcinogen urethane (Glaros et al., 2007). The interplay of SWI/SNF with various 
tumour suppressors and oncoproteins may contribute significantly to its tumour 
suppressor activity. However, the mechanistic details of this activity are still 
unclear and more work is required in order to understand these. 
 31 
1.4 DNA Methylation 
DNA methylation is an epigenetic modification found in both prokaryotic and 
eukaryotic genomes. The occurrence of a methyl group at the 5th position of the 
cytosine nucleotide ring was first proposed by Wheeler and Johnson in 1904 
(Figure 1.6). Naturally occurring 5-methylcytosine (5mC) was first discovered by 
Johnson and Coghill in 1925, following hydrolysis of nucleic acids from Tubercule 
Bacillus (Johnson and Coghill, 1925). In prokaryotes, both cytosine and adenine 
residues are found to be methylated, whereas in multicellular eukaryotes only 
cytosine bases are methylated. In human somatic cells, 5mC constitutes 1% of all 
DNA bases and usually occurs in the context of CpG dinucleotides (meCpG) 
(Ehrlich et al., 1982; Ehrlich and Wang, 1981; Gruenbaum et al., 1981).  
Non-CpG methylation is widely prevalent in plants and forms a part of the host 
restriction system which protects the plant genome from foreign DNA (Finnegan 
et al., 1998). Non-CpG methylation in mammals is limited to the ES cell 
compartment and was initially recognised in mouse ES cells (Ramsahoye et al., 
2000). Recently, the single-base-resolution map of the human DNA methylome 
revealed that nearly a quarter of DNA methylation in human ES cells exists at 
non-CpGs (Lister et al., 2009). This methylation is lost in differentiated cells, 
and is thought to have a role in maintaining stem cell pluripotency. The recent 
discovery of 5-hydroxymethylcytosine (hmC)(Figure 1.6), which occurs by 
hydroxylation of 5mC by Tet enzymes, adds to the repertoire of identified 
cytosine modifications (Tahiliani et al., 2009). Preliminary evidence suggests 
that hmC is involved in pluripotency, differentiation and carcinogenesis (Munzel 
et al., 2011). However, only meCpG and the associated literature will be 
discussed here. 
 
Figure 1.6: Molecular structures for 5-methylcytosine and 5-hydroxymethylcytosine 
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CpG methylation is essential for genomic imprinting, X-chromosome inactivation 
and spatiotemporal regulation of transcription during embryogenesis. It is also 
thought to be necessary for immobilization of mammalian retrotransposons, 
minimising genomic transcriptional noise and regulation of tissue specific 
transcriptional programmes (Bird and Wolffe, 1999). Despite these useful 
properties, the major hazard of the presence of 5mC is its mutability. 
Spontaneous deamination of cytosine results in uracil, which being an alien DNA 
base, is recognised by uracil glycosylases and corrected back to cytosine. 
However, deamination of 5mC leads to the formation of thymidine, which being 
a genuine DNA component is inefficiently repaired (Duncan and Miller, 1980). 
Glycosylases that can act on T:G mismatches have been identified, but due to 
the high frequency of deamination (approximately four C to T transitions per day 
in germ cells) mismatches are not always repaired (Millar et al., 2002). 
Due to this high mutability, most regions of vertebrate genomes are distinctly 
devoid of CG dinucleotides. However, there are punctuated CpG-rich regions 
called CpG islands (CGIs). These ~1000 bp sequences have 10 times higher CpG 
content than the bulk genomic DNA, but these CpGs are distinctly devoid of 
methylation (Bird et al., 1985). This lack of DNA methylation has recently been 
attributed to the action of Tet1 enzymes and hmC, which were shown to 
preferentially associate with CGIs in mouse ES cells (Wu et al., 2011). CGIs 
contain unstable nucleosomes, and are found to be associated with origins of 
replication and transcription start sites. Proteins containing a “CXXC” motif 
specifically recognise unmethylated CpGs. Cfp1 (CXXC finger protein 1), a 
component of the Set1/COMPASS complex, localises at the vast majority of CGIs 
and causes high levels of H3K4me3 at these elements. This H3K4 methylation 
allows transcription initiation even at ‘orphan’ promoter-less CGIs (Deaton and 
Bird, 2011). Adrian Bird described CGIs as ‘beacons for transcriptional initiation’ 
(Personal communication). 
1.4.1 DNA methyltransferases 
Methylated CpGs are not randomly distributed throughout genomes and this 
observation suggests that DNA methylation is an enzymatic process. In vitro 
assays revealed that DNA polymerases are unable to distinguish between 
unmethylated and methylated cytosines, indicating that cytosines already 
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incorporated into DNA are methylated by an enzyme. The first DNA methylase 
was identified in E.coli and was shown to use AdoMet as the methyl donor (Gold 
et al., 1966). 
It is now well-established that two different types of DNA methyltransferases 
(DNMTs) exist within mammalian cells: de novo methyltransferases and 
maintenance methyltransferases. Timothy Bestor and co-workers purified the 
first mammalian DNA methyltransferase from Friend murine erythroleukemia 
cells and named it DNMT1 (Bestor and Ingram, 1983). Initially its de novo 
methylation activity was identified, however further biochemical studies 
revealed that it has an increased preference for hemimethylated DNA. This was 
unlike the previously identified prokaryotic DNA methylases, which do not 
distinguish between hemimethylated and unmethylated DNA. The cloning and 
sequencing of mouse DNMT1 revealed a C-terminal catalytic domain which is 
similar to its prokaryotic counterparts. However, the mammalian enzyme also 
has a large N-terminal domain which is absent from the bacterial enzyme (Bestor 
et al., 1988; Lei et al., 1996). This N-terminal domain is thought to be 
responsible for the preference for hemimethylated DNA that has earned DNMT1 
its classification as the maintenance methyltransferase.   
Methylation maintenance refers to the process that maintains methylation 
patterns following DNA replication. The parental DNA strand retaining its 
methylation is used as a template for the methylation of the newly synthesised 
daughter strand. The palindromic nature of the CpG dinucleotide allows for the 
faithful reproduction of the methylation patterns onto the nascent daughter 
strands. The N-terminal domain of DNMT1 contains a replication fork targeting 
domain, which is responsible for its association with the replication fork (Liu et 
al., 1998). DNMT1 binds proliferating cell nuclear antigen (PCNA), an auxiliary 
factor for DNA replication, thus tightly coupling DNA methylation with 
replication (Chuang et al., 1997).  
DNMT1 knockout (Dnmt1-/-) mice were reported to be embryonically lethal, 
however ES cells carrying this mutation showed no detectable effect on viability 
or proliferation in culture (Li et al., 1992). In contrast to ES cells, differentiated 
cells do not tolerate the loss of DNMT1 well. Deletion of DNMT1 in proliferating 
neural cells leads to functional impairment and poor survival (Fan et al., 2001). 
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Fibroblast cells undergo apoptosis in the absence of DNMT1, through a p53-
dependent mechanism (Jackson-Grusby et al., 2001). 
DNMT2 is the most conserved of all known cytosine methyltransferases. It lacks 
the N-terminal recognition domains and more closely resembles bacterial DNA 
methylases. The strong conservation of all catalytic motifs indicates that DNMT2 
should be a DNA cytosine methyltransferase; however, it does not show any in 
vitro or in vivo DNA methylation activity (Okano et al., 1998). There is recent 
evidence to suggest that DNMT2 may be involved in tRNA methylation (Goll et 
al., 2006) and RNA processing during cell stress (Thiagarajan et al., 2011). 
Moreover, DNMT2 has also been shown to have a role in retrotransposon silencing 
and telomere integrity in Drosophila somatic cells (Phalke et al., 2009).  
Pre-implantation embryos show a dramatic drop in 5mC levels between the 8-
cell and blastocyst stages, which is a consequence of the exclusion of DNMT1 
from the nucleus. Following this, there is a rapid gain in 5mC levels and adult 
levels are reached by gastrulation (Carlson et al., 1992). The de novo DNMTs 
(mammalian DNMT3 family), as their name suggests, are responsible for 
establishing novel genomic DNA methylation patterns. DNMT3a and DNMT3b are 
highly expressed during early embryogenesis when most of the de novo 
methylation occurs and their deletion leads to impaired embryonic development 
(Lei et al., 1996). DNMT3a and DNMT3b do not show any preference for 
hemimethylated over fully unmethylated DNA substrate, which reflects their de 
novo methylation function (Okano et al., 1998). It has been proposed that they 
may also play a role in the maintenance of methylation (Hsieh, 2005; Liang et 
al., 2002). DNMT3a and DNMT3b double-knockout ES cells show disruption of de 
novo methylation; however, this does not cause demethylation at imprinted loci 
(Okano et al., 1999).  
The third member of the DNMT3 family, DNMT3L, is expressed specifically in 
germ cells and lacks the methyltransferase activity. However, DNMT3L was 
shown to be crucial for establishment of genomic methylation imprints. DNMT3L-
null females show a loss of methylation from imprinted regions of the genome, 
whereas null males are sterile with a complete absence of germ cells (Bourc'his 
et al., 2001). DNMT3L has been shown to stimulate the activities of DNMT3a and 
DNMT3b by direct interaction (Suetake et al., 2004). DNMT3L was shown to 
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interact with histone H3 tails with unmethylated K4 residues and target de novo 
methylation (Ooi et al., 2007). DNMT1 and DNMT3 family members are thought 
to interact with each other and together they establish genomic methylation 
patterns (Kim et al., 2002). 
1.4.2 DNA methylation and transcriptional repression 
Evidence accumulated over the past three decades suggests that DNA 
methylation plays an important role in transcriptional silencing. There are two 
primary ways in which the presence of meCpG is thought to suppress 
transcription. The first way is by reducing the affinity of transcription factors for 
their cognate DNA recognition sequences (Bird and Wolffe, 1999; Watt and 
Molloy, 1988). Many transcription factors have GC-rich binding sites and the 
presence of a methyl moiety may sterically hinder the specific contacts required 
for their recruitment to this target DNA (Figure 1.7a). Even though it doesn’t 
alter the structure of the double helix significantly, the presence of the methyl 
group reduces the flexibility of the DNA molecule. Many transcription factors 
require bending of the DNA for successful binding and the increased inflexibility 
may impede bending of methylated DNA (Derreumaux et al., 2001). However, 
certain transcription factors, for example SP1 and CTF, are unperturbed by 
methylation of their recognition sequences (Ben-Hattar et al., 1989).  
The second way in which DNA methylation can inhibit transcription is through 
the recruitment of methylated DNA-binding proteins (MBPs) (Figure 1.7 b). 
MeCP2 was the founding member of this family of proteins and was 
demonstrated to possess a methyl CpG-binding domain (MBD) sequence motif 
that is sufficient and necessary for 5mC binding (Lewis et al., 1992; Nan et al., 
1993). MeCP2 is found to be concentrated on methylation-rich pericentromeric 
heterochromatin in mouse cells. On the other hand, MeCP2 shows a much more 
diffused chromosomal localisation in human or rat cells which do not contain 
highly methylated satellite DNA (Nan et al., 1997). This chromosomal 
localisation of MeCP2 is disrupted in Dnmt1 mutant mouse ES cells, indicating 
that it specifically binds methylated DNA (Nan et al., 1996). 
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Figure 1.7: Modes of transcriptional repression by DNA methylation 
DNA methylation can inhibit transcription by a) inhibiting transcription factor (TF) binding to its 
cognate recognition element (RE) and/or b) recruiting methylated DNA-binding proteins and 
associated inhibitory complexes [Adapted from (Klose and Bird, 2006)] 
 
The role of MeCP2 in transcriptional repression was first demonstrated in vitro 
where it significantly repressed transcription from methylated promoters. This 
repression seemed to depend on the presence of its central transcriptional 
repression domain (TRD)(Nan et al., 1997). MeCP2 was also found to associate 
with DNMT1, suggesting a close co-ordination between DNA methylation and 
transcriptional repression following DNA replication (Kimura and Shiota, 2003). 
Despite this, imprinted genes that are known to be misexpressed in the absence 
of DNMTs are not misexpressed in the absence of MeCP2. This suggests that 
MeCP2 is not the only MBP recruited by DNA methylation patterns.  
Indeed a sequence homology search with the MBD domain of MeCP2 revealed the 
presence of MBD1 in 1997 (Cross et al., 1997), followed by MBD2, MBD3 and 
MBD4 in 1998. All these new members, except MBD3, were shown to have 
specific methylated DNA-binding activity in vitro and in vivo. None or very low 
levels of MBP transcripts are detected in ES cells, except MBD3 transcripts can 
clearly be detected in all cell types (Hendrich and Bird, 1998). MBD3-null mice 
show early embryonic lethality, whereas MBD1 and MBD2 is dispensable for 
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mouse development and viability (Hendrich et al., 2001). MBD3 seems different 
to other MBPs and how MBD3 is targeted to its chromosomal loci was a mystery 
for a long time. However, some years ago, MBD3 was shown to interact with c-
Jun in a yeast two hybrid screen (Nateri et al., 2004). Recently, the same group 
went on to show that unphosphorylated c-Jun recruits MBD3 to AP-1 target genes 
to inhibit expression, and this repression is relieved by c-Jun N-terminal 
phosphorylation by Jun-kinases (Aguilera et al., 2011). 
MeCP2 has a 75 amino acid MBD domain, the disruption of which eliminates the 
chromosomal localisation of the protein. The MBD domain is the only common 
sequence feature amongst the MBP family members, the exception being MBD2 
and MBD3 which are highly homologous (Dhasarathy and Wade, 2008). The MBD 
motifs from various species form a very similar, wedge-shaped structure. One 
side of the wedge is formed of beta sheets and the other side contains a short 
alpha helix (Dhasarathy and Wade, 2008). The recognition of meCpGs is due to 
four highly conserved residues: two arginines, an aspartic acid and a tyrosine. 
These form a hydrophilic patch that makes contacts within the major grove of 
the DNA. These contacts were found to be mediated by several highly structured 
water molecules. Thus, the MBD domain recognises hydration of the major 
groove of methylated DNA rather than cytosine methylation per se (Ho et al., 
2008). MBD2 was recently shown to bind its target sequence in a single 
orientation. This binding orientation was reversed by partially reversing the 
sequence surrounding the meCpG. Moreover, a guanine residue directly following 
the meCpG significantly reduced the binding affinity. These data suggest the 
binding preferences of MBPs may also depend on sequences surrounding the 
meCpG (Scarsdale et al., 2011). 
MBD1 was found to be recruited to both methylated and non-methylated CpGs. 
In addition to the MBD domain, MBD1 was found to contain three CXXC motifs 
that enable its binding to non-methylated CpGs. However, only one of these 
CXXC copies is conserved and able to bind DNA, while the other two may have 
roles in protein-protein interactions (Jorgensen et al., 2004). Point mutations in 
the CXXC domains that completely abolish unmethylated CpG binding, do not 
alter MBD1 binding to its target genes via the MBD domain. Thus, despite having 
binding preferences distinct from MBD2 and MeCP2, these findings suggest that 
MBD1 is primarily a methyl CpG binding protein (Clouaire et al., 2010). 
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There are two reports in the literature where MBD4 has been associated with 
transcriptional repression of methylated p16INK4a and hMLH1 genes (Fukushige et 
al., 2006; Kondo et al., 2005). However, the role of MBD4 in genome-wide 
transcriptional repression is still questionable (Hendrich and Bird, 1998). Aside 
from the MBD domain, it has a glycosylase domain which was shown to be 
involved in repair of the G:T and G:U mismatches resulting from deamination of 
5mC and C residues. Due to this function, MBD4 is considered a crucial 
component of the base excision repair machinery (Aziz et al., 2009). 
The Kaiso family of transcription factors are the newest members of the MBP 
family. Kaiso was identified as a p120 catenin binding partner using a yeast two-
hybrid screen. Sequence analysis revealed that the Kaiso protein contained an N-
terminal BTB/POZ protein-protein interaction domain and three C-terminal DNA-
binding zinc fingers (Daniel and Reynolds, 1999). Further studies have shown 
that Kaiso behaves as a methylation-dependent transcriptional repressor and 
preferentially recognises two concurrent meCpG residues (Prokhortchouk et al., 
2001). In vivo, Kaiso is required to maintain DNA methylation-dependent 
transcriptional silencing during early Xenopus development (Ruzov et al., 2004). 
p120-catenin is usually bound to E-cadherin and regulates its function and 
stability. However, following Wnt-stimulated phosphorylation, p120 is released 
from E-cadherin and associates with Kaiso (Del Valle-Perez et al., 2011). This 
association leads to nuclear export of Kaiso and enabling its binding to 
methylated CpGs at repressed promoters (Zhang et al., 2011). Thus, Kaiso 
provides a bridge between membrane signalling and DNA methylation-dependent 
transcriptional repression. Moreover, Kaiso has been shown to localise at the 
mitotic spindle and the centrosome, suggesting that Kaiso’s transcriptional 
regulation may be linked to the control of the cell cycle (Soubry et al., 2010). 
1.4.3 DNA methylation and chromatin 
There is a clear bidirectional relationship between the DNA methylation and 
histone modification systems. It has been known for a long time that DNA 
methylation can influence histone modification patterns. DNA methylation levels 
of human HGMT gene variants demonstrated a direct correlation with their 
promoter accessibility and inverse correlation with their expression. This early 
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observation suggested that DNA methylation could effect the chromatin 
environment and thus influence transcription (Davey et al., 1997).  
DNA methylation was shown to directly influence the positioning of nucleosomes 
at specific sequences in vitro (Davey et al., 1997). The transcription inhibition 
activity of MBPs is closely linked with their ability to recruit inhibitory chromatin 
complexes through their TRDs. The transcriptional repression by MeCP2 was 
found to involve Sin3A/HDAC co-repressor complex (Nan et al., 1998). MeCP2 
TRD directly interacts with and recruits Sin3A, HDAC1 and HDAC2 to target loci. 
The transcriptional repression by MeCP2 can be alleviated by treatment with 
HDAC inhibitor trichostatin A (TSA) (Jones et al., 1998). MeCP2 has also been 
shown to co-immunoprecipitate with the BRM subunit of the SWI/SNF chromatin 
remodelling complex, which subsequently inhibits the transcription of the 
methylated genes (Harikrishnan et al., 2005).  
MBD3 was identified as one of the seven subunits of the Mi-2/NuRD HDAC 
complex along with Swi2/Snf2 helicase/ATPase domain containing Mi2, HDAC1 
and HDAC2 (Zhang et al., 1998). MBD2 has also been shown to interact with Mi-
2/NuRD (Zhang et al., 1999) and Sin3A complexes (Boeke et al., 2000). Kaiso co-
purifies with NCoR complex containing HDAC3, whereas Kaiso-like protein 
ZBTB38 has been shown to interact with several HDACs and co-repressor CtBP 
(Clouaire and Stancheva, 2008). 
MeCP2 TRD was also shown to interact with proteins showing histone 
methyltransferase activity (Fuks et al., 2003b). However, this interaction could 
be mediated by DNMT1, since MeCP2 interacts with DNMT1 (Kimura and Shiota, 
2003) and DNMT1 has been shown to interact with SUV39H1 (Fuks et al., 2003a). 
Treatment with 5-azacytidine, a cytosine analogue that inhibits DNMTs, was 
shown to cause a loss of H3K9 methylation at the p14ARF/p16INK4α locus (Nguyen 
et al., 2002). MBD1 has also been shown to associate with SETDB1, SUV39H and 
HP1 (Fujita et al., 2003). MBD1 was found to recruit SETDB1 to newly replicated 
DNA and facilitate methylation of H3-K9, thus coupling DNA and histone 
methylation (Sarraf and Stancheva, 2004). There seems to be a direct link 
between DNA methylation and H3K9 methylation. 
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Genomic analysis has revealed strong inverse correlation of DNA methylation 
with H3K4 methylation, while finding no correlation with methylation of H3K27 
(Laurent et al., 2010). In contrast to meCpG, unmethylated CGIs are found to be 
enriched for H3K4 methylation and lack H3K9 methylation (Deaton and Bird, 
2011). The maintenance of this reciprocal methylation of H3K4 and H3K9 in 
response to the DNA methylation state is intriguing. It could be due to different 
preferences in histone methylases recruited by MBD and CXXC protein families. 
However, Jumonji proteins are thought to contribute considerably to this inverse 
correlation. For example, PHF8 contains an N-terminal PHD domain that binds 
H3K4me3 and a Jumonji domain that demethylates H3K9me2 (Loenarz et al., 
2010). JARID Jumoji family proteins bind H3K9me3 and demethylate H4K4Me3 
(Iwase et al., 2007).  
Thus DNA methylation recruits chromatin-associated repressors such as HDACs, 
HKMTS and HP1 through MBPs. However, the inverse influence of chromatin 
modification on DNA methylation has also become clear (Cheng and Blumenthal, 
2010). H3K9 methylation has been shown to be required for recruitment of 
DNMTs via their interactions with G9a, GLP, SUV39H1 and HP1 at various loci 
(Cheng and Blumenthal, 2010; Fuks et al., 2003a; Lehnertz et al., 2003). A loss 
of DNA methylation in DNMT knockout cells does not lead to reduction in 
H3K9me3 levels (Dong et al., 2008; Lehnertz et al., 2003; Matsui et al., 2010), 
implying that H3K9 methylation is not dependent on the presence of meCpG as 
previously observed following 5-azacytidine treatment (Nguyen et al., 2002). In 
addition to this, a Snf2 family ATPase, LSH, was also found to be required for 
efficient DNA methylation. LSH was found to cooperate with G9a and facilitate 
histone and DNA methylation at target loci (Myant et al., 2011). 
Methylation of H3K4 is thought to inhibit de novo methylation by suppressing the 
chromatin binding of DNMT3L (Ooi et al., 2007), DNMT3a and DNMT3b (Zhang et 
al., 2010). The de novo DNMTs were also shown to be catalytically less active on 
H3K4 methylated chromatin compared to unmodified or H3K9 methylated 
chromatin (Zhang et al., 2010). Despite this, orphan CGIs that show high levels 
of H3K4me3 are only partially resistant to DNA methylation, indicating that H3K4 
methylation may not be sufficient for protecting gene promoters from DNA 
methylation (Thomson et al., 2010). The presence of transcriptional apparatus 
may also be required to provide complete immunity from DNA methylation 
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(Deaton and Bird, 2011). Thus, the relationship between DNA methylation and 
histone modifications is a complex bidirectional affair. 
1.4.4 DNA Demethylases 
DNA methylation levels in somatic cells do not fluctuate much. However, during 
embryonic development and reprogramming during gametogenesis, there is a 
requirement for DNA methylation to be in a spatiotemporal flux. DNA 
demethylation is also thought to be important during immune response, 
neurogenesis and tumorigenesis. This defined demethylation must require an 
active removal of the 5mC mark (Zhu, 2009). In contrast to the well known 
processes of DNA methylation, the enzymatic chemistry responsible for the 
removal of the methyl moiety from DNA was unknown for a long time. The 
chemistry necessary for active demethylation is energetically challenging and 
requires the disruption of a carbon-carbon bond.  
Passive loss of meCpG through mutagenesis and spontaneous deamination were 
the only candidate mechanisms for DNA demethylation until the discovery of the 
first mammalian demethylase, MBD2b, in 1999 (Bhattacharya et al., 1999). 
MBD2b was shown to have DNA demethylase activity in vitro, however, this 
turned out to be “a red herring” and the findings could not be replicated by 
other groups (Boeke et al., 2000). Moreover, mice with mutant MBD2b show 
normal embryonic demethylation phases (Santos et al., 2002).  
Another proposed mechanism for DNA demethylation is through base excision 
repair (BER), which is initiated by DNA glycosylases. MBD4 has been found to 
have DNA glycosylase activity that cleaves the glycosidic bond between the 5mC 
base and the deoxyribose. An endonuclease removes the deoxyribose and the 
gap is then filled in by the BER machinery. A thymine DNA glycosylase (TGD) has 
also been shown to have DNA glycosylase activity. However, both MBD4 and TGD 
show low in vitro glycosylase activity and much stronger G:T mismatch repair 
activity. Furthermore, no defect in DNA methylation was observed in MBD4 
knockout mice (Zhu, 2009). However unlike other DNA glycoslases, knockout or 
catalytic inactivation of TDG leads to enryonic lethality in mice (Cortellino et 
al., 2011). TGD-/- MEFs show imbalanced histone modification and CpG 
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methylation at promoters of multiple genes with altered transcription (Cortazar 
et al., 2011).  
Active enzymatic deamination of 5mC may also contribute to DNA 
demethylation. As previously stated, Tet1 enzymes deaminate 5mC and the hmC 
produced by this action can be reverted back to cytosine by DNA glycosylases 
and BER (Guo et al., 2011; Wu et al., 2011). DNMT1 cannot recognise 
hydroxymethylation a property which will also facilitate passive DNA 
demethylation (Zhu, 2009). Both DNMT3a and DNMT3b have also been found to 
deaminate meCpGs in vitro, thus contributing to DNA demethylation (Metivier et 
al., 2008). Moreover, DNMT3b was recently shown to interact with TGD and 
MBD4 and enhance their mismatch repair efficiency (Boland and Christman, 
2008). Thus, de novo methyltransferases seem to have yet another function. 
Deamination coupled with mismatch repair seems to be the two step mechanism 
required for active demethylation in cells.  
1.5 Short Interspersed nucleotide elements 
The earliest reports of mammalian repetitive DNA date back to 1959, when Paul 
Doty and colleagues fractionated mammalian genomic DNA by centrifugation 
through density gradients and reported the presence of discrete satellite 
fractions (Sueoka et al., 1959). Following these initial studies, multiple groups 
embarked on the quest to characterise this fraction (Kit, 1961; Waring and 
Britten, 1966). Repetitive sequences were consequently shown to occupy large 
proportions of mammalian genomes (Britten and Kohne, 1970). Electron 
microscopy (Wu et al., 1972) and CsCl equilibrium sedimentation (Kram et al., 
1972) indicated an interspersion of repetitive sequences in Drosophila DNA. 
However, it was not until 1973 that the existence of interspersed genomic 
repeats was clearly demonstrated by Roy Britten and co-workers. Using various 
physiochemical techniques that exploited the different thermodynamic 
properties of repeat sequences, they provided evidence for the presence of 
interspersed repeat sequences in Xenopus (Davidson et al., 1973) and sea urchin 
genomes (Graham et al., 1974). 
In 1975, Carl Schmid entered the stage and published back-to-back reports with 
Paul Britten studying the interspersion of unique single copy and repetitive DNA 
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in sea urchin and Drosophila genomes (Davidson et al., 1975; Manning et al., 
1975). By the end of that year, Schmid et al, using C0t renaturation values, 
thermal elution and thermal hyperchromism, had demonstrated that at least 52% 
of the human genome consists of long interspersed single copy sequences of an 
average length of 2kb and their shorter counterparts, with the average length of 
0.4kb (Schmid and Deininger, 1975). Approximately a third of the short 
interspersed repeats where shown to exist as inverted repeats. HeLa nuclear 
RNA was also found to contain 300nt inverted repeats that are resistant to 
single-strand specific nucleases (Fedoroff et al., 1977; Jelinek et al., 1974a); 
these were later attributed to transcription from the inverted nucleotide 
repeats. At least half of the human 300bp inverted repeats were found to have a 
site for AluI restriction endonuclease; thus, they were named the Alu family of 
SINEs. Early estimates predicted that the Alu SINEs populate at least 3% of the 
human genome and with 500,000 copies were dispersed over 30-60% of the 
genome (Houck et al., 1979). Following the publication of the partial nucleotide 
sequence of Alu SINEs in 1980 (Rubin et al., 1980), various primate genomes 
were also shown to contain related repeat families (Houck and Schmid, 1981).  
At the same time, Kramerov et al screened for DNA sequences complementary to 
pre-mRNA with double-stranded ‘fold back’ structures and discovered the 
murine B1 and B2 repeats (Kramerov et al., 1979). They predicted that these 
repeats were present in excess of 105 copies in the mouse genome. Nucleotide 
sequence of B1 SINEs was found to be similar to that of the human Alu sequences 
(Krayev et al., 1980), whereas B2 repeats were found to have a different 
sequence. The authors suggested that B1 and B2 repeats may have possible roles 
in genome organisation, DNA replication and pre-mRNA processing (Krayev et al., 
1982). William Ramsey and co-workers used a computational approach to show 
that murine B2 elements were derived from a tRNA sequence. The B2 elements 
have a 5' tRNA lysine-like sequence and terminate in a relatively divergent 3' A-
rich sequence. The presence of the internal tRNA promoter was suggested to 
drive transcription by Pol III (Lawrence et al., 1985).  
Sequence comparisons showed that T1 RNase resistant double stranded ‘fold 
back’ RNA are comprised in part of Alu transcripts (Jelinek et al., 1974b; Rubin 
et al., 1980). Alu sequences were estimated to comprise 18-25% of HeLa nuclear 
RNA (Fedoroff et al., 1977). The presence of Alu sequences in the human v-sis 
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gene (Dalla-Favera et al., 1981) and two B1 sequences in rat growth hormone 
genes (Gutierrez-Hartmann et al., 1984; Page et al., 1981) provided specific 
examples where SINEs are transcribed by Pol II. Thus, it was clear that SINEs 
could be ‘read through’ by Pol II as a part of an mRNA molecule.   
However, previous in vitro transcription assays had shown that cloned human 
DNA containing β-globin genes could be transcribed by Pol III from a 
transcription unit located approximately 1500bp upstream of the TSS (Duncan et 
al., 1979). Sequence comparison analysis revealed that this transcription unit 
belonged to the Alu SINE family, thus indicating that Alus were transcribed by 
Pol III (Jelinek et al., 1980). Later that year, Alan Weiner reported that 7SL RNA 
could form strong hybrids with Alu DNA; however, these hybrids were imperfect 
and could be digested by T1 RNase (Weiner, 1980). These sequence similarities 
were confirmed when the 7SL cDNA was cloned and sequenced two years later. 
The authors also reported differences between Alu and 7SL sequences; however 
at this point 7SL was thought to be a conserved subset of Alu repeats and the 
observed differences were due to divergent Alu family members (Ullu et al., 
1982). Following two years of sequence homology and conservation analysis it 
was concluded that 7SL was an older conserved parent element from which Alu 
repeats had arisen (Ullu and Tschudi, 1984).  
Our knowledge of the SINE family of repeats has come on in leaps and bounds 
since these early seminal works. It is now well-established that most mammalian 
SINE elements are derived from tRNA genes, except the human Alu and murine 
B1 families, which are derived from the 7SL locus (Daniels and Deininger, 1985; 
Okada, 1991b). SINEs are found throughout mammalian genomes; however, they 
are enriched in the gene-coding euchromatic regions and reside in the negative 
bands in Giemsa/Quinacrine metaphase staining. This is contrary to long 
interspersed nucler repeats (LINEs) that reside in the Giemsa/Quinacrine positive 
bands (Korenberg and Rykowski, 1988). Despite this relative abundance in gene-
rich regions, very few SINEs are found within the 5' noncoding or coding regions 
of exons, where insertions may prove very deleterious. However, there are 
multiple examples of Drosophila, sea urchin, human and mouse SINEs that have 
provided an invaluable source of regulatory variation in evolution by insertions 
into vital regions of the genome (Britten, 1997; Deininger and Batzer, 1999). 
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1.5.1 SINEs and transposition 
Individual Alu repeats are surrounded by short direct repeats and terminate in a 
polyA-rich 3' end. These observations suggest that Alu elements are dispersed 
through an RNA intermediate via retrotransposition (Jagadeeswaran et al., 
1981). With over 1 million insertions, Alu elements are the most abundant 
retrotransposons in the human genome. The completion of whole genome 
sequencing has revealed that Alus comprise around 10% of the human genome 
(Lander et al., 2001; Smit, 1999). On average, there is one Alu insertion 
approximately every 3kb. Surprisingly, Alu elements are estimated to have 
originated only 65 million years ago, and are considered a young retrotransposon 
family. MIR elements, an older SINE family, have been estimated to have arisen 
130 million years ago. However, despite their age, they only show 120,000 
insertions within the human genome (Jurka et al., 1995). Comparatively, Alus 
have shown a phenomenal rate of expansion. Alu family shows 18% sequence 
divergence from the parental 7SL sequence and there is a further 14% sequence 
divergence of various Alu subfamilies from the Alu consensus sequence 
(Deininger and Daniels, 1986). 
B1 and B2 are the most abundant murine SINE families. The mouse SINEs are 
relatively less abundant than the human counterparts, but show higher 
divergence from the parental genes. Mouse B1 elements, with 564,000 repeats, 
show 25% divergence from the murine 7SL sequence and various B1 subfamilies 
show a further 8% divergence from the consensus. Mouse B2 sequences, with 
348,000 repeats, show 34-39% divergence from the parental tRNA, and B2 
subfamilies show a further 10% sequence variability from the consensus 
(Deininger and Daniels, 1986; Waterston et al., 2002). 
It is well-established that the propagation of Alu sequences occurs through the 
process of reverse transcription of a Pol III transcribed Alu RNA via 
retrotransposition. Alu sequences lack protein-coding ORFs. It is believed that 
they piggyback on the LINE retrotransposition machinery. LINE elements code for 
a functional reverse transcriptase, which also shows endonuclease activity (Feng 
et al., 1996; Mathias et al., 1991). This provides the infrastructure required for 
SINE retrotransposition by target-primed reverse transcription (TPRT). The 
endonuclease domain nicks one strand and the exposed 3'-OH is used to prime 
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the reverse transcription. Once the transposon cDNA is fully synthesised, the 
second strand is nicked and the transposition event is completed by ligating the 
5' end of the transposon to the genomic DNA. The short tandem repeats found at 
3' ends of many SINE insertion sites are thought to arise due to addition of 
untemplated nucleotides followed by template switching (Batzer and Deininger, 
2002; Cost et al., 2002; Luan et al., 1993). 
Even though LINE L1 reverse transcriptase exhibits a strong preference for L1 
RNA, Alu elements have been remarkably successful in hijacking it for their own 
means, thus earning the name “a parasite’s parasite” (Schmid, 2003; Wei et al., 
2001). But with 1 million insertions in 65 million years, Alus are more successful 
at transposition compared to L1 elements, which have 500,000 insertions in 160 
million years. So why is Alu ‘in-trans’ transposition better than LINE ‘in-cis’ 
transposition? Firstly, Alu flanking sequences have a conserved endonuclease 
cleavage motif that is highly homologous to the L1 endonuclease motif (Jurka, 
1997). Moreover, the size of the A-rich tail was found to be highly correlated 
with increased transposition of Alu subfamilies (Roy-Engel et al., 2002). Alu RNA 
is known to interact with SRP9 and SRP14 with high affinity (Chang et al., 1996), 
which would enable its interaction with the large ribosomal subunit. This could 
increase the chances of Alu RNA interacting with the nascent L1 reverse 
transcriptase before its L1 RNA counterpart. A longer A-rich tail hanging out of 
the ribosome would improve these chances further (Boeke, 1997; Schmid, 2003). 
LINE L1 codes for two proteins, ORF1p and ORF2p, which are both deemed 
necessary for LINE retrotransposition. However, Alus are only thought to require 
ORF2p, even though the presence of ORF1p is beneficial to their transposition 
(Wallace et al., 2008). This may also provide SINEs with an advantage and 
explain their augmented prevalence compared to LINEs. 
Apart from the Alu family, the MIR family is the other major SINE family resident 
in the human genome. This older family is thought to be transcriptionally and 
transpositionally silent (Smit and Riggs, 1995). MIRs are 260bp tRNA-derived 
sequences and comprise 0.2-0.3% of the human genome (Lander et al., 2001). 
These old elements provide a fossilised record of the period when, prior to the 
expansion of the LINE L1 and its Alu parasite, the genome had to withstand the 
expansion of the LINE L2 and its MIR parasite. The impact of these transposable 
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elements on the evolution of the human genome should not be underestimated 
(Cordaux and Batzer, 2009). 
The rate of Alu expansion has varied throughout primate evolution (Shen et al., 
1991). 65 million years of mutagenesis, methyl CpG deamination (Cooper and 
Krawczak, 1989) and ADAR editing of Alu RNA (Chen and Carmichael, 2008) have 
caused many Alu sequences to diverge significantly from the parental consensus. 
Despite this there is 70% homology between all Alu family members. This 
indicates that not all Alu sequences are capable of transposition, and only a few 
‘master Alu genes’ were responsible for the spread of this SINE family. These 
master genes can be classified into subfamilies depending on 18 individual 
diagnostic mutations. The evolution of each subfamily can be explained by the 
sequential accumulation of alterations and these in turn indicate the age of the 
subfamily (Shen et al., 1991).  
The nomenclature for the Alu subfamilies follows a alphabetical progression 
from the oldest (J) to the intermediate (S) and the young (Y) (Batzer et al., 
1996). Two of the oldest and largest subfamilies, Alu-J and Alu-S, represent 
approximately 83% of all Alu sequences. Alu-S is further sub-divided into Alu-Sx, 
-Sp, -Sq, -Sc and –Sb sub-classes (Jurka and Milosavljevic, 1991; Jurka and Smith, 
1988). Alu-Y is the youngest subfamily and shows the least amount of sequence 
divergence from the master gene. Studying the prevalence of the various 
subfamilies in various primate species has revealed that most Alus originated 60 
to 40 million years ago and the rate of transposition has decreased dramatically 
since then (Shen et al., 1991).  
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1.5.2  SINE DNA and RNA structures 
A typical Alu element has a dimeric sequence, with the left and the right 
monomeric arms linked by a variable length central A-rich linker. Both arms are 
believed to have evolved separately and fused together later to form the 
contemporary dimeric element. Since retrotransposons frequently insert into the 
A-rich tail of other retrotransposons, such a fusion can be easily conceived 
(Okada, 1991a). The sequence of the right arm is very similar to the 7SL 
sequence, except for the loss of 155bp that form the S domain of the 7SL 
molecule. The left arm has the same 155 nucleotides missing, but has undergone 
a further 31bp deletion (Weiner et al., 1986). The 3' end comprises of an A-rich 
tail of variable length (Figure 1.8a). The left arm of the consensus Alu sequence 
has functional A and B-boxes required for the recruitment of Pol III transcription 
apparatus. Moreover, the left arm lacks a terminator sequence and thus allows 
the transcription of the whole element, since the A and B-boxes in the right arm 
are degenerate and non-functional (Batzer and Deininger, 2002).  
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Figure 1.8: DNA sequence schematics and RNA secondary structures of SINEs. 
a) Schematic depicting the DNA sequence and domains of human Alu and murine B1 and B2 
SINEs. Functional A and B-boxes of a Pol III promoter are shown (adapted from (Batzer and 
Deininger, 2002; Krayev et al., 1980; Maraia, 1991)). b) Models for the secondary structures of 
SINE RNA molecules (adapted from (Mariner et al., 2008)).  
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The monomeric mouse B1 sequence is similar to the human Alu right monomer, 
however the internal deletion of the 7SL sequence extends 14nt further. The B2 
SINEs are generally ~190bp long, with a 5' tRNA-like region, followed by a tRNA 
unrelated sequence and an AT-rich tail (Figure 1.8a). Both B1 and B2 elements 
contain functional Pol III promoters; however, they lack conventional Pol III 
transcription terminator sequences (Krayev et al., 1980; Krayev et al., 1982; 
Maraia, 1991; Singh et al., 1985).  
As previously mentioned, SINEs can be transcribed by Pol II as a part of mRNAs. 
Alu sequences were identified in more than 80 fully spliced cDNA sequences, 82% 
of which were located in the 3'-UTRs and 14% in the 5'-UTRs (Yulug et al., 1995). 
It is widely believed that SINE transcription by Pol III is a rare event in vivo 
(discussed further in chapter 3). Human Alu RNA is a ~300nt molecule and its 
secondary structure consists of two 7SL-like arms linked by an A-rich linker 
(Sinnett et al., 1991). Mouse B1 RNA is the monomeric equivalent of one of the 
Alu arms and shows the highly conserved 7SL folding pattern (Labuda et al., 
1991; Maraia, 1991). The B2 RNA has a more complex secondary structure 
consisting of a central bulge, one long arm and three short arms. The long arm is 
made up of three stems, two bulges and a loop (Espinoza et al., 2007) (Figure 
1.8b). 
1.5.3  Functional significance of SINEs 
For a long time, SINEs were considered to be junk filler DNA that was of no 
functional significance; however, this point of view has dramatically altered. 
Several groups have observed that Pol III-derived SINE transcripts are elevated 
following cell stress, indicating that the transcripts may serve a purpose (Li et 
al., 1999; Liu et al., 1995; Rudin and Thompson, 2001; Schutz et al., 2005). The 
prevalence of SINEs in mammalian genomes also indicates that they may provide 
a selective advantage and may have one or more cellular functions. 
Heat-shock response is an elegant example of a rapid and robust mechanism of 
cellular defence against environmental stress. A well-known feature of heat-
shock response is the dramatic change in cellular transcription, whereby the 
transcription of heat-shock response genes is upregulated and the transcription 
of a multitude of housekeeping genes is downregulated. The heat-shock 
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transcription factor 1, elongation factor eEF1A and non-coding heat-shock RNA1 
play important roles in inducing expression of heat-shock proteins (Sarge et al., 
1991; Shamovsky et al., 2006). However, the mechanism for the transcriptional 
inhibition of housekeeping genes remained elusive until recently. 
Both human and mouse SINEs show dramatic increases in Pol III-mediated 
transcription during heat-shock response. However, this increase is unique to 
SINEs and other Pol III-transcribed RNAs remain unaffected (Li et al., 1999; Liu 
et al., 1995). James Goodrich and co-workers have shown that Alu RNA and B2 
RNA specifically bind to Pol II and inhibit mRNA transcription by interfering with 
preinitiation complex formation (Allen et al., 2004; Espinoza et al., 2007; 
Mariner et al., 2008). Only one arm of Alu RNA seems to show the transcriptional 
inhibition, even though both the arms can bind the polymerase. The inhibitory 
effect is attributed to two loosely-structured repression domains, which can 
transmit their inhibitory function in trans to other Pol II-binding RNA molecules. 
Both B1 and B2 RNAs can bind Pol II; however, only B2 RNA contains the 
inhibitory domains required to inhibit transcription (Shamovsky and Nudler, 
2008). 
The increase in levels of Pol III-transcribed SINE transcripts is very transient and 
upon recovery from stress, the abundance of SINE RNA rapidly decreases to its 
basal level (Liu et al., 1995). This is thought to be due to the very short half-life 
of Alu transcripts. In K562 cells, the half life of Alu RNA following actinoMycin 
block was calculated to be 0.5hrs (Li et al., 2000). This is extremely short 
compared to the parental 7SL RNA, which has a half life of ~10hrs. Using 
transiently-expressed Alu deletion constructs, it has been shown that the right 
Alu monomer is inherently unstable and causes the full-length transcript to be 
rapidly degraded (Li and Schmid, 2004). Moreover, Alu RNA was recently shown 
to be a direct target of DICER1-dependent degradation in human and mouse 
retinal pigmented epithelium. The elevated levels of Alu RNA in the absence of 
DICER1 were shown to directly contribute to disease progression in geographic 
atrophy, an untreatable advanced form of age-related macular degeneration 
(Kaneko et al., 2011). 
SINE transcripts exist as full length nuclear and 3' processed cytoplasmic small 
cytoplasmic RNAs (scRNAs) (Maraia, 1991; Matera et al., 1990). However, it was 
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observed that very high expression of Alu RNA by transient transfections was 
unable to increase the abundance of scAlu RNA. This suggests that the level of 
these scRNAs is very tightly regulated by factors other than the abundance of 
the primary transcript (Chu et al., 1995). These cytoplasmic transcripts have 
been shown to associate with SRP9 and SRP14 with high affinity (Chang et al., 
1996). The Alu domain of the 7SL RNA is thought to be responsible for blocking 
protein chain elongation until the protein reaches the ER membrane (Siegel and 
Walter, 1988). As assumed previously, Alu-SRP9/14 complexes were shown to 
inhibit protein translation in vitro. However, Alu-SRP9/14 particles seemed to 
act at the chain initiation step, rather than chain elongation, and resulted in 
lower polysome levels (Hasler and Strub, 2006). 
Full length Alu transcripts have also been shown to interact with dsRNA-
regulated protein kinase (PKR), which upon binding dsRNA, autophosphorylates 
and inhibits translation initiation via phosphorylation of eIF2α (Williams, 1999). 
Low level Alu transcripts activate PKR, whereas high levels of Alu transcripts 
have a strong inhibitory effect on PKR activity thus elevating global translation 
(Chu et al., 1998). Moreover, it was shown that the right arm of Alu RNA 
increase translation of specific mRNAs in a PKR-independent manner. In this 
case, levels of global translation are not affected (Rubin et al., 2002). The 
interaction of Alu RNA with poly(A)-binding protein, a regulator of translation, 
could also contribute to its translational regulation (Kondrashov et al., 2005). 
Therefore, SINE RNA seems to be capable of modulating cellular protein 
translation in multiple ways. 
Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional alteration of 
dsRNA by adenosine deaminases ADAR1, ADAR2 and ADAR3 (Bass, 2002). It has 
been observed that the primary targets of this process are 3' UTRs containing 
reversely oriented Alu elements (Athanasiadis et al., 2004). It was recently 
reported that there are 333 human genes which contain such Alu sequences. 
Edited mRNAs have been shown to be retained in the nucleus, thus inhibiting the 
protein expression (Chen et al., 2008). Varying degrees of A-to-I editing has also 
been thought to contribute to transcript diversity (Barak et al., 2009). 
When Krayev et al sequenced mouse B1 SINE, they also observed that two 
regions within the B1 sequence were homologous to intron-exon junctions. This 
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was one of the earliest suggestions that SINE sequences may be involved in pre-
mRNA splicing (Krayev et al., 1982). We know now that internal exons containing 
SINEs, predominantly in antisense orientation, are generally alternatively spliced 
(Sorek et al., 2002). SINEs are responsible for generating new exons by a process 
termed as exonisation. There are 7810 Alus within the human genome that are 
prone to exonisation; these may contribute considerably to protein diversity and 
also potentially lead to genetic disorders (Sorek et al., 2004).  
SINEs have also been implicated in driving human miRNA transcription (Borchert 
et al., 2006; Monteys et al., 2010) and influence targeting of mRNAs by RNAi 
(Smalheiser and Torvik, 2006). Alus have also been shown to be sites of cohesin 
loading onto DNA, thus contributing potentially to genome organisation (Hakimi 
et al., 2002). Transcription at SINEs is also thought to influence the local 
chromatin environment. By serving as boundary elements, SINEs are thought to 
block the spread of heterochromatin and thus help regulate transcription 
(Lunyak et al., 2007). However, the boundary element function may be a general 
feature of Pol III transcribed loci, where the binding of TFIIIC is seen to be 
sufficient for stopping heterochromatin spreading (Raab et al., 2011). Thus, 
SINEs seem to provide modulatory and evolutionary contributions to mammalian 
genomes and are a lot more than a mere nuisance. 
However, SINEs and their transcripts also have a darker side to them. SINE 
transcript overexpression has recently been shown to be cytotoxic in retinal cells 
and cause geographic atrophy, an untreatable form of human blindness (Kaneko 
et al., 2011). Moreover, SINE retrotransposition has the potential to disrupt vital 
genetic pathways and be of great detriment to the cell. SINE sequences are also 
responsible for chromosomal instability through transpositions and deletions 
caused by erroneous repair [reviewed in (Konkel and Batzer, 2011) and Discussed 
further in chapter 5]. 
Increasing amounts of evidence are emerging for the role of SINE transcripts in 
modulating various cellular processes. It seems that SINE elements and their 
transcripts also play a role in human diseases, and therefore it is vital to 
understand transcriptional regulation of SINEs (chapter3 and chapter4). 
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1.6 General Aims 
The general aim of this study was to study the effects of DNA methylation on 
transcription by Pol III at SINEs. The effect of chromatin remodelling by SWI/SNF 
at tRNA genes was also investigated. 
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Chapter 2 Methods and materials 
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2.1 Cell Culture and treatments 
All cell culture was performed in a class II hood, using aseptic techniques, sterile 
equipment and reagents. All cell lines were cultured in humid incubators set at 
37oC and 5% CO2.  
HeLa, A31, MEF and IMR90 cells were cultured in DMEM (Dulbecco’s Modified 
Eagle Medium) supplemented with 10% foetal bovine serum (FBS), 2mM L-
glutamine, 100U/mL penicillin-streptoMycin. Dmnt1 wild-type and knockout 
MEFs were cultured in DMEM supplemented with 10% FBS, 2mM L-glutamine, 
100U/ml penicillin-streptoMycin, 2mM sodium pyruvate, 1% non-essential amino 
acids and 0.01% β-mercaptoethanol. Hom6.9 cells were cultured in DMEM 
supplemented with 10% ES batch-tested FBS, 2mM L-glutamine, 100U/ml 
penicillin-streptoMycin, 1% non-essential amino acids, 5x105 U leukemia 
inhibitory factor (ESGRO® LIF, Millipore) and 0.01% β-mercaptoethanol. ES cells 
were grown on plates coated with 0.1% gelatine. 
For cell passaging, the media was aspirated from a 75-85% confluent flask/plate 
and the adhered cells were washed with 2ml of buffered trypsin-EDTA (0.05% 
trypsin, 0.02% EDTA). A further 2ml of buffered trypsin-EDTA was added after 
the wash and the flask was left at 37oC for approximately 2 mins. Following 
trypsinisation, fresh medium was immediately added to the dissociated cells in 
order to neutralise the trypsin and cell suspensions were transferred to new 
flasks/plates. 
2.1.1 Cryo-freezing and recovery 
Cryo-freezing was used for storage of all cell lines. Cells were trypsinised as 
described, pelleted by centrifugation at 500g for 5mins, and resuspended in 70% 
FBS, 20% DMEM and 10% dimethyl sulphoxide (DMSO, Sigma). Cells were frozen 
gradually by submerging the cryo-vials in propanol and placing the propanol 
container in -80oC overnight. The cells were transferred to liquid nitrogen 
storage the following day. For cell recovery after liquid nitrogen storage, the 
cryo-tubes were rapidly thawed at 37oC and the cells were washed in media at 
37oC to remove the DMSO. The cells were then cultured in small 25cm2 flasks. 
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2.1.2 Drug treatments 
Cells were treated with 4µM 5-azacytidine (Sigma) in DMEM for 16 – 72hrs 
depending on the cell type and 5ug/ml bleoMycin (Calbiochem) in water for 16 
hours. Indicated concentrations of Chaetocin (Sigma) in dH2O and 50µg/ml α-
amanitin (Sigma) in dH2O were used to treat cells for 24 hours.  
2.2 Translocation assay 
Maria Jasin generously provided Hom6.9 cells on which the translocation assays 
were conducted as previously [Elliott, 2005 #2797]. 7 x 106 cells were plated per 
10cm gelatinised dish 16hrs prior and the growth media was changed 2hrs prior 
to the experiment. The cells were washed quickly with PBS and trypsinised with 
2ml of buffered trypsin-EDTA (0.05% trypsin, 0.02% EDTA). These cells detach 
relatively quickly and should not be trypsinised for longer than 1min. The trypsin 
was neutralised using 8ml of media and the cells were passed gently through a 
10ml pipette to ensure a single cell suspension. The cells were pelleted by 
centrifugation at 500g for 5mins at room-temperature and washed once with 
10ml PBS. The cell pellet was then resuspended in 2ml PBS. 900μl of this cell 
suspension was transferred to two sterile microfuge tubes and 25μg of pTK-hyg 
and pCBAS (provided by Maria Jasin) plasmids were added to the tubes. The cell 
suspension was then transferred into 4mm electroporation cuvettes without 
introducing bubbles. The cells were elecroporated using a GenePulser XcellTM 
electroporator (BIO-RAD) at 250V, 950μF and infinite resistance settings. The 
cells were then allowed to recover in the cuvettes for 20 minutes. Cells were 
treated at room-temperature throughout the electroporation procedure. 
The cells were then resuspended in appropriate volume of warm growth medium 
and plated on labelled gelatinised plates. Cells were allowed to recover for 
10hrs after electroporation and treated for 16 hrs with 4μM 5-azacytidine or 
5μg/ml bleoMycin for 16hrs. Following drug treatment, the cells were washed 
with PBS and provided with fresh growth medium. 24hrs following media 
replacement, selection in 200µg/ml neoMycin was performed for 8-10days. One 
plate for each treatment was left without selection in order to ascertain loss of 
cell viability. The colonies obtained following selection were fixed for 10 
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minutes with methanol and stained with 1:40 GIEMSA stain. The clones were 
then counted manually. 
2.3 RNAi and protein overexpression 
Transient transfections were performed using Lipofectamine2000® (Invitrogen) 
and Opti-MEM® reduced serum media (Invitrogen). 2 x 105 cells were seeded in 
10cm plates 16-24 hrs prior to transfection. The growth medium aspirated off 
and the cells were washed in PBS twice. After removing the PBS, 5ml of warm 
Opti-MEM® was added to the medium. The transfection solution per plate was 
prepared by adding siRNA (Table 2.3) or 5-10μg plasmid to 1.5ml Opti-MEM® and 
20μl of Lipofectamine2000® to 1.5ml Opti-MEM® in separate tubes. Following 
5min incubation at room-temperature, these two solutions were mixed and 
incubated at room-temperature for 20mins to allow complex formation. This 
transfection solution was then added to the 10cm plate with cells in 5ml Opti-
MEM® and the cells were incubated at 37oC 5% CO2 for 6hours. The Opti-MEM® 
was then replaced with growth medium and the cells were left to grow for 48hrs 
before harvesting. For knockdown ChIP assays, the transfection process was 
repeated twice on consecutive days to ensure a reproducible knockdown.  
2.4 Preparation of protein extracts 
Cells were cultured in either 10cm plates or 6-well plates to about 80% 
confluency before harvesting. Preparation was performed on ice, as rapidly as 
possible, in order to avoid protein denaturation. The maintenance medium was 
aspirated and cells were washed twice with ice-cold PBS. They were then 
scraped into microextraction buffer (MEB) (20mM HEPES pH7.8, 150mM NaCl, 
25% glycerol, 50mM NaF, 0.2mM EDTA, 0.5% Triton X-100, 0.5% NP40, 1mM PMSF, 
1mM DTT, 1µg/ml protease and phosphatase inhibitor cocktail) and transferred 
to sterile microfuge tubes. 100-500µl of buffer was used per plate depending on 
cell type and plate size. The cell lysates were then passed through a 26G needle 
five times and centrifuged at 13000g for 10mins at 4oC. The supernatants were 
aliquoted and snap-frozen on dry ice, before being stored at -80oC. 
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2.5 Determination of protein concentrations 
The protein concentrations of protein extracts were determined using Bradford’s 
reagent diluted 1 in 5 with dH2O. For each experiment, a standard curve was 
constructed by measuring the absorbance at 595nm of 1, 2, 4, 6, 8 and 10µg of 
BSA in 1ml of diluted Bradford’s reagent. The absorbance readings of protein 
extracts were performed in duplicates at 595nm, and the protein concentration 
of each sample was determined by plotting the average reading on the standard 
curve. 
2.6 Sodium-dodecyl sulphate polyacrylamide gel 
electrophoresis  
Protein extracts containing 10-20µg of protein per lane were resolved by 
denaturing SDS-PAGE typically on a 7.8% or 10% polyacrylamide (375 mM Tris 
pH8.8, 0.1% SDS) minigel with a 4% polyacrylamide (120mM Tris pH6.8, 0.1% SDS) 
stacking gel. Prior to loading, samples were boiled at 100oC for 2 mins in 1x 
protein sample buffer (62.5mM Tris pH6.8, 0.5% SDS, 5% β-mercaptoethanol, 10% 
glycerol, 0.125% bromophenol blue). Electrophoresis was performed in 1x SDS 
running buffer (0.1% SDS, 76.8 mM glycine, 10mM Tris pH8.3) at 150V. 
2.7 Western blot analysis 
After separation by SDS-PAGE, the resolved proteins were transferred to 
nitrocellulose membranes using a Bio-Rad Mini Trans-Blot Electrophoretic 
Transfer Cell system. The transfer was carried out in 1x transfer buffer (76.8mM 
glycine, 10mM Tris pH8.3, 20% methanol) at 50V for 2hrs at 4oC for proteins 
smaller than 100 kDa and overnight for bigger proteins. The proteins transferred 
to the nitrocellulose were visualised by staining with 1x Ponceau S solution 
(Sigma) to ensure their efficient transfer. Subsequently, the membranes were 
washed with PBS and then blocked in milk buffer (32.5mM Tris, 150mM NaCl, 
0.2% Tween-20, 5% skimmed milk powder) for 30-60mins at room-temperature. 
The membranes were then incubated in the presence of the appropriate primary 
antibody (Table 2.2) diluted in milk buffer for 2 hours at room-temperature or 
overnight at 4oC. Following incubation with the primary antibody, the 
membranes were washed three times for 5mins in PBS 0.5% Tween-20, in order 
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to remove any unbound primary antibody. The membranes were then incubated 
for 45mins at room-temperature in the appropriate secondary antibody at a 
dilution of 1:1000 in milk buffer. The membranes were then washed for 
approximately 45mins with PBS 0.5% Tween-20 with regular changes of wash 
buffer. The bound antibodies were then detected with enhanced 
chemiluminescence (ECL) reagents according to manufacturer’s instructions 
(Amersham). 
2.8 Co-immunoprecipitation assay 
50µg of protein extracts were used per reaction. The protein extract was 
incubated overnight at 4oC with 5μg of IgG or appropriate antibody (Table 2.2) 
and 1μg/ml protease inhibitor cocktail made up to the total volume of 250μl 
with PBS/NP-40 (PBS, 0.015% NP40). 10Units of DNaseI or heat-denatured DNaseI 
were added prior to the overnight incubation. 30μl of DynaI® protein G magnetic 
beads were used for each reaction. The beads were washed three times in 
PBS/NP-40 using a magnetic rack and then blocked with 50μl of PBS/NP-40 
1mg/ml BSA for 15mins at room-temperature using a rotating wheel. Once the 
blocking buffer was removed from the beads, the appropriate IP sample was 
added and incubated with the beads for 30mins at room-temperature or 2hrs at 
4oC on a rotating wheel. The beads were then washed 4-6 times in PBS/NP-40. 
To elute the proteins, 50μl of protein sample buffer was added and the beads 
were incubated for 10mins at 70oC on a shaker. The co-IP samples were 
collected into fresh microfuge tubes and were resolved next to 20% input (i.e. 
10μg protein extract). SDS-PAGE and Western blotted were performed as 
described above. 
2.9 Gene expression analysis 
2.9.1 RNA extraction 
Total RNA was extracted using TRI reagent (Sigma-Aldrich) according to 
manufacturer’s specifications. The maintenance medium was aspirated and the 
cells were washed two times in ice-cold PBS. 1ml or 500µl of TRI was used per 
10cm plate or 6-well plate respectively, and the cells were harvested with a cell 
scraper. The samples were incubated for 5mins at room-temperature to allow 
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complete dissolution of nucleoprotein complexes, before addition of 0.2ml of 
chloroform per 1ml of TRI. Each sample was thoroughly mixed using a vortex for 
1min. The samples were then centrifuged at 13000g for 15mins at 4oC, which 
resulted in the separation of the samples into three phases. The top aqueous 
phase containing the RNA was carefully transferred into new microfuge tubes 
and 0.5ml isopropanol was added to precipitate the RNA. The samples were 
mixed by vortexing briefly and centrifuged at 13000g for 10mins at 4oC. Once the 
supernatant had been removed, the RNA pellet was washed in 70% ethanol and 
briefly dried, before resuspension in 10-15µl RNase-free water. The RNA 
concentration was determined by spectrophotometry at 260nm, considering that 
OD of 1 at 260nm corresponds to 40µg/ml of RNA. 
2.9.2 cDNA synthesis 
cDNA was synthesised using the SuperScriptIII reverse transcriptase (Invitrogen). 
0.2µg and 0.4µg of RNA was mixed with 2µl of 1x hexanucleotide mix (Roche) 
and made up to a final volume of 25µl with RNase-free water. This mix was then 
incubated at 80oC for 10mins and cooled down rapidly on ice to allow primer 
annealing. 14μl of reaction mix (8µl of First Strand Buffer (Invitrogen), 4µl of 
0.1M DTT and 2μl of 10mM dNTP mix) with 1μl of SuperScriptIII was added to the 
random primed RNA mix. This was then incubated at 42oC for 1hour to allow 
cDNA synthesis and the reaction was stopped by boiling the samples at 70oC for 
15mins. cDNA was stored at -20oC. In order to rule out DNA contamination of the 
RNA samples, a duplicate tube for each sample was incubated with the reaction 
mix without the SuperScriptIII. DNA contamination could be detected in the PCR 
reaction for the SuperScriptIII negative samples. cDNA prepared with 0.2 and 
0.4μg RNA determined the quantitative nature of the cDNA synthesis reaction. 
RT- PCR primers are described in (Table 2.1). 
2.10 Chromatin immunoprecipitation (ChIP) assays.  
Cells were grown in 10cm plates to about 80% confluency and approximately one 
10cm plate of cells was used per IP. Formaldehyde, to the final concentration of 
1%, was added to the cell maintenance medium for 10mins at room-temperature 
in order to cross-link the protein-DNA complexes. A 15min cross-linking step was 
performed in ChIP assays for SWI/SNF subunits, SUV39H1 and HP1 proteins. The 
 62 
cross-linking was stopped by the addition of 0.125M final concentration of 
glycine and the plates were left at room-temperature for 5mins. The plates were 
then transferred to ice and the cells were scraped in the culture 
media/formaldehyde/glycine solution into a 50ml Falcon® tube. The cells were 
pelleted by centrifugation at 500g for 5mins and washed twice in ice-cold PBS 
and twice in ice-cold PBS 0.5% NP-40. The cells were then resuspended in high 
salt buffer (PBS, 0.5% NP-40, 1M NaCl) and incubated in ice for 30mins. This was 
followed with one wash in PBS 0.5% NP-40 and incubation in low salt buffer 
(10mM Tris-CL pH8.0, 1mM EDTA, 0.1M NaCl, 0.5% NP-40) in ice for 30mins. 
Following this incubation, the cells were pelleted as previously, resuspended in 
1ml of low salt buffer, and passed five times through a 26G needle. The final 
volume was made up to 2.7ml with low salt buffer and 300μl 20% w/v N-
Laurylsarcosine sodium salt was added to the cell suspension. Once mixed, this 
solution was then layered carefully on top of a 40ml LSB/100mM sucrose cushion 
and centrifuged at 4000g for 10mins at 4oC. The resultant pellet was 
resuspended in 2ml TE (10mM Tris pH8.0, 1mM EDTA) and passed through 
another sucrose cushion. The pelleted chromatin was then resuspended in 2ml 
TE and was sheared into fragments smaller than 0.5kb by sonicating in a water 
bath sonicator (BioruptorTM, Diagenode) at full power for 30 (30sec on/off) 
cycles at 4oC. 200μl 11xNET buffer (1.56M NaCl, 5.5mM EDTA, 5.5% NP-40, 
550mM Tris-Cl pH7.4) was added to the sonicated material, which was then 
centrifuged at 13000g for 5mins at 4oC. The supernatant was aliquoted evenly 
into microfuge tubes and 10% of this was kept as the input sample. 5-25μg of the 
appropriate antibody (Table 2.2) was added to each labelled aliquot tube and 
this mix was then incubated overnight at 4oC to allow the antibody protein 
interaction. 
The next day, 50μl of protein A/G sepharose beads (washed three times in 1xNET 
buffer) were added to the IP samples and were allowed to incubate for a further 
2hrs at 4oC. The beads were then recovered on 5ml polypropylene columns, 
washed twice in ice-cold RIPA buffer (50mM Tris-Cl pH8.0, 150mM NaCl, 0.1% 
SDS, 0.5% deoxycholate, 1% NP-40), twice with ice-cold LiCl buffer (10mM Tris-Cl 
pH8.0, 250mM LiCl, 0.5% deoxycholate, 0.5% NP-40, 1mM EDTA) and twice with 
ice-cold TE. Following removal of excess TE from the last wash, the bound 
chromatin was eluted with 400μl TE/1%SDS at room-temperature. The eluted 
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material was digested overnight with 0.125mg/ml proteinase K at 420C. DNA 
purification was performed with Qiagen PCR purification kit using 
manufacturer’s instructions. The ChIP DNA was then analysed by PCR. 
2.10.1 Sequential ChIP assay 
For sequential ChIP analysis, the primary ChIP antibodies were freshly 
crosslinked to the sepharose beads using DMP (Pierce) the day before each 
sequential ChIP reaction. This was done in order to reduce background caused by 
primary antibody elution following the first ChIP. 100μl of protein G sepharose 
beads per IP were washed three times in 1ml HEPES lysis buffer (20mM HEPES-
NaOH pH8.5, 150mM NaCl, 1% NP-40, 2mM EDTA). 5μg of antibody was added to 
the beads and the solution was made up to 1ml with HEPES lysis buffer. The 
beads and the antibody were incubated at 4oC overnight on a rotating wheel to 
allow antibody-binding. 
The next day, the beads were washed three times in 1ml HEPES lysis buffer and 
two times in 1ml 100mM HEPES-NaOH pH8.5. The beads were then incubated in 
1ml of freshly prepared cross-linking buffer (100mM HEPES-NaOH pH8.5, 
10mg/ml DMP) for 1hr at room-temperature on a rotating wheel. Following 
cross-linking, the beads were washed twice in 1ml HEPES cross-linking wash 
buffer and the reaction was then quenched with 100μl 1M glycine pH7.5 for 
30mins at room-temperature. The beads were then washed twice in HEPES lysis 
buffer and used for the ChIP reaction in 100mM HEPES-NaOH pH 8.5. Following 
the first ChIP reaction the eluate in TE/1% SDS was diluted 1 in 10 before the re-
ChIP in order to reduce the amount of SDS in the solution. 
2.10.2 ChIP-ChOP assay 
ChIP DNA was spiked with 100ng of unmethylated PCR product containing a 
HpaII/MspI site, which was obtained by PCR using pCDNA3 primers on a empty 
pCDNA3 vector. This cocktail was digested for 1 hr with 1μg of HpaII (Invitrogen) 
or MspI (NEB). Mock digestions with buffer only were also performed in order to 
ascertain the digestion efficiency. The digested samples were normalized to the 
unmethylated DNA in order to normalise for the differences in digestion 
efficiency between the two enzymes.  
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2.10.3 ChIP-sequencing 
ChIP-bisulphite sequencing for Pol III-binding at Alu loci was performed by 
Andrew Oler (NIH) using the Illumina Bisulfite sequencing protocol. The Qiagen 
EpiTech kit was used for bisulfite conversion. ChIP-sequencing data for the Pol 
III, TFIIIC and SWI/SNF subunits was mined from the UCSC hg18 genome 
database. 
2.11 Methylcollector assay 
Separation of genomic DNA according to CpG methylation status was achieved by 
affinity chromatography with immobilised recombinant MBD2b and MBD3L1 using 
a MethylCollectorTM Ultra kit (Active Motif), according to the manufacturer's 
specifications. 
2.12 Polymerase chain reaction (PCR) 
Each PCR reaction had a total volume of 20μl and contained 1μl of template 
DNA, 20pmol of the appropriate primers, 0.5U of Taq DNA polymerase 
(Promega), 1 x Taq DNA polymerase buffer (Promega), 1.5mM MgCl2 and 0.2mM 
dNTPs. The cycling parameters and primers used are listed in Table 2.1. The 
PCRs were performed using a Dyad® Peltier thermal Cycler (BIO-RAD). The 
samples were resolved on 5% polyacrylamide native gels next to a 100bp DNA 
ladder. 
Quantitative PCR (qPCR) was performed using the C1000TM Thermal Cycler (BIO-
RAD). The qPCR reaction had a total volume of 10μl and contained 0.5μl of 
template DNA, 5μl of 2 x PerfeCTaTM SYBR® Green FastMixTM and 0.25μM of 
appropriate primers. An appropriate standard curve encompassing the samples 
within the linear range was constructed for each qPCR. Each sample was loaded 
in duplicate to avoid pipetting errors. The expression levels in qRT-PCR assays 
were obtained using ΔΔC(t) of the average of duplicate samples and the average 
of loading control, e.g. ARPP P0. The ChIP signal was quantified with the formula 
(Avg. IP/Avg. Input)-(Avg. Neg. IP/Avg. Input). Data from multiple experiments 
were then used to calculate overall average and standard deviation values. 
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Table 2.1: PCR primers for various analyses in mouse and human cells 
PCR amplification was performed with the following cycling parameters: 95oC for 30sec, T(a) for 
30sec, 72oC for 30sec for n cycles, where T(a) and n are specified for each primer pair. The same 
qPCR programme was used for all primer pairs, i.e. 95oC for 30sec, 60oC for 30sec, 72oC for 30sec 
for 45 cycles. The species specificity of a primer pair is mentioned next to its name, i.e. [m] for 
mouse, [r] for rat and [h] for human primers. 
Locus name [Species]   Primers T(a) N 
28S rRNA [m] F CCCGACGTACGCAGTTTTAT 58 oC 23-25 
 R CCTTTTCTGGGGTCTGATGA   
5S rRNA [h, m] F GGCCATACCACCCTGAACGC 58 oC 16-18 
 R CAGCACCCGGTATTCCCAGG   
7SL [h, m] F GTGTCCGCACTAAGTTCGGCATCAATATGG 70 oC 25-30 
 R TATTCACAGGCGCGATCCCACTACTGATC   
7SL set1 [h] F CCGTGGCCTCCTCTACTTG 60 oC 22-27 
 R TTTACCTCGTTGCACTGCTG   
7SL set2 [h] F CGTCACCATACCACAGCTTC 60 oC 22-27 
 R CGGGAGGTCACCATATTGA   
7SL set3 [h] F GTTGCCTAAGGAGGGGTGA 60 oC 22-27 
 R TCTCTTGAGAGTCCAAAATTAA   
7SL set4 [h] F TTTTTGACACACTCCTCCAAGA 60 oC 22-27 
 R ATCTGGTCAAAGCAACATACACTG   
7SL set5 [h] F TGCCTCCAGATAAAACTGCTC 60 oC 22-27 
 R ACCCCACTAGAACCCTGACA   
Alu (ch6) [h]  F CCAGAAAAATTACCAATTAGTTC 53 oC 25-30 
  R GGGCCTATTGACTATGCTTAC   
Alu (ch10) [h] F GATTCTCAACAGCAGAATTCCA 53 oC 25-30 
  R CATGTTTGAGAATGTCTACTTC   
Alu (ch19) [h] F CCACGTGTTTATCTGTAAGGTG  53 oC 25-30 
  R GTTAGGAGCTAGAAGGAGCCT   
Alu (C19J) [h] F CTACTCAAAATATTAAACATAGGC 53 oC 25-30 
  R GCTGCAACGCTGCTATGAAC   
Alu (ch22) [h] F GTTCTGACACACTTGGAGAAA 53 oC 25-30 
  R GTTGTTGTTATTGCACAACTCA   
Alu RNA [h] F CTTACACGTGTCATCCCAGC 58 oC 30-32 
  R GACAGTGTCTCACTCTGCTACC   
Alu (MLL) [m] F CGATTACCCTGTTATCCCTAGGCTGGGCACAGTGGT 60 oC 25-30 
 R AAGCTAGCGGCTGAAATTCTCCTCTTC   
APC [h] F GAGGAAGGTGAAGCACTCAGTT 60 oC 23-25 
 R AGGGTGAGACATGGAGAGAAGA   
Apo-E [m] F TTCGGAAGGAGCTGGTAAGAC 57 oC 23-25 
  R CGACAGTCCCGTACTCCTTC   
Apo-E [h] F CAGCGGAGGTGAAGGACGTC 57 oC 23-25 
  R CTCCTCCTCTCCCCAAG   
Apo-E mRNA [m] F GTTTCGGAAGGAGCTGACTG 57 oC 30-32 
  R AGCGCAGGTAATCCCAGAAG   
Apo-E mRNA [h] F GGTCGCTTTTGGATTACCT 57 oC 30-32 
  R TTCCTCCAGTTCCGATTTGT   
ARPP P0 [h, m] F GCACTGGAAGTCCAACTACTTC 58 oC 16-20 
 R TGAGGTCCTCCTTGGTGAACAC   
B1 [m] F TGGTGGTGCATGCCTTTAAT 58 oC 10-12 
  R CCTGGTGTCCTGGAACTCACT   
B2 [m] F GGGGCTGGAGAGATGGCT 58 oC 10-12 
  R CCATGTGGTTGCTGGGAT   
B1 (c9) [m] F GCATGCATACCACTCCACAC 58 oC 25-30 
  R CAGAGAATCTGCAGTCGTATTTCC   
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B2 (c9) [m] F CTGCCTTCAGACACACCAGAAG 58 oC 25-30 
  R GATGGAAGAGGTTTTGCCAAG   
BRG1 cDNA [m] F TACAGGCTTCAGGCTCGAAT 60 oC  
 R TCTCCAGGGCTGTGTCTCTT   
BRM cDNA [m] F TATGTCGCCAATCTGACCAA 60 oC  
 R AGGTCACTCATCTGGCTGCT   
GAPDH mRNA [m] F TCCACCACCCTGTTGCTGTA 60 oC 23-25 
  R ACCACAGTCCATGCCATCAC   
p53BP2 mRNA [m] F GTTGGTTTCGGCGAGAAGG 60 oC 23-25 
  R GAAGCCAAGCGAGAACGAG   
p16 cDNA [m] F TCTGGAGCAGCATGGAGTCC 58 oC 22-25 
  TCGCAGTTCGAATCTGCACC   
p21 promoter [m] F CTCTGGGAAGCCAGAAGTTGTT 58 oC 25-30 
 R GGTCCAGTCCTGCATCTAAGT   
p21 promoter [h] F TATTGTGGGGCTTTTCTG 58 oC 25-30 
 R CTGTTAGAATGAGCCCCCTTT   
pre-tRNALeu [h, r, m] F GTCAGGATGGCCGAGTGGTCTAAGGCGCC 68 oC 20-25 
 R CCACGCCTCCATACGGAGACCAGAAGACCC   
pre-tRNATyr [h, r, m] F CCTTCGATAGCTCAGCTGGTAGAGCGGAGG 65 oC 20-25 
 R CGGAATTGAACCAGCGACCTAAGGATCTCC   
pre-tRNAiMet [m] F CTGGGCCCATAACCCAGAG 55oC 20-25 
 R TGGTAGCAGAGGATGGTTTC   
pCDNA3 F ATTATGCAGAGGCCGAGG 58 oC 20 
 R CCATCTTGTTCAATCATGCG   
SNF5 cDNA [m] F AGCGTGTCATCATCAAGCTG 58 oC 22-25 
 R CACTGTGGGAAGTGGGTTCT   
tRNALeu downstream F CTTGGGAAGAAAACACTGGCAGTGGT 60 oC 22-25 
 R CAGACAGCTTGGTAGTGTGGCCG   
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Table 2.2 Antibodies used for various analyses in human and mouse cells 
The supplier and the catalogue numbers are listed for the antibodies used, alongside the 
application for which that particular antibody was used. WB stands for Western Blotting. Most 
antibodies were used at a 1:1000 dilution, except the actin and Tubulin antibodies that were used 
at a 1:400 dilution for Western blotting. 
 
Protein recognised Supplier Cat./I.D. No. Application 
TFIIA SantaCruz Biotechnology sc-25365 ChIP 
TAFI48 SantaCruz Biotechnology sc-6571 ChIP 
SUV39H1 SantaCruz Biotechnology sc-25366 ChIP 
SUV39H1 Upstate Biotechnology 05-615 ChIP 
HP1 SantaCruz Biotechnology sc-28735 ChIP 
Histone H3 Abcam ab1791 ChIP 
Histone H4 Upstate Biotechnology 07-108 ChIP 
BRF1 In house 128 ChIP, co-IP 
BRF1 In house 482 WB, co-IP 
TFIIIC110 In house 3208 WB, co-IP 
TFIIIC220 In house Ab7 WB, ChIP, co-IP 
TFIIIC220 In house Ab2 WB, ChIP, co-IP 
Rpc155 In house 1900 WB, ChIP 
MBD1 Imgenex IMG-306A ChIP 
MBD2 Sigma-Aldrich M7318 ChIP 
MeCP2 Sigma-Aldrich M9317 ChIP 
H3K9me3 Cell Signalling Technology 9754S ChIP 
H3K27me3 Cell Signalling Technology 9756S ChIP 
Ini1 SantaCruz Biotechnology sc-13055 ChIP, co-IP 
Ini1 Abcam ab12167 WB 
BRG1 SantaCruz Biotechnology sc-10768 ChIP, co-IP 
BRG1 Abcam ab4081 WB 
BRM SantaCruz Biotechnology sc-28710 ChIP, co-IP 
BRM Abcam ab15597 WB, co-IP 
HDAC1 SantaCruz Biotechnology sc-7872 ChIP 
HDAC2 SantaCruz Biotechnology sc-7899 ChIP 
ac-H3 Upstate Biotechnology 06-599 ChIP 
Actin SantaCruz Biotechnology sc-1615 WB 
TFIIB SantaCruz Biotechnology sc-225 WB 
α-Tubulin Sigma-Aldrich T9026 WB 
HA SantaCruz Biotechnology sc-805 WB 
TBP In house 4C8/26 WB 
c-MYC SantaCruz Biotechnology sc-764 ChIP, WB 
DNMT1 Abcam ab87656 WB 
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Table 2.3: siRNA oligos used for protein knockdowns in mouse cells 
The oligo pairs were ordered from Invitrogen and resuspended in RNase-free water. The 
scrambled control oligos were also ordered from Invitrogen. 
 
Oligo pair name 5' to 3' sequence 
Sense oligo GCUCCGAGGUGGGAAACUAtt SNF5 siRNA1 
Antisense oligo UAGUUUCCCACCUCGGAGCcg 
Sense oligo GCUUUUACCUGGAACAUGAtt SNF5 siRNA2 
Antisense oligo UCAUGUUCCAGGUAAAAGCgt 
Sense oligo CGAGGUUCUCUGUACAAGAtt SNF5 siRNA3 
Antisense oligo UCUUGUACAGAGAACCUCGga 
Sense oligo GAGCGAAUCCGUAAUCAUAtt BRM siRNA1 
Antisense oligo UAUGAUUACGGAUUCGCUCct 
Sense oligo GCUUCUCUGUCACAACGCAtt BRM siRNA2 
Antisense oligo UGCGUUGUGACAGAGAAGCat 
Sense oligo GGUCAACGGUGUCCUCAAAtt BRG1 siRNA1 
Antisense oligo UUUGAGGACACCGUUGACCat 
Sense oligo CACCUAACCUCACCAAGAAtt BRG1 siRNA2 
Antisense oligo UUCUUGGUGAGGUUAGGUGgg
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Chapter 3 DNA methylation and Pol III 
transcription of SINEs 
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3.1 Introduction 
The large numbers of SINEs present within mammalian genomes could potentially 
provide a huge reservoir for Pol III transcription factors, thus contributing 
significantly to the global regulation of essential Pol III-transcribed genes. The 
first clear evidence of Alu transcription by Pol III was provided by Peter 
Geiduschek and co-workers in 1981, when they in vitro transcribed a series of 
clones containing Alu sequences using a soluble Pol III system (Fuhrman et al., 
1981). Despite their relative genomic abundance, very low levels of Pol III-
transcribed SINE RNA can be detected in cells (Maraia et al., 1993; Matera et al., 
1990; Paulson and Schmid, 1986; Sinnett et al., 1992). Many Alus have highly 
degenerate promoters and thus were thought to be incapable of recruiting Pol III 
transcription apparatus. It has been reported that transcription from Alu Pol III 
promoters may require the presence of conserved 7SL upstream sequence (the 
first 37 nucleotides upstream of 7SL TSS) (Ullu and Weiner, 1985). A 7SL-like 
terminator sequence was also shown to increase Alu transcription in cells, thus 
suggesting that the lack of an efficient terminator may also reduce SINE 
transcription (Chu et al., 1995). In contradiction with these reports, it has been 
shown that Alu elements can be strongly transcribed both in vitro and in vivo 
(Fuhrman et al., 1981; Liu et al., 1995). 
However, DNA methylation has been thought to be primarily responsible for the 
inhibition of Pol III-driven SINE transcription (Liu et al., 1994; Liu and Schmid, 
1993; Schmid, 1991). The Alu consensus sequence contains 24 CpG sites and Alus 
account for up to one-third of all CpG sites within the human genome. In most 
normal tissues, these Alu CpGs are found to be methylated (Rubin et al., 1994; 
Schmid, 1991). In vitro transcription assays using nuclear extracts showed that 
DNA methylation inhibits Alu transcription at low template concentrations, 
however no such inhibition was observed at higher template concentrations. This 
lack of inhibition at higher Alu concentrations was attributed to limiting 
concentrations of MBPs in the extracts (Liu and Schmid, 1993).  Methylation of a 
single CpG within the A-box was seen to inhibit transcription. 
Further evidence came from treatment of HeLa cells with 5-azacytidine, a DNA 
demethylating agent. 5-azacytidine is a cytosine analogue, which incorporates 
into DNA during replication and inhibits the methylation of cytosine residues by 
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DNA methyltransferases (Jones and Taylor, 1980). Treatment with 5-azacytidine 
was shown to cause a 5-to 8-fold increase in full length Alu transcripts (Liu et 
al., 1994). K562 cells, which show considerably lower level of DNA methylation 
on Alus than other cell types, have highly elevated levels of Alu transcripts. 
ActinoMycin D treatment was used to show that this abundance is due to 
increased levels of SINE transcription and not increased transcript stability. Two 
independent studies have also shown that methylated Alu sequences transiently 
transfected into cells are transcribed at a reduced rate compared to their 
unmethylated counterparts (Li et al., 2000; Yu et al., 2001). SINEs have also 
been shown to be target sequences for MBPs, which may contribute to the 
transcriptional repression. The fraction of human genomic DNA fragments that 
was retained by an MBD column was found to be highly enriched for Alu 
sequences (Brock et al., 1999). MeCP2 was also shown to selectively bind Alu 
sequences by ChIP assays in MCF7 cells (Koch and Stratling, 2004).  
Most lines of evidence for DNA methylation-mediated inhibition of SINE 
transcription arise from in vitro and artificial systems. Not only is there a 
distinct lack of endogenous data, but also there are many unexplained 
curiosities within the existing literature. For example, an unmethylated PV Alu 
repeat stably transfected into mouse cells was found to be transcriptionally 
silent (Leeflang et al., 1992).  Demethylated Alu templates transiently 
transfected into HeLa cells were inactive, whereas these templates were highly 
expressed in 293 cells (Liu et al., 1995). Co-transfection of methylated Alu 
sequences with the MeCP2 TRD relieved the methylation mediated 
transcriptional repression, rather than compounding it (Yu et al., 2001). Cell 
stress cannot alleviate the transcriptional repression of transiently transfected 
methylated Alus (Li et al., 2000), although cell stress is able to elevate 
endogenous SINE transcription without altering DNA methylation (Chu et al., 
1998; Liu et al., 1995).  
Therefore, it seems we still lack a clear understanding of how DNA methylation 
regulates SINE transcription in cells. Increasing amounts of evidence are 
emerging for the role of SINE transcripts in modulating various cellular 
processes. Therefore it is increasingly important we try to understand the 
transcriptional regulation of these sequences. This chapter will try and address 
this question in detail. 
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3.2 Results 
3.2.1 Alu sequences are occupied by Pol III transcription 
apparatus and MBPs in multiple human cell lines 
Since low levels of Pol III-synthesised SINE transcripts are clearly detected in 
cells (Paulson and Schmid, 1986), ChIP assays for Pol III transcription machinery 
were performed in order to investigate the polymerase loading on these 
elements. HeLa cells were subjected to ChIP analysis with antibodies against the 
Rpc155 subunit of Pol III, the BRF1 subunit of TFIIIB and the 220kDa subunit of 
TFIIIC (Figure 3.1). ChIP with an antibody against histone H3 was performed to 
provide a positive control IP. ChIPs with beads only (mock) and an antibody 
against RNA polymerase I specific transcription factor TAFI48 (Rudloff et al., 
1994) were performed to provide the negative controls. 
Analysis was performed at five randomly-chosen Alu loci at five independent 
genomic locations. The primers were designed within the flanking unique DNA 
sequences to allow specific amplification of these loci. Alu(ch19) is a primer set 
aimed at an Alu located centrally within a long stretch of tandem Alu repeats. 
The selected Alu elements all belong to the AluS subfamily and have 7-13 CpGs 
each. Primers that amplify two copies of the human 7SL gene, an actively-
transcribed Pol III gene, provide the positive control for Pol III transcription 
apparatus occupancy. The apolipoprotein E precursor (Apo-E) gene, which is a 
Pol II-transcribed locus and is known to be silenced by DNA methylation 
(Ballestar et al., 2003), provides a negative control for Pol III transcription 
apparatus occupancy. 
Surprisingly, the enrichment of Pol III transcription machinery at Alu loci is 
clearly above background. The Apo-E gene does not show any enrichment for Pol 
III transcription apparatus, showing the specificity of the ChIP reaction. The 7SL 
locus shows a considerably higher enrichment for Pol III and TFIIIB compared to 
the Alu loci. The Alu consensus sequence shows 67% reduction (p<0.05) in Pol III 
occupancy compared to the 7SL loci (data not shown). Individual Alu sequences 
show much lower polymerase occupancy compared to the 7SL loci, whereas no 
such differences are observed for TFIIIC occupancy. 
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Figure 3.1: Pol III transcription apparatus occupies Alu SINEs in HeLa cells 
ChIP assay in HeLa cells with antibodies against Rpc155, BRF1 and TFIIIC220 at Alu loci on 
chromosome 6, 10, 19 and 22. Alu(ch19J) is also on chromosome 19. 7SL and Apo-E loci 
respectively provide the positive and negative controls for Pol III transcription apparatus 
occupancy. ChIPs with beads only (Mock) and TAFI48 antibody provide the negative controls, 
whereas ChIP with histone H3 antibody provides the positive control. Serial dilutions of the inputs 
show the quantitative nature of the PCR. 
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The presence of Pol III transcription apparatus at various SINEs was startling, 
seeing that the transcription of these sequences is believed to be inhibited by 
DNA methylation. Previous studies have suggested that this inhibition may be in-
part due to the presence of MBPs at SINEs (Brock et al., 1999; Koch and 
Stratling, 2004). In order to investigate this possibility, HeLa cells were 
subjected to ChIP assays with antibodies against MBD1, MBD2 and MeCP2 (Figure 
3.2). Beads only and TAFI48 ChIPs provide the negative control IPs, whereas 
histone H3 ChIP provides the positive control. The Apo-E locus provides a 
positive control for the presence of MBPs (Ballestar et al., 2003), whereas 7SL 
locus provides the negative control. 
Alu loci, previously showing the occupancy of Pol III transcription apparatus, also 
seem to be enriched for all three MBPs. The 7SL locus does not show any MBP 
enrichment, indicating the specificity of the assay. MeCP2 occupancy on Alus is 
higher than MBD1 and MBD2. However, this was not due to higher IP efficiency of 
the MeCP2 antibody since the opposite is observed on the Apo-E locus, which 
shows considerably higher MBD1 occupancy. The presence of MBPs also suggests 
that these specific Alu loci are methylated. 
The enrichment of Pol III transcription apparatus and MBPs at these Alus is 
intriguing, however this could be a cell type-specific effect. In order to rule out 
this possibility, ChIP assays with antibodies against Pol III transcription apparatus 
and MBPs were performed in IMR90 human diploid fibroblasts (Figure 3.3), 
HCT116 colon carcinoma (data not shown) and HEK293 embryonic kidney cells 
(data not shown). All human cells lines analysed show the occupancy of Pol III 
transcription apparatus and MBPs on Alu SINEs. The Pol III enrichment at Alus is 
consistently lower than at the 7SL locus, whereas no such difference is observed 
for transcription factor occupancy. MBPs show variable enrichment at SINEs in 
different cell lines, however MBP occupancy is always observed at SINEs.  
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Figure 3.2: MBPs occupy Alu SINEs in HeLa cells 
ChIP assay in HeLa cells with antibodies against MBD1, MBD2 and MeCP2 at Alu loci on 
chromosome 6, 10, 19 and 22. Alu(ch19J) is also on chromosome 19. Apo-E and 7SL loci 
respectively provide the positive and negative controls for MBP occupancy. ChIPs with beads only 
(Mock) and TAFI48 antibody provide the negative controls, whereas ChIP with histone H3 antibody 
provides the positive control. Serial dilutions of the inputs show the quantitative nature of the PCR. 
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Figure 3.3: Pol III transcription apparatus and MBPs occupy Alu SINEs in IMR90 cells 
ChIP assay in IMR90 cells with antibodies against Rpc155, BRF1, TFIIIC220, MBD2 and MeCP2 at 
Alu loci on chromosome 6, 10, 19 and 22. 7SL and Apo-E loci respectively provide the positive and 
negative controls for Pol III transcription apparatus occupancy and visa versa for MBP occupancy. 
ChIP for TAFI48 provides the negative control. Serial dilutions of the inputs show the quantitative 
nature of the PCR. 
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3.2.2 B1 and B2 SINEs are occupied by Pol III transcription 
apparatus and MBPs in multiple mouse cell lines 
Steady state expression of mouse B1 RNA is low in cultured cells (Maraia, 1991), 
whereas B2 transcripts are a little more abundant (Ryskov et al., 1983). There 
are some reports suggesting that B1 sequences in the mouse genome are 
methylated (Jeong and Lee, 2005; Yates et al., 1999), however there is not 
much evidence in the literature for B2 sequence methylation. Both B1 and B2 
SINE transcript levels are upregulated in response to cell stress (Li et al., 1999). 
This indicates that murine SINEs may be regulated in the same manner as their 
human counterparts. However, nothing is known about the regulation of B1 and 
B2 SINE transcription by DNA methylation.  
Since Pol III transcribed B1 and B2 RNA can be clearly detected in cells, the 
occupancy of Pol III transcription apparatus was investigated on these mouse 
SINEs. Mouse fibroblasts were subjected to ChIP assays with antibodies against 
Pol III transcription apparatus (Figure 3.4). Primers against the consensus B1 and 
B2 sequences were used to detect enrichment on most mouse SINEs. Moreover, 
enrichment at two specific SINEs, B1(ch9) and B2(ch9), was also analysed using 
primers designed against flanking DNA. Primers amplifying three different copies 
of the murine 7SL gene provide the positive control for Pol III transcription 
machinery. 
As observed on human Alu SINEs, B1 and B2 SINES also show clear enrichment of 
Pol III and the transcription factors TFIIIB and TFIIIC. The negative control Apo-E 
shows no enrichment for the transcription apparatus, indicating the specificity 
of the assay. Pol III enrichment is considerably lower on SINEs compared to the 
actively transcribed 7SL loci, however no such difference is seen in TFIIIB and 
TFIIIC occupancy. B2 consensus sequence shows higher Pol III loading compared 
to its B1 counterpart (p<0.05). This indicates that the comparatively higher 
levels of B2 transcripts seen in mouse cells (Ryskov et al., 1983) could be due to 
increased Pol III loading onto these elements. The presence of Pol III on B1 and 
B2 sequences was also confirmed in mouse ES cells (Figure 3.14). 
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Figure 3.4: Pol III transcription apparatus occupies B1 and B2 SINEs in MEFs 
ChIP assay in MEFs with antibodies against Rpc155, BRF1 and TFIIIC220 at B1 and B2 genomic 
consensus sequences. B1(ch9) and B2(ch9) are specific SINEs on chromosome 9. 7SL and Apo-E 
loci respectively provide the positive and negative controls for Pol III transcription apparatus 
occupancy. ChIPs with TAFI48 antibody and histone H3 antibody provide the negative and positive 
controls, respectively. Serial dilutions of the inputs show the quantitative nature of the PCR. 
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The binding of MBPs to B1 and B2 sequences in mouse fibroblasts was also 
investigated using ChIP assays (Figure 3.5). Clear enrichment of all three MBPs is 
detected on mouse SINEs, suggesting that both murine SINE families are 
methylated. The 7SL locus does not show any enrichment, indicating the 
specificity of the reaction. Compared to MBD1 and MBD2, MeCP2 showed higher 
enrichment on SINEs. However the positive control, Apo-E, shows higher MBD1 
binding and lower MBD2 and MeCP2 occupancy. Elevated MeCP2 occupancy 
seems to be a feature of SINEs. No significant differences are observed in MBP 
loading between B1 and B2 sequences (p>0.1). So in spite of having similar levels 
of MBPs, B2 SINEs are still capable of higher polymerase loading.  
Thus it seems that both human and murine SINEs are occupied by Pol III 
transcription apparatus and MBPs. 
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Figure 3.5: MBPs occupy B1 and B2 SINEs in MEFs 
ChIP assay in MEFs with antibodies against MBD1, MBD2 and MeCP2 at B1 and B2 genomic 
consensus sequences. B1(ch9) and B2(ch9) are specific SINEs on chromosome 9. Apo-E and 7SL 
loci respectively provide the positive and negative controls for MBP occupancy. ChIPs with beads 
only and TAFI48 antibody provide the negative controls, whereas histone H3 antibody provides the 
positive control. Serial dilutions of the inputs show the quantitative nature of the PCR. 
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3.2.3 Human and mouse cells contain sufficient Pol III 
transcription factors to occupy SINEs 
SINEs are very abundant in human and mouse genomes. If all these loci are 
enriched for Pol III transcription apparatus, then the cell would require a huge 
reservoir of these transcription factors. Previous estimates in yeast have shown 
TBP, BRF1 and Bdp1 to be equimolar with ~1000 molecules per cell each (Sethy-
Coraci et al., 1998). In HeLa cells, the number of TBP molecules has been 
estimated to be 1.9 x105 per cell (Kimura et al., 1999). So there seems to be 
sufficient TBP in a cell. But are there enough of Pol III specific transcription 
factor molecules per cell? 
Table 3.1: TBP, BRF1 and TFIIIC110 protein quantification. 
HeLa and MEF total cell extracts were subjected to quantitative western blot analysis. The number 
of molecules per cell was estimated using total cell extracts from a known cell number and a 
recombinant protein titration. Errors represent standard deviations. n=3 [TFIIIC110 (n=1) data 
provided by Damian Grazcyk] 
 
Molecules/Cell HeLa MEF 
TBP 5.1x105 ± 1.6x105 2.9x106 ± 0.2x105 
BRF1 6.4x105 ± 0.9x105 1.4x106 ± 2.8x105 
TFIIIC110 5x105   
 
In order to quantify the number of molecules of Pol III transcription factors per 
cell, HeLa and MEF total cell extracts obtained from a known number of cells 
were used alongside titrations of purified recombinant proteins in Western blot 
analysis. Table 3.1 shows the estimated molecules per cell counts for TBP, BRF1 
and TFIIIC110. All three proteins have roughly half a million molecules per HeLa 
cell. MEFs have an estimated 3million TBP molecules and 1.4million BRF1 
molecules. Thus it seems that these transcription factors have enough protein 
molecules per cell to occupy all SINE sequences. 
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3.2.4 The presence of MBPs and DNA methylation does not inhibit 
polymerase loading onto SINEs 
The data so far suggest that SINEs in human and mouse cells occupied by Pol III 
transcription apparatus are also enriched for MBPs. However, these two protein 
subsets could be binding to the same locus at different times or in different 
cells, i.e. not simultaneously. In order to investigate this possibility, sequential 
ChIP assay was performed on HeLa cells (Figure 3.6). The primary ChIP was 
performed with an antibody against the 155kDa subunit of Pol III. TAFI48 
antibody provided the negative control for this IP and did not show any 
enrichment at Pol III transcribed sequences, indicating the specificity of the 
primary reaction (data not shown).  
The chromatin obtained from the Pol III ChIP was then subjected to sequential 
ChIP with antibodies against MBPs. 100% input was taken from the primary ChIP 
material in order to make the input dilutions. Secondary ChIPs with Pol III and 
BRF1 antibodies provide the positive controls. The Pol III re-ChIP signal is nearly 
as strong as the undiluted input, indicating the specificity of the primary ChIP 
and the efficiency of the secondary reaction.  
Sequential ChIPs show clear enrichment of MBPs on Pol III-bound Alu loci, 
indicating their co-occupancy. The 7SL locus, which is clearly enriched for BRF1 
and Pol III in the sequential ChIP, remains negative for MBP occupancy. Alu(ch22) 
shows a distinct lack of MBD1 co-occupancy. This was due to experimental 
variation, and other repeats showed MBD1 co-occupancy at this locus. Different 
Alu loci show variable MBP co-occupancy in different experiments; however MBP 
co-occupancy is almost invariably seen. Thus it seems that the presence of MBPs 
is not sufficient to exclude Pol III from Alu sequences. 
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Figure 3.6: Pol III transcription apparatus and MBPs co-occupy Alu SINEs 
Sequential ChIP assay in HeLa cells where the first ChIP performed with antibody against Rpc155 
was followed with a second ChIP with antibodies against MBD1, MBD2 and MeCP2. TAFI48 
provides the negative control for the first (data not shown) and second ChIPs. Re-ChIPs with 
Rpc155 and BRF1 antibodies provide the positive controls. 7SL locus provides the negative control 
for MBP occupancy. Serial dilutions of the inputs show the quantitative nature of the PCR. 
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DNA methylation can directly inhibit the binding of transcription factors to their 
cognate sequences (Watt and Molloy, 1988). Since methylation of a single CpG 
within the A-box was seen to inhibit transcription (Liu and Schmid, 1993), this 
could be the mode of transcriptional inhibition at SINEs. In order to find out if 
Pol III transcription apparatus can occupy methylated DNA, material obtained 
from Pol III and TFIIIC ChIP was subjected to methylation-sensitive digests 
(Figure 3.7). Restriction endonucleases HpaII and MspI are isoschizomers that 
cleave at CCGG sequences. Cleavage by HpaII is prevented by the presence of a 
5-methyl group at the internal cytosine of its recognition sequence, whereas 
MspI can cleave the DNA irrespective of its methylation status (Waalwijk and 
Flavell, 1978). 
HeLa DNA obtained from Pol III, TFIIIC, MBD2 and MeCP2 ChIPs was spiked with 
100ng of an unmethylated PCR product containing a central CCGG sequence. 
This cocktail was then digested with HpaII and MspI for 1 hour. PCRs against the 
unmethylated ‘spike’ were used to normalise for the differences in the digestion 
efficiency between the two enzymes. These normalised samples were then 
subjected to PCRs targeting an Alu sequence that contains two CCGG sites, one 
near the 5' end and another towards the 3' end of its sequence. 
It can be seen that the Alu(ch6) DNA in the input sample is resistant to HpaII 
digestion compared to MspI digestion, indicating that this sequence is 
methylated in HeLa cells. As expected, the DNA from the positive control MBD2 
and MeCP2 ChIPs is also methylated. Moreover, this resistance to HpaII digestion 
remains following Pol III and TFIIIC ChIPs. Surprisingly, this suggests that Pol III 
and TFIIIC are capable of occupying methylated Alu sequences. 
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Figure 3.7: Pol III transcription apparatus occupies methylated Alu DNA 
a) Schemaic for the ChIP-ChOP assay. b) ChIP-ChOP assay in HeLa cells where ChIP with 
antibodies against Rpc155, TFIIIC220, MBD2 and MeCP2 was followed by restrictions digests with 
DNA methylation-sensitive endonuclease HpaII and its methylation-insensitive isoschizomer MspI. 
The ChIP DNA was spiked with 100ng of unmethylated PCR product prior to digestion, which was 
then used to normalise for digestion efficiency. PCR for Alu(ch6) was performed using the 
normalised sample dilutions. 
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It is unlikely that only the CpGs within the restriction endonuclease recognition 
sites are methylated and the surrounding CpGs are unmethylated. However, the 
enzymatic approach is a crude one and in order to thoroughly investigate the 
methylation status of the polymerase-bound SINEs, ChIP bisulphite sequencing 
was performed on input DNA and Pol III ChIP DNA (Figure 3.8) by Andrew Oler 
from Bradley Cairns Lab. 
Sodium bisulphite treatment of fully denatured DNA causes the conversion of 
cytosine residues to uracil. However, 5-methylcytosine residues are non-reactive 
to sodium bisulfite. Upon sequencing the DNA, one could determine the 
methylation status of the CpGs by looking for unconverted cytosine residues 
(Grunau et al., 2001). With the advent of high-throughput and massively parallel 
sequencing techniques, bisulphite sequencing has become a powerful technique 
and has been successfully used for methylation analysis of various genomes 
(Bernstein et al., 2007; Smith et al., 2009). ChIP-bisulphite sequencing is a 
variation on this technique, where DNA obtained from ChIP is converted with 
sodium bisulphite and sequenced. This is used to shed light on the methylation 
status of DNA bound to particular proteins.  
Prior to bisulphite treatment, both input and Pol III ChIP DNA were spiked with 
unmethylated lambda DNA. The efficiency of bisulphite conversion was 
determined to be 99.87% based on the conversion of cytosine residues in this 
‘spike’ DNA. Bisulfite conversion has been previously shown to introduce single 
strand breaks, thus making the DNA prone to breaking (Munson et al., 2007).  
Bisulfite treatment is also thought to cause DNA degradation through 5mC-
selective hydrolysis and depyrimidination (Tanaka and Okamoto, 2007). Due to 
these technical shortcomings, small insert size distribution (median 80bp, peak 
60bp) was observed in the ChIP bisulfite sequencing data. Unique alignments 
depend on fragments covering unique flanking regions alongside the consensus 
sequence. The small insert size resulted in low numbers of unique alignments for 
Alu sequences, which meant the overall coverage of Alus was low. Due to these 
technical limitations the sequencing data was aligned to 14 consensus sequences 
for different Alu families (Figure 3.8). 
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All Alu families show higher level of DNA methylation (5% to 14%) compared tRNA 
genes (0% to 5%). Alus are also generally less enriched for Pol III than tRNA 
genes, which is in agreement with the data previously obtained by ChIP-PCR. As 
expected, Pol III ChIP DNA does not show a decrease in Alu methylation 
compared to the Input sample. Input DNA also shows the presence of CpG 
methylation on A- and B-box sequences. However, Pol III ChIP sample also shows 
the presence of DNA methylation at these crucial regulatory sequences.  
The newer AluY elements have higher methylation than their older AluJ or AluS 
counterparts. The same pattern is observed for A- and B-box methylation, where 
B-box methylation is 13% in AluJ, 30-50% in AluS and 55-65% in AluY. Thus it 
seems Alu methylation diminishes with age. However, the younger Alu elements 
also show higher Pol III loading compared to the older families. AluY families 
show more than two-fold higher Pol III occupancy than AluJ families (data not 
shown). Thus the newer Alu families are able to load more Pol III despite having 
a higher level of methylation. 
These data strengthen the opinion that DNA methylation, including methylation 
within the A- and B-box sequences, is unable to inhibit Pol III loading onto SINEs. 
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Figure 3.8: ChIP-bisulphite sequencing analysis of Alu consensus sequences 
Bisulphite sequencing of input and Rpc155 ChIP DNA from HeLa cells aligned to 14 consensus 
sequences for various SINE families. 99.87% efficiency was calculated for the bisulphite 
conversion reaction. The Y-axis represents % of unconverted cytosine residues obtained in the 
Input fraction and the Pol III ChIP fraction (i.e. Rpc155_Fraction) respectively (Data provided by 
Andrew Oler).  
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3.2.5 Loss of DNA methylation neither increases Pol III loading 
onto SINEs, nor does it elevate SINE expression 
From the evidence so far, it is clear that human and mouse SINEs are occupied 
by Pol III transcription apparatus and this polymerase loading is not prevented by 
the presence of MBPs or DNA methylation. However, this is contrary to what is 
suggested by the existing literature, where SINE transcription is reported to be 
inhibited by DNA methylation (see section 3.1). So what does the absence of DNA 
methylation on SINEs do to the polymerase loading onto these elements? And 
how does it affect their cellular transcript levels? 
Dnmt1-/- mice were reported to be embryonically lethal, however ES cells 
carrying this mutation showed no detectable effect on viability or proliferation 
in culture (Li et al., 1992). Deletion of the first exon of Dnmt1 led to 80% 
genomic demethylation, where the residual DNA methylation was attributed to 
activity of de novo methyltransferases DNMT3a and DNMT3b (Lei et al., 1996). It 
has been observed that only Dnmt1 mutants show this marked loss of genomic 
methylation. Dnmt3a and Dnmt3b double knockout ES cells show disruption of de 
novo methylation however this does not cause demethylation at imprinted loci 
(Okano et al., 1999), whereas loss of DNMT2 shows little effect on genomic 
methylation (Okano et al., 1998). 
In cortrast to ES cells, differentiated cells do not tolerate the loss of DNMT1 
well. Deletion of Dnmt1 in proliferating neural cells lead to functional 
impairment and poor survival (Fan et al., 2001). Fibroblast cells undergo 
premature senescence in the absence of DNMT1 through a p53-dependent 
mechanism (Jackson-Grusby et al., 2001). Lande-Diner et al obtained a viable 
Dnmt1 null MEF cell line by crossing Dnmt1-/- animals to a p53-/- null background 
(Lande-Diner et al., 2007). These cells grow at normal exponential rates and do 
not show senescence even after 100 passages. Since these cells are 
differentiated, they lack de novo methyltransferase activity and have no residual 
maintenance methyltransferase. Due to progressive loss of DNA methylation, 
their genome was shown to be severely hypomethylated compared to control 
p53-/- fibroblasts. Thus, these cells provide an ideal ‘methylation free’ 
environment to study the effect of DNA methylation on SINE transcription. 
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The levels of genomic methylation in p53-/- and Dnmt1-/- p53-/- MEFs were 
analysed by methylation-sensitive restriction digests (Figure 3.9). 1µg of 
genomic DNA obtained from both cell types was subjected to 30 minute 
digestion with HpaII and MspI. The digested material was then resolved on a 1% 
agarose gel alongside mock-digested DNA. The undigested material stays at the 
top of the lane, whereas MspI-digested DNA forms a smear in the entire lane 
lacking a clear ‘table’ at the top. It can be clearly seen that the genomic DNA 
from Dnmt1 null MEFs is readily digested by HpaII, unlike its counterpart from 
the control cells. Moreover, the smear formed by HpaII digest is very similar to 
the one formed by MspI digestion, suggesting that the Dnmt1-/- genome is almost 
completely demethylated. 
In order to study the effect of the loss of DNA methylation on SINEs, both the 
p53-/- and Dnmt1-/- p53-/- cells were subjected to ChIP assay with antibodies 
against Pol III transcription apparatus (Figure 3.10). ChIP with MBD2 antibody 
provided the control for the DNA methylation status. The ChIPs from the two 
different cell types were normalised to serial input dilutions. Apo-E locus was 
unoccupied by Pol III in both the control and null cells. Moreover, MBD2 
occupancy on the Apo-E locus shows a dramatic reduction in the Dnmt1 null 
cells, indicating the loss of DNA methylation. The occupancy of transcription 
apparatus on the positive control, 7SL, does not alter upon DNMT1 loss. This 
suggests that there is no overall change in Pol III loading at generic Pol III 
transcribed loci. 
Surprisingly, neither B1 nor B2 sequences show any change in polymerase 
loading. This is also confirmed on the specific B1 and B2 loci on chromosome 9. 
There are no alterations in TFIIIB or TFIIIC loading on SINEs either, whereas MBD2 
occupancy on SINEs is clearly diminished, indicating that these sequences are 
demethylated. This result, contrary to expectations, suggests that loss of DNA 
methylation does not cause any elevation in Pol III loading onto SINEs. 
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Figure 3.9: Dnmt1-/- cells have markedly reduced DNA methylation 
Restriction digests on 1µg genomic DNA from p53-/- and p53-/- Dnmt1-/- cells with DNA methylation-
sensitive endonuclease HpaII and its methylation-insensitive isoschizomer MspI.  
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Figure 3.10: Loss of DNA methylation and MBP occupancy does not alter Pol III 
transcription apparatus occupancy on SINEs 
ChIP assay in p53-/- and p53-/- Dnmt1-/- MEFs with antibodies against Rpc155, TFIIIC220 and BRF1 
at B1 and B2 genomic consensus sequences. B1(ch9) and B2(ch9) are specific SINEs on 
chromosome 9. ChIP with MBD2 antibody indicates the DNA methylation status of the locus. Apo-E 
and 7SL loci respectively provide the positive and negative controls for MBP occupancy and visa 
versa for Pol III transcription apparatus. ChIPs with beads only and TAFI48 antibody provide the 
negative controls. The ChIPs were normalised to serial dilutions of the inputs. 
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It is possible that a few of the B1 and B2 SINEs in the Dnmt1-/- cells have 
elevated polymerase loading, but this increase can not be detected by the 
consensus primers. This is a limitation of the ChIP PCR approach and ChIP 
sequencing is required to detect these genome wide locu-specific changes. 
However, increased transcription at these few SINEs would still lead to a 
detectable increase in cellular transcript levels. 
SINEs are widely transcribed by Pol II as a part of mRNA transcripts (Yulug et al., 
1995). In order to study the effects of DNA methylation loss on Pol III-driven SINE 
transcription, one must discriminate between Pol II-transcribed and Pol III-
transcribed RNA. Traditional approaches have used primer extension technique, 
where the larger Pol II-transcribed RNA extension products can be resolved from 
the smaller Pol III-transcribed RNA products (Liu et al., 1994). 
At low concentrations, α-amanitin specifically inhibits Pol II transcription whilst 
allowing normal Pol I and Pol III transcription (Lindell et al., 1970). Therefore in 
order to discriminate between Pol II and Pol III driven SINE transcription, p53-/- 
and p53-/- Dnmt1-/- cells were treated with 50µg/ml α-amanitin for 24hrs. Any 
changes observed in the SINE transcript levels following this treatment cannot be 
a response of genes transcribed by Pol II. Total RNA from mock-treated and α-
amanitin-treated cells was subjected to RT-PCR analysis using primers against B1 
and B2 consensus transcripts (Figure 3.11). The reaction was normalised to Pol I-
transcribed 28S rRNA levels. c-MYC mRNA provides the control for the successful 
ablation of Pol II transcription. Apo-E mRNA shows elevated transcription in 
Dnmt1-/- cells, indicating that the DNA methylation-dependent transcriptional 
repression of this locus is lost in these cells. However, the Apo-E transcript 
levels are not reduced following α-amanitin treatment, which could be due to 
higher transcript stability.  
Contrary to expectations, SINE transcript levels are not elevated in the absence 
of DNA methylation. This result remains unchanged following α-amanitin 
treatment. Therefore, we conclude that a genetic ablation of DNA methylation 
neither elevates Pol III loading onto SINEs, nor does it elevate cellular SINE 
transcript levels. 
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Figure 3.11: Loss of DNA methylation does not elevate SINE expression in Dnmt1-/- cells 
Analysis by RT-PCR of expression levels of B1 and B2 transcripts in p53-/- and p53-/- Dnmt1-/- 
MEFs. Apo-E mRNA provides a positive control for loss of DNA methylation. Cells were treated 
with 50µg/ml α-amanitin for 24hrs. c-MYC mRNA provides a control for α-amanitin treatment. 28S 
rRNA provides the loading control. 
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The major drawback of using a genetic approach for reducing DNA methylation is 
that the cells may compensate for the alterations caused by the genetic deletion 
and use alternative pathways for silencing SINEs. It was therefore deemed 
necessary to use an acute pharmacological approach to reduce DNA methylation 
and study alteration in SINE transcription. Levels of Alu transcripts were shown 
to be highly elevated following 5-azacytidine treatment of HeLa cells for eight 
days (Liu et al., 1994). However, this long treatment may be unnecessary since 
clear demethylation of HeLa DNA could be seen following 72hr treatment of 
HeLa cells with 4µM 5-azacytidine (Figure 3.12). 
Methylcollector assay (Active Motif) was performed on sonicated genomic DNA 
from HeLa cells that were mock-treated or treated with 4µM 5-azacytidine for 
72hrs. The assay uses his-tagged recombinant MBD2b/MBD3L1 protein, which 
shows remarkable affinity to meCpG (Jiang et al., 2004) and specifically binds 
methylated DNA. PCRs were then performed on the collected (methylated) and 
wash-through (unmethylated) fractions. 7SL and APC loci, which provide controls 
for unmethylated DNA, are eluted in the wash-through fraction in both 
untreated and 5-azacytidine treated cells. Apo-E locus, which provides the 
positive control for DNA methylation, is present in the collected fraction in the 
untreated cell, whereas, upon 5-azacytidine treatment it is eluted in the wash-
through, suggesting that it was successfully demethylated.  
It can be clearly seen that Alus, which elute in the methylated fraction in 
untreated cells, are demethylated by 5-azacytidine treatment and elute in the 
unmethylated fraction. Thus, it is sufficient to treat HeLa cells for 72 hours with 
4µM of 5-azacytidine in order to demethylate the majority of Alu repeats. This 
treatment was used in the following experiments to study the SINE transcript 
levels and promoter Pol III loading. 
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Figure 3.12: 5-azacytidine treatment reduces DNA methylation on Alus 
Methylcollector assay on genomic DNA from HeLa cells treated with 4µM 5-azacytidine for 72hrs. 
me-CpG lanes contain methylated DNA retained by the methylcollector and the CpG lanes contain 
unmethylated DNA collected from the wash-through. Apo-E PCR provides the positive control for 
methylated DNA, whereas APC and 7SL PCRs provide the negative controls. 
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Total RNA from mock-treated or 5-azacytidine-treated MEF and HeLa cells was 
subjected to RT-PCR analysis in order to detect the levels of cellular SINE 
transcripts (Figure 3.13). ARPP P0 mRNA was used to normalise the PCR 
reactions (Laborda, 1991). As expected, Apo-E mRNA levels are increased 
following 5-azacytidine treatment and DNA demethylation, whereas no change is 
observed in the levels of pre-tRNALeu in HeLa cells. However, contrary to 
previous reports, neither mouse nor human SINE transcript levels show any 
increase after demethylation.  
ChIP assay with antibodies against MBPs and Pol III was then performed on 
chromatin from mock-treated and 5-azacytidine-treated mouse ES cells (Figure 
3.14). It was observed that 16hrs of 5-azacytidine treatment was enough to 
demethylate SINEs in this cell type. The ChIPs from the untreated and treated 
cells were normalised to serial input dilutions. 7SL sequence provides the 
negative control for MBP occupancy and positive control for Pol III occupancy. 5-
azacytidine treatment leads to a clear eviction of MBD2 and MeCP2 from B1 and 
B2 consensus sequences, indicating that this DNA has been successfully 
demethylated. However, as observed in the Dnmt1-/- cells, 5-azacytidine 
treatment does not lead to increased polymerase loading onto murine SINEs. 
Alu(MLL) is a transgenic Alu sequence, which is introduced into these mouse ES 
cells (Elliott et al., 2005). This ectopic sequence also shows Pol III loading and 
loss of methylation is unable to elevate this polymerase occupancy either. 
Thus, it can be concluded that genetically or pharmacologically stimulated loss 
of DNA methylation does not alleviate SINE transcriptional repression. 
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Figure 3.13: 5-azacytidine treatment does not elevate SINE expression 
Analysis by RT-PCR of expression levels of B1 and B2 transcripts in MEFs and Alu transcripts in 
HeLa cells following treatment with 4µM 5-azacytidine for 16hrs and 72hrs respectively. Apo-E 
mRNA provides the positive control and ARPP P0 mRNA provides the loading control. 
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Figure 3.14: 5-azacytidine treatment does not alter Pol III occupancy on SINEs 
ChIP assay in mouse ES cells with antibody against Rpc155 at B1 and B2 genomic consensus 
sequences following treatment with 4µM or without 5-azacytidine for 16hrs. ChIP with beads only 
and TAFI48 antibody provide the negative controls. ChIPs with antibodies against MBD2 and 
MeCP2 indicate the DNA methylation status of the loci. 7SL locus provides positive control for Pol 
III binding and negative control for MBP occupancy. Alu(MLL) is an ectopic Alu sequence 
introduced into the mouse genome (Refer to chapter 4). The ChIPs were normalised to serial 
dilutions of the inputs. 
  
 100 
3.3 Discussion 
Recently published genome wide studies have suggested the presence of Pol III 
on SINES. Using ChIP-sequencing for Pol III in K562 cells, Kevin Struhl and co-
workers reported ~1000 Pol III enriched loci that had not been previously 
described. 90% of these sites are found to be located near SINEs and comprise 
~61% of total Pol III binding sites in the genome. These sites showed considerably 
reduced polymerase loading compared to tRNA genes, however enrichment 
levels were clearly above background (Moqtaderi et al., 2010). This could be 
unique to K562 cells, which have reduced DNA methylation on SINEs (Li et al., 
2000). However, ChIP-sequencing in IMR90 cells (Canella et al., 2010) and HeLa 
cells (Oler and Cairns) has also revealed the clear presence of Pol III on Alus 
sequences.  
In agreement with these genome-wide approaches and contrary to expectations, 
this chapter provides clear evidence for the presence of Pol III transcription 
apparatus on human and mouse SINE sequences. SINEs show a distinct reduction 
in Pol III loading compared to the actively transcribed 7SL locus. No such 
difference is observed in TFIIIB or TFIIIC occupancy. As yet the reason for this 
defect in Pol III recruitment on SINEs is unclear. 
In order for transcription apparatus to occupy the sheer number of SINES, a cell 
would require a large amount of Pol III transcription factors. Estimates from 
quantitative western blots suggest that TBP, BRF1 and TFIIIC110 are equimolar in 
MEF (2x106 mol./cell) and HeLa cells (5x105 mol./cell). Since TBP is required for 
all nuclear transcription (Cormack and Struhl, 1992) it could be reasoned that a 
cell would require a higher amount of this transcription factor. The relatively 
high amounts Pol III specific transcription factors means that the cell possesses 
sufficient quantities of these molecules to quench the thirst of SINEs for these 
transcription factors. MEFs show higher amount of all three transcription factors 
quantified compared to HeLa cells, which may be to maintain equal 
concentrations over the larger nuclear volume observed in MEFs (personal 
observation). 
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As very low levels of SINE transcripts are present in a cell (Maraia et al., 1993; 
Paulson and Schmid, 1986), it seems that the preassembled transcription 
complexes on SINEs are transcriptionally inactive or have very low 
transcriptional output. The innate unstable nature of SINE transcripts (Li and 
Schmid, 2004) and degradation by DICER1 (Kaneko et al., 2011) may also 
contribute to the low transcript levels. The quick transcriptional response of 
SINEs to cell stresses (Li et al., 1999; Liu et al., 1995) may require the presence 
of these poised transcription complexes. 
For more than a decade, DNA methylation has been thought to be primarily 
responsible for inhibiting SINE transcription. One mode of transcriptional 
repression by DNA methylation is through the recruitment of MBPs, which can 
repress transcription through their transcription repression domains (Hendrich 
and Bird, 1998). This study demonstrates the enrichment of MBPs on both human 
and mouse SINEs. B2 elements also seem to be occupied by MBPs, for which 
there is no previous precedent. MBD1, MBD2 and MeCP2 have been previously 
shown to have differing binding preferences. For example, high affinity binding 
of MeCP2 to DNA requires a stretch of four or more A/Ts adjacent to the meCpG, 
whereas MBD1 prefers to bind meCpGs within TCGCA and TGCGCA sequences 
(Clouaire et al., 2010). MeCP2 shows higher occupancy on SINEs compared to 
MBD1 and MBD2, however the reason for this is unclear since the SINEs studied 
are not distinctly enriched for CpGs flanked by A/Ts. However, the presence of 
various MBPs is not enough to inhibit polymerase recruitment to these 
sequences. Sequential ChIP assays revealed that Pol III is able to co-occupy SINE 
sequences alongside MBPs. 
DNA methylation can also repress transcription by directly inhibiting 
transcription factor binding to their recognition sequences (Watt and Molloy, 
1988). A considerable number of DNA-binding proteins require contact with 
cytosine in the major groove of the double helix. Most mammalian transcription 
factors have recognition sites which are within GC-rich sequences (Bird and 
Wolffe, 1999). Indeed, the consensus B-block binding sequence in Pol III 
promoters has a central CG dinucleotide (Galli et al., 1981). The methylation of 
an A-block CpG was shown to be deleterious for Alu transcription in vitro, 
although the methylation of surrounding CpGs was found to be equally disruptive 
(Liu and Schmid, 1993). 
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This study clearly demonstrates that TFIIIC and Pol III are capable of recruitment 
to methylated DNA in cells. It is possible that TFIIIC averts the binding inhibition 
by meCpG due to the numerous points of contacts it makes with the DNA 
(Bartholomew et al., 1990; Braun et al., 1992; Gabrielsen et al., 1989; Kovelman 
and Roeder, 1992; Yoshinaga et al., 1989). However, as B-block binding 
determines the promoter affinity of this multi-subunit transcription factor, it is 
possible that B-block CpG methylation would be more deleterious to TFIIIC and 
therefore Pol III recruitment.  
Bisulfite sequencing revealed the presence of DNA methylation on Pol III 
occupied Alu sequences. Analysis of 14 Alu family consensus sequences shows 
that there is no difference in the DNA methylation levels between the input and 
Pol III ChIP samples. Pol III ChIP sample also contains Alu sequences methylation 
within the A- and B-boxes. These data suggest that Pol III loading is not affected 
by DNA methylation, even when A- and B-box regulatory elements are 
methylated. 
Moreover, the young AluY elements show higher DNA methylation compared to 
their older AluJ and AluS counterparts, which may have lower CpG content due 
to a loss of meCpGs through deamination (Duncan and Miller, 1980). Despite 
having higher DNA methylation, AluY families show higher Pol III loading 
compared to AluJ or AluS elements. This may be due to the more intact A- and 
B-boxes found within these younger transposons which show the least amount of 
sequence divergence from the master Alu gene (Shen et al., 1991). Therefore, 
DNA methylation is not found to negatively correlate with RNA Pol III loading at 
SINEs. 
This study finds no evidence to support the idea that DNA methylation inhibits 
SINE transcription. In Dnmt1-/- cells, loss of DNA methylation does not elevate 
Pol III loading onto SINEs, neither does it increase SINE expression. This result is 
also confirmed with 5-azacytidine treatment of human and mouse cells, which is 
surprising and contradictory to the existing literature. 5-azacytidine treatment 
of HeLa cells was previously shown to cause 5- to 8-fold elevation in Alu 
transcripts (Liu et al., 1994). However, the cells were treated for 8 days with 5-
azacytidine, and the transcriptional effect observed may have been due to 
downstream effects of this long treatment. The authors confirmed that Alus 
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were demethylated, but this does not prove that demethylation was directly 
responsible for upregulation of Alu expression. 5-azacytidine has been shown to 
cause DNA damage (Juttermann et al., 1994; Murakami et al., 1995) and SINE 
transcription is upregulated in response to DNA damaging agents (Rudin and 
Thompson, 2001). The present study found that 16 – 72hr treatment of mouse 
and human cells was sufficient to cause SINE demethylation, but does not lead 
to elevation of SINE expression. Moreover, this expression data is strongly 
supported by the promoter occupancy analysis. 
There have been multiple studies showing DNA methylation dependent inhibition 
of SINE transcription in vitro (Kochanek et al., 1993; Liu and Schmid, 1993) and 
following transient transfections (Koch and Stratling, 2004; Yu et al., 2001). DNA 
methylation inhibited Alu transcription at low template concentration, whereas 
no such inhibition was observed at higher template concentrations which would 
more accurately represent the high SINE copy number found in vivo (Liu and 
Schmid, 1993). Co-transfection of methylated Alu sequences with the MeCP2 TRD 
relieved the methylation-mediated repression, rather than compounding it (Yu 
et al., 2001). In agreement with this, there is evidence in our lab that a genetic 
loss of MeCP2 does not lead to elevation in cellular SINE transcript levels 
(Unpublished data, Jana Vávrová). Cell stress response is able to elevate SINE 
transcription without affecting DNA methylation status (Chu et al., 1998; Liu et 
al., 1995), suggesting that transcription through methylated SINE DNA may be 
possible. Thus, it is possible that SINE transcriptional inhibition is achieved 
through chromatin modifications. This possibility has been investigated in 
Chapter 4. 
This chapter demonstrates that human and mouse SINEs are occupied by Pol III 
transcription apparatus and this occupancy is unaffected by the presence of DNA 
methylation and MBPs. Moreover, genetically or pharmacologically stimulated 
loss of DNA methylation does not elevate SINE transcriptional repression. 
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Chapter 4 Chromatin and Pol III mediated 
transcription of SINEs 
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4.1 Introduction 
As previously described, human and mouse SINE elements are occupied by Pol III 
transcription apparatus. However, Pol III loading on SINEs is considerably 
diminished compared to actively transcribed 7SL genes. Loss of DNA methylation 
neither leads to increased cellular SINE transcript levels, nor does it cause 
increased Pol III loading at SINEs. The presented data, along with the 
observation that cell stresses can alleviate SINE transcription from methylated 
templates (Chu et al., 1998; Liu et al., 1995), suggest that SINE transcription is 
being inhibited by mechanisms other than DNA methylation. 
Reconstitution experiments have shown that an Alu element can direct the 
rotational positioning of a nucleosome. Moreover, it was also observed that the 
methylation of this Alu template enhanced its capacity to position nucleosomes 
(Englander et al., 1993). This positioned nucleosome completely abrogated the 
Pol III-dependent in vitro transcription of the Alu template. The positional 
information was found to be an intrinsic property of the Alu family and could 
influence the conformation of the chromatin surrounding the element (Englander 
and Howard, 1995). These studies suggest that repressive chromatin could be an 
intrinsic feature of SINEs and may be responsible for their transcriptional 
repression. 
There are clear structural and functional differences between Alu chromatin 
obtained from unstressed cells and that from cells stressed with viral infections. 
Stressed Alu chromatin is more readily transcribed in vitro and is more 
accessible to enzymatic digestion (Li et al., 2000; Russanova et al., 1995). There 
is genome-wide increase in chromatin accessibility of Alu and other repetitive 
sequences following heat shock (Kim et al., 2001), whereas the levels of DNA 
methylation are unaltered (Chu et al., 1998; Liu et al., 1995). These 
observations suggest that transcriptional repression at SINEs is primarily 
maintained by repressive chromatin.  
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The relationship between DNA methylation and chromatin modifications is well 
established. Chromatin modifications are well-known downstream effectors of 
DNA methylation (see section 1.4.3). However, there is increasing evidence to 
suggest that chromatin modifications are required for the maintenance of DNA 
methylation at many locations. For example, H3K9 methylation by G9a, GLP and 
SUV39H have been shown to be necessary for maintaining DNA methylation at 
retrotransposons and satellite repeats (Dong et al., 2008; Lehnertz et al., 2003). 
Loss of DNA methylation does not lead to a decrease in H3K9me3 (Gilbert et al., 
2007; Lehnertz et al., 2003), whereas loss of K9MTs leads to a loss of DNA 
methylation (Dong et al., 2008; Lehnertz et al., 2003). 
Alu sequences have been shown to be enriched for H3K9 methylation (Kondo and 
Issa, 2003), which is a mark for repressive chromatin and transcriptional 
repression. H3K9me3 modification is responsible for the recruitment of the 
heterochromatin protein 1 (HP1) family of highly conserved non-histone 
proteins, which were identified as a component of heterochromatin in 
Drosophila. However, more recently HP1 has also been shown to cause silencing 
of euchromatic genes (Fanti and Pimpinelli, 2008). 
HP1 contains an N-terminal chromodomain which recognises H3K9 methylation. 
However, this recognition is not sufficient for the recruitment of HP1 to 
chromatin. SUV39H1 was the first K9MT identified to interact with HP1 and this 
protein-protein interaction was found to be crucial for HP1 targeting. Once 
recruited to a target HP1 can in turn recruit more SUV39H1 and propagate the 
H3K9me3 modification (Stewart et al., 2005). HP1 is now known to recognise the 
SET domain found in all K9MTs (Fritsch et al., 2010). Thus, HP1 and SUV39H1 can 
together mediate the formation of non-permissive chromatin. HP1α and HP1β 
isoforms are associated with gene repression, whereas HP1γ is associated with 
transcriptional activation (Kwon and Workman, 2010).  
Recently, Barski et al showed that levels of H3K9me3 displayed a clear negative 
correlation with Pol III loading at tRNA loci (Barski et al., 2010). This chapter 
investigates the possibility that H3K9me3 may be responsible for the repression 
of Pol III-mediated SINE transcription. 
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4.2 Results 
4.2.1 SINEs are enriched for H3K9me3, SUV39H1 and HP1. 
H3K9me3 at SINEs was shown to be sensitive to 5-azadeoxycytidine treatment, 
indicating that the presence of this modification depends on DNA methylation 
(Kondo and Issa, 2003). However, there is contradictory evidence that the 
genetic loss of DNMTs does not lead to a reduction of H3K9me3 from repeat 
sequences (Lehnertz et al., 2003). H3K9me3 along with H3K27me3, which causes 
transcriptional repression through recruitment of the polycomb group of 
proteins, are enriched at silent tRNA loci and correlate with diminished Pol III 
loading (Barski et al., 2010). To investigate the role of these repressive histone 
modifications in transcriptional silencing of SINEs, comparative ChIP assays were 
performed at SINEs in Dnmt1 wild-type and null MEFs (Figure 4.1). 
ChIPs with beads only (mock) and TAFI48 antibody provide the negative controls. 
ChIP with histone H3 provides the positive control and also controls for the 
nucleosome occupancy. The ChIP DNA was normalised to serial input dilutions. 
7SL gene, which was previously shown to be highly enriched for Pol III, shows a 
complete absence of both H3K9me3 and H3K27me3. Apo-E locus only shows the 
presence of H3K27me3. Trimethylation at H3K9 and H3K27 residues is observed 
on both mouse SINE families in control cells. Alu SINEs are also enriched for 
H3K9me3 in HeLa cells (Figure 4.2). 
Histone H3 occupancy is unaltered following the loss of DNA methylation in 
Dnmt1-/- cells. Thus, any change observed in the levels of histone modifications 
is not a function of altered nucleosome occupancy. There is a clear reduction in 
H3K27me3 at SINEs and Apo-E gene in Dnmt1-/- cells, whereas, the H3K9me3 at 
SINEs is unperturbed. This is contradictory to what was previously observed with 
5-azadeoxycytidine treatment (Kondo and Issa, 2003) and suggests that H3K9me3 
at SINEs is not dependent on DNA methylation. SINEs were found to have very 
low enrichment for active marks such as H3 acetylation, H4 acetylation and 
H3K4me3, indicating a repressive chromatin environment (data not shown). 
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Figure 4.1: Histone H3 Lysine 9 trimethylation on SINEs is unaltered in Dnmt1 null cells 
ChIP assay in p53-/- and p53-/- Dnmt1-/- MEFs with antibodies against histone H3, histone H3 Lys9 
trimethylation (H3K9me3) and histone H3 Lys27 trimethylation (H3K27me3) at B1 and B2 genomic 
consensus sequences. B1(ch9) and B2(ch9) are specific SINEs on chromosome 9. ChIPs with 
beads only and TAFI48 antibodies provide the negative controls. ChIPs were normalised to serial 
dilutions of the inputs. 
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Therefore, SINEs are enriched for H3K9me3 and the presence of this histone 
modification is independent of DNA methylation. Histone lysine 
methyltransferases responsible for the methylation of H3K9 (K9MTs) include 
SUV39H1, G9a and SETDB1 (Kouzarides, 2007). SUV39H is thought to be 
responsible for H3K9me3 at pericentric repeat sequences (Lehnertz et al., 2003). 
Moreover, SUV39H knockout mouse ES cells show elevated levels of B1 and B2 
SINE transcripts (Martens et al., 2005). These observations suggest that SUV39H 
may have a role in SINE transcriptional repression. 
In order to investigate the presence of SUV39H1 and associated HP1 at SINEs, 
chromatin from HeLa cells was subjected to ChIP assays with an antibody against 
H3K9me3, two antibodies against SUV39H1 and an antibody against all HP1 
isoforms (Figure 4.2). Histone H3 antibody provides a positive control, whereas 
TAFI48 antibody provides a negative control. Promoter of the human p21 gene, 
which has previously been shown to be occupied by SUV39H1, provides a positive 
control PCR (Cherrier et al., 2009). 7SL locus, that was previously seen to be not 
enriched by H3K9me3, provides a negative control PCR. Serial input dilutions 
show the quantitative nature of the PCRs. 
Three of the four Alu loci tested show the clear presence of both SUV39H1 and 
HP1. Alu(ch6) is enriched for H3K9me3, however it is not enriched for SUV39H1. 
The lack of HP1 at this site indicates that SUV39H1 occupancy may be necessary 
for HP1 recruitment at SINEs. It has been previously shown that the presence of 
H3K9me3 is insufficient for the recruitment of HP1 to its target loci. The 
presence of SUV39H1, but not G9a, alongside H3K9me3 was found to be required 
for successful HP1 recruitment (Stewart et al., 2005). Thus, the H3K9me3 at 
Alu(ch6) may be due to the activity of a alternative K9MT. 
Thus, it can be concluded that SINEs are enriched for H3K9me3, SUV39H1 and 
HP1. 
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Figure 4.2: Histone H3 Lysine 9 methyltransferase SUV39H1 and HP1 occupy Alu sequences 
ChIP assay in HeLa cells with antibodies against H3K9me3, two different antibodies against 
SUV39H1 and an antibody against HP1 at Alu loci on chromosome 6, 10, 19 and 22. ChIP with 
TAFI48 antibody provides the negative control. 7SL and p21 promoter respectively provide the 
negative and positive controls for the ChIP. Serial dilutions of the inputs show the quantitative 
nature of the PCR. 
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4.2.2 SUV39H1 inhibits SINE transcription irrespective of DNA 
methylation status 
Chaetocin, a fungal metabolite from chaetomium minutum, was initially 
described in the 1970s. It was identified as a specific inhibitor of SUV39H 
methyltransferase both in vitro and in vivo (Greiner et al., 2005). More recently, 
chaetocin has been used to demonstrate SUV39H1 mediated repression of the 
p21WAF1 gene in microglial cells (Lakshmikuttyamma et al., 2010) and repression 
of p15INK4B and E-cadherin genes in myeloid leukaemia cell lines (Cherrier et al., 
2009). The anti-myeloma activity of chaetocin was initially reported to be 
mediated via imposition of oxidative stress, however the apoptosis observed has 
now been shown to be also due to derepression of the p21 gene promoter 
(Cherrier et al., 2009). 
In order to investigate the role of H3K9me3 and SUV39H1 in SINE transcriptional 
repression, control and Dnmt1-/- cells were treated with increasing 
concentrations of chaetocin for 24hrs. Total RNA obtained from mock and 
chaetocin treated cells was subjected to RT-PCR analysis using primers against 
B1 and B2 consensus transcripts (Figure 4.3). Expression levels were normalised 
to ARPP P0 mRNA levels. Since the Apo-E locus was not found to be enriched for 
H3K9me3 (Figure 4.1), Apo-E mRNA levels do not respond to chaetocin treatment 
as expected. This demonstrates the specificity of the response. 
A dose-dependent increase in both B1 and B2 expression is observed following 
chaetocin treatment of Dnmt1 wild-type and null cells. An increase in levels of 
Alu transcripts was also observed in response to chaetocin treatment of HeLa 
cells (data not shown). These results suggest that SUV39H1 is responsible for 
SINE transcriptional inhibition. Moreover, chaetocin is able to derepress SINE 
transcription regardless of SINE DNA methylation status. 
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Figure 4.3: SUV39H inhibitor, Chaetocin, de-represses SINE transcription irrespective of the 
DNA methylation state 
Analysis by RT-PCR of expression levels of B1 and B2 transcripts in p53-/- and p53-/- Dnmt1-/- 
MEFs following treatment with the shown concentrations of chaetocin for 24hrs. ARPP P0 mRNA 
provides the loading control.  
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The increase observed in SINE transcript levels in response to chaetocin 
treatment could be a function of increased transcript stability or reduced 
degradation and not elevated transcription. Since, SINEs show reduced Pol III 
occupancy compared to actively transcribed Pol III genes (Chapter 3), the 
release from transcriptional repression may lead to elevation in Pol III loading. 
Thus, the Pol III loading at SINEs could be considered a surrogate for the 
transcriptional activity.  
Therefore, in order to establish if the observed effect was transcriptional, the 
levels of Pol III occupancy at SINEs were analysed following chaetocin treatment. 
HeLa cells treated with 100nM chaetocin were subjected to ChIP assays with 
antibodies against H3K9me3, Pol III and TFIIIC (Figure 4.4). TAFI48 antibody 
provides the negative control, whereas, histone H3 antibody provides the 
positive control. 7SL gene provides the positive control PCR for Pol III 
transcription factor occupancy, whereas Apo-E gene provides the negative 
control PCR. ChIPs were normalised to serial input dilutions. 
As expected, chaetocin treatment leads to a decrease in H3K9me3 enrichment 
at most Alu sequences analysed. No change in H3 enrichment is observed, 
suggesting that the decrease in H3K9mes is not due to an overall loss of 
nucleosomes but a specific reduction in the post-translational histone 
modification. Alu(ch6) does not show a decrease in H3K9me3 levels, but this 
locus is also not enriched for SUV39H1 (Figure 4.2). Since, at concentrations 
used, chaetocin is a specific inhibitor of SUV39H (Greiner et al., 2005), this 
suggests that H3K9 at Alu(ch6) is methylated by an alternative K9MT. As 
expected, the Pol III and TFIIIC occupancy on Alu(ch6) is not affected by 
chaetocin treatment.  
All Alu loci showing a decrease in H3K9me3 in response to chaetocin treatment 
show a concordant elevation in Pol III loading. This suggests that the elevated 
SINE expression observed by RT-PCR is due to an increase in Pol III-mediated 
transcription at SINEs. No increase in TFIIIC occupancy is observed following 
chaetocin treatment, suggesting that H3K9me3 specifically represses polymerase 
recruitment at SINEs. Chaetocin causes no increase in Pol III loading at the 7SL 
locus, which indicates that the elevated Pol III-loading on SINEs is not part of a 
global increase in cellular Pol III transcription. 
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Figure 4.4: Chaetocin treatment leads to increased polymerase loading onto selected SINEs 
without altering TFIIIC occupancy 
ChIP assay in HeLa cells with antibodies against H3K9me3, RPC155 and TFIIIC220 at Alu loci on 
chromosomes 6, 10, 19 and 22 following treatment with 100nM chaetocin for 24hrs. ChIPs with 
TAFI48 and H3 antibodies provide the negative and positive controls respectively. 7SL and Apo-E 
loci respectively provide the positive and negative controls for polymerase occupancy. The 
samples were normalised to serial dilutions of the inputs. 
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ChIP assays in Dnmt1 wild-type and null MEFs with antibodies against H3K9me3, 
MBD2 and Pol III were performed in order to investigate the interplay between 
DNA methylation and H3K9 methylation at SINEs (Figure 4.5). Just like the 
human SINEs, both B1 and B2 SINE sequences show reduced H3K9me3 and 
elevated Pol III occupancy in response to chaetocin treatment. However, the Pol 
III loading on a tRNALeu gene, negative for H3K9me3, is unaltered. 
Chaetocin is able to elevate Pol III loading onto SINEs both in the presence and 
absence of DNA methylation. H3K9me3 can recruit DNMTs and induce 
methylation of the target sequences (Cheng and Blumenthal, 2010). The DNA 
methylation at SINEs could be a result of such targeting. However, this is not 
found to be the case since MBD2 occupancy in Dnmt1 wild-type cells is unaltered 
following the loss of H3K9me3. Moreover, this MBD2 occupancy and the implied 
DNA methylation at B1 and B2 SINEs is unable to perturb the chaetocin-mediated 
increase in Pol III transcription, indicating that Pol III may be able to transcribe 
through methylated DNA at SINEs. 
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Figure 4.5: Chaetocin treatment leads to increased polymerase loading onto SINEs without 
altering and irrespective of the DNA methylation state 
ChIP assay in p53-/- and p53-/- Dnmt1-/- MEFs with antibodies against H3K9me3, MBD2 and 
RPC155 at B1 and B2 genomic consensus sequences following treatment with 100nM chaetocin 
for 24hrs. ChIPs with TAFI48 and H3 antibodies provide the negative and positive controls 
respectively. Apo-E and tRNALeu genes respectively provide the negative and positive controls for 
polymerase occupancy and visa versa for MBD2 occupancy. ChIPs were normalised to serial 
dilutions of the inputs. 
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4.2.3 SINE transcription and histone deacetylation 
The data so far indicate that in human and mouse cells the transcriptional 
repression of SINEs is due to the trimethylation of H3K9 by SUV39H1 and this 
repression is independent of DNA methylation. H3K9 methylation is thought to 
impose transcriptional silencing through the recruitment of HP1. However, the 
presence of H3K9 methylation has also been shown to cause deacetylation of H3 
and H4 in an HP1-independent manner (Stewart et al., 2005). There is a 
functional interaction of SUV39H1 with HDAC1, HDAC2 and HDAC3, which causes 
this HP1-independent silencing (Vaute et al., 2002). Moreover, DNA methylation 
also recruits HDACs via MBPs (Zhang et al., 1999) and therefore the involvement 
of HDACs in SINE transcriptional silencing cannot be excluded. 
To investigate this, total RNA from Dnmt1 wild-type and null cells was subjected 
to RT-PCR analysis following 6hr treatment with 100nM TSA (Figure 4.6). The 
expression levels were normalised to ARPP P0 mRNA levels. The levels of B1 and 
B2 consensus transcripts are elevated two-fold (p<0.05) following TSA treatment 
of wild-type cells, which suggests that HDACs may contribute to SINE 
transcriptional repression. In stark contrast, SINE expression is not increased 
following TSA treatment of Dnmt1 null cells (p>0.1). This surprisingly suggests 
that there is a switch from HDAC-dependent SINE repression in wild-type cells to 
a HDAC-independent repression in Dnmt1 null cells. The DNA methylation 
coupled HDAC-mediated repression indicates that DNA methylation may have a 
minor contribution in SINE transcriptional repression. 
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Figure 4.6: SINE expression is sensitive to TSA treatment in a DNA methylation-dependent 
manner. 
Analysis by RT-PCR of expression levels of B1 and B2 transcripts in p53-/- and p53-/- Dnmt1-/- 
MEFs following treatment with 100nM TSA for 6hrs. ARPP P0 mRNA provides the loading control. 
The quantification was performed using ImageJ. 
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To further study the involvement of DNA methylation and HDACs in SINE 
silencing, chromatin from Dnmt1 wild-type and null cells was subjected to ChIP 
assays with antibodies against HDAC1, HDAC2 and Pol III (Figure 4.7). TAFI48 
antibody provides the negative control. Sequential input dilutions demonstrate 
the quantitative nature of the PCRs and tRNALeu gene provides the negative 
control for HDAC occupancy. B1, B2 and Apo-E genes are clearly enriched for 
HDAC1 and HDAC2 in wild-type cells. Since the Apo-E gene does not show 
H3K9me3 enrichment, HDACs at this locus are recruited by MBPs only. A 
reduction in HDAC1 and HDAC2 enrichment is observed following the loss of DNA 
methylation, whereas no resultant increase in Pol III loading is seen at SINEs.  
The release of HDACs in Dnmt1-/- cells does not cause elevation in histone 
acetylation at SINEs (data not shown). Residual HDAC occupancy can still be seen 
in Dnmt1-/- cells, which may be recruited by SUV39H1. However, the SINEs which 
are still occupied by HDACs seem to be insensitive to TSA treatment and the 
reason for this is unclear. SINE transcription might be more sensitive to an acute 
loss of HDAC activity following TSA treatment of wild type cells. However, long 
term removal of HDAC-dependent repression in Dnmt1 null cells may be 
compensated for by a switch to ‘HP1 only’ repression, which causes the SINE 
transcription to become HDAC-independent in Dnmt1-/- cells. 
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Figure 4.7: Loss of DNA methylation leads to reduced HDAC occupancy at SINEs 
ChIP assay in p53-/- and p53-/- Dnmt1-/- MEFs with antibodies against HDAC1 and HDAC2 at B1 
and B2 genomic consensus sequences. ChIPs with TAFI48 and Pol III antibodies provide the 
negative and positive controls respectively. Apo-E and tRNAleu genes respectively provide the 
positive and negative controls for HDAC occupancy and visa versa for Pol III occupancy. The 
ChIPs were normalised to serial dilutions of the inputs. 
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SINE expression shows clear differences in the sensitivity to TSA treatment in the 
presence and absence of DNA methylation. In order to look for any effect of DNA 
methylation on SINE transcriptional sensitivity to chaetocin treatment, RT-PCR 
data in Figure 4.3 was further analysed by ImageJ densitometry (Figure 4.8). The 
expression data were normalised to ARPP P0 mRNA levels. Both B1 and B2 
expression shows an increased sensitivity to chaetocin treatment in Dnmt1 null 
cells compared to the wild-type controls. These results collectively suggest that 
the DNA methylation may be contributing to transcriptional inhibition of SINEs, 
possibly through HDACs. However, this inhibition is superseded by HDAC-
independent repression by H3K9me3-mediated repressive chromatin.  
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Figure 4.8: SINE expression shows increased sensitivity to chaetocin treatment in absence 
of DNA methylation 
Quantification by ImageJ of expression levels of B1 and B2 transcripts in p53-/- and p53-/- Dnmt1-/- 
MEFs following treatment with shown concentrations of chaetocin for 24hrs. The expression was 
normalised to ARPP P0 mRNA levels. 
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4.3 Discussion 
There is a considerable amount of evidence in the literature correlating DNA 
methylation with H3K9 methylation. DNA methylation can recruit K9MTs via 
MeCP2, whereas K9MTs can in turn lead to DNA methylation by recruiting DNMTs. 
These two represent conserved pathways that cooperate to achieve 
transcriptional repression (Cheng and Blumenthal, 2010).  
K9MTs G9a and GLP have been shown to be required for DNA methylation at 
various loci, including retrotransposons and satellite repeats. G9a-/- cells show 
reduced DNA methylation, whereas no reduction in H3K9me3 or HP1 occupancy 
is observed. Despite the loss of DNA methylation, G9a-/- cells do not show 
elevated expression of these repeat sequences. Therefore, transcriptional 
repression at repeats in G9a-/- cells is dependent on H3K9 methylation (Dong et 
al., 2008). Similarly, H3K9 methylation is sufficient to maintain endogenous LTR 
retroviral silencing in Dnmt1/3a/3b triple knockout mouse ES cells which lack 
DNA methylation (Matsui et al., 2010).  
SUV39H was also shown to be required for directing H3K9me3 and DNMT3b-
dependent DNA methylation at pericentric repeats. Dnmt1 single or 
DNMT3a/DNMT3b double-deficient mouse ES cells neither show reduced 
H3K9me3 nor show increased transcription at these repeats. However, unlike the 
G9a-/- cells, SUV39H-/- cells show loss of H3K9me3 and elevated repeat 
transcription (Lehnertz et al., 2003). From these studies, the presence of 
H3K9me3 seems to be responsible for transcriptional repression, whereas the 
presence of DNA methylation is optional. 
CTIP2, which gets recruited to the p21WAF1 promoter through interactions with 
DNMTs and HDACs, cooperates with SUV39H1 to cause transcriptional repression 
in a DNA methylation-dependent manner (Cherrier et al., 2009). At the p16INK4a 
and the E-cadherin loci in myeloid leukaemia cells, H3K9 methylation and 
transcriptional silencing also seem dependent on DNA methylation. 5-azacytidine 
treatment of these cells is sufficient to dissociate SUV39H1 from these loci and 
cause transcriptional de-repression (Lakshmikuttyamma et al., 2010). However, 
elegant time-course experiments with colorectal cancer cells show that, even 
though the loss of DNA methylation leads to reduction in H3K9 methylation at 
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the p16 locus, it’s re-silencing following multiple passages is first established by 
H3K9 trimethylation and then followed by DNA methylation (Bachman et al., 
2003). In these examples, transcriptional repression is lost by the removal of 
DNA methylation, however the initial establishment of repression may be due to 
H3K9 methylation. It is becoming clearer that histone modification are not mere 
effectors of DNA methylation mediated silencing, but, on the contrary, may be 
responsible for the establishment of silencing. DNA methylation simply seems to 
be responsible for ‘locking in’ the repressed state per se. 
SINEs have been previously shown to be enriched for H3K9 methylation (Kondo 
and Issa, 2003). H3K9me3 and H3K27me3 marks also correlate with low Pol III 
loading on inactive tRNA genes (Barski et al., 2010). The data presented in this 
chapter show SINEs to be enriched for H3K9me3 and H3K27me3. Although both 
H3K9me and H3K27me pathways are often found overlapping in transcriptionally 
silenced regions, the crosstalk between these pathways is not well understood. 
Dnmt1 null cells show a loss of H3K27me3 modification, suggesting that 
polycomb group proteins that recognise this mark may be recruited to SINEs in a 
DNA methylation-dependent manner. However, loss of DNA methylation does not 
lead to alleviation of SINE transcriptional repression (Chapter 3). Since the 
reason for repression in the absence of DNA methylation was being investigated, 
H3K27me3 was not studied further. 
Kondo et al had observed that H3K9me3 at SINEs is sensitive to 5-
azadeoxycytidine treatment, suggesting that the presence of this modification at 
SINEs is dependent on DNA methylation (Kondo and Issa, 2003). However, 
contrary to these findings, Dnmt1 null cells do not show a reduction in H3K9me3 
at SINEs. It is possible that an acute removal of DNA methylation by 5-
azadeoxycytidine causes a temporary decrease in H3K9me3 by disturbing the 
repression equilibrium at these loci, whereas this cannot be seen in stable 
genetic deletions. 5-azacytidine may also be causing a reduction of H3K9me3 
due to associated cytotoxicity and cell stress responses (Juttermann et al., 
1994). 
The H3K9me3 observed at SINEs is accompanied by K9MT SUV39H1 and 
associated HP1. Since, H3K9me3 occupancy is not sensitive to loss of DNA 
methylation, the same can be assumed for SUV39H1 and HP1. Apo-E locus is not 
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enriched for H3K9me3 and can therefore be transcriptionally de-repressed 
following loss of DNA methylation (Chapter3).  
Chaetocin, a specific SUV39H inhibitor, has recently been used to show the 
SUV39H1-mediated transcriptional repression of p16, p21 and E-cadherin loci 
(Cherrier et al., 2009; Lakshmikuttyamma et al., 2010). In the data presented 
here, chaetocin treatment causes a clear de-repression of SINE transcription, 
which is accompanied by a decrease in H3K9me3 and increased Pol III occupancy 
at SINEs. In 2005, Martens et al observed that B1 and B2 SINE transcript levels 
were elevated following SUV39H1h2 knockout in mouse ES cells. However, 
Dnmt1-/- and Dnmt3ab-/- cells did not show a similar elevation in SINE transcript 
levels (Martens et al., 2005). The data obtained in Chapters 3 and 4 agree with 
these findings. 
No increase in TFIIIC enrichment is observed following chaetocin treatment, 
suggesting that H3K9me3 inhibits transcription by specifically limiting the 
polymerase recruitment at SINEs. B1 and B2 expression levels increase in 
response to chaetocin treatment even in Dnmt1-/- cells, indicating that SUV39H1 
and H3K9me3 can maintain SINE transcriptional inhibition even in the absence of 
DNA methylation. Moreover, in wild-type cells, a reduction in H3K9me3 does not 
cause reduced MBD2 occupancy, indicating that these epigenetic modifications 
are not dependent on each other at SINEs. However, these data are obtained 
from a 24hr drug treatment that does not allow for a passive loss of DNA 
methylation and a genetic deletion of SUV39H1 may show a loss of DNA 
methylation at SINEs. 
HDACs are associated with both DNA methylation and H3K9me3-mediated 
transcriptional silencing (Vaute et al., 2002; Zhang et al., 1999). B1 and B2 
expression is found to be sensitive to TSA treatment in control cells. However, 
this is found not to be the case in absence of DNA methylation in Dnmt1-/- cells. 
Dnmt1-/- cells also show a reduction in HDAC1 and HDAC2 occupancy at SINEs, 
whereas, no consequent elevation in Pol III loading is observed. These data 
together suggest that HDAC-dependent silencing of SINEs is reliant on DNA 
methylation; however this repression is superseded by an alternative mechanism 
in the absence of DNA methylation, involving H3K9me3 and HP1.  
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This chapter demonstrates that DNA methylation and H3K9me3 provide two 
different mechanisms for SINE transcriptional repression, the former being 
HDAC-dependent and the later being HDAC-independent. However, H3K9 
methylation is the primary cause of SINE transcriptional repression that 
supersedes DNA methylation. 
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Chapter 5 DNA methylation and 
recombination at SINEs 
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5.1 Introduction 
Alu sequences show a high level of CpG methylation in most somatic tissues 
(Rubin et al., 1994; Schmid, 1991). DNA methylation also seems to be feature of 
murine SINEs (Jeong and Lee, 2005; Yates et al., 1999). The data obtained 
during this study clearly demonstrate that a loss of DNA methylation does not 
cause elevated SINE expression. Even though DNA methylation seems to have a 
contribution to SINE transcriptional inhibition, this contribution is relatively 
minor and is superseded by repression due to H3K9 trimethylation. So why is DNA 
methylation so prevalent on SINEs and does it serve any other purpose? 
Hypomethylation is common in solid tumours such as metastatic hepatocellular 
carcinomas (Lin et al., 2001), cervical cancers (Kim et al., 1994) and prostate 
tumours (Bedford and van Helden, 1987), and is also found in non-solid tumours 
such as B-cell chronic lymphocytic leukaemias (Wahlfors et al., 1992). Genomic 
hypomethylation correlates with increased disease progression and poor 
prognosis (Ehrlich, 2002). Hypomethylation is also often linked to chromosomal 
instability (CIN) in multiple human diseases (Ehrlich, 2005). 
Loss of methylation on centromeric satellite repeats is observed in multiple 
tumour types, including Wilms tumours, breast adenocarcinomas, ovarian 
epithelial carcinomas and hepatocellular carcinomas (Ehrlich, 2005). Pericentric 
repeat hypomethylation has been shown to be highly correlative with CIN in 
hepatocellular carcinomas (Wong et al., 2001). The best example for the link 
between DNA hypomethylation and CIN is provided by the rare recessive 
autosomal disorder known as immunodeficiency, centromeric instability and 
facial anomalies syndrome ICF). Biallelic mutations in DNMT3B cause 
hypomethylation at centromeric repeats leading to CIN in ICF (Xu et al., 1999). 
The loss of DNA methylation has been thought to lead to elevated transcription 
of transposable elements and thus contribute to genomic instability via an 
increase in transposition. This may be true for LINE and IAP (intercisternal A 
particle) elements (Bourc'his and Bestor, 2004; Howard et al., 2008; Jurgens et 
al., 1996), but no such evidence for Alu elements has been published. Moreover, 
the data presented in the previous chapters would argue against this possibility, 
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since the loss of DNA methylation does not lead to an elevation in SINE 
expression. 
Double-strand breaks are a threat to genomic stability and the two primary 
cellular mechanisms for dealing with this threat are homologous repair (HR) and 
non-homologous end joining (NHEJ). HR uses an identical sequence from the 
sister chromatid as a template for repair, whereas NHEJ simply ligates the 
broken ends back together. The choice between HR and NHEJ can depend on 
multiple factors such as the stage of the cell cycle, the DNA structure and the 
difficulty of repair. NHEJ is thought to be the preferred repair pathway for DSBs, 
but when the repair is more complicated HR machinery is engaged (Helleday et 
al., 2007). 
A third repair pathway called single strand annealing (SSA) is used particularly if 
two adjacent repeat sequences are involved. During SSA, the double-stranded 
DNA on both the repeat sequences is resected to give single-stranded DNA 
(ssDNA), which are then aligned and ligated. One of the repeat alleles and any 
intermediate DNA are always lost during SSA. Therefore, this repair pathway is 
highly mutagenic and can lead to permanent large deletions or chromosomal 
translocations (Haber, 2006).   
Alu sequences are homologous repeats and are, therefore, prime substrates for 
SSA. Erroneous repair between Alu repeats can be quite deleterious, since Alus 
are spread throughout the protein-coding regions of the genome (Korenberg and 
Rykowski, 1988). Areas of higher than average Alu density appear to be 
particularly associated with genomic instability. Alus are often found in the 
vicinity or even within the breakage points of translocations (Kolomietz et al., 
2002). Recombination between Alu sequences has been implicated in the 
etiology of several human genetic diseases, including α-thalassemia (Nicholls et 
al., 1987), hypercholesterolemia (Lehrman et al., 1987) and many cancers 
(Kolomietz et al., 2002). 
Erroneous repair at Alu sequences and DNA hypomethylation are both directly 
linked to genomic instability. So, does DNA methylation at Alus repress 
erroneous repair? 
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A model system designed by Elliot et al was employed to answer this question 
(Figure 5.1). Two homologous Alu elements have been stably inserted at the Rb 
locus on chromosome 14 and the Pim1 locus on chromosome 17 in a mouse ES 
cell line called Hom6.9 (Elliott et al., 2005). The Alu was derived from the mixed 
lineage leukaemia gene (MLL), where the erroneous recombination between Alu 
sequences in introns 6 and 1 gives rise to a MLL self-fusion protein (So et al., 
1997). These Alu sequences are inserted 3' and 5' of the neoMycin 
phosphotransferase gene splice donor and splice acceptor portions. An I-SceI site 
is inserted 5' and 3' of the Alu sequences respectively (Elliott et al., 2005). 
A targeted double-strand break can be introduced by electroporating the cells 
with a plasmid coding for the I-SceI restriction endonuclease. It was observed 
that an erroneous recombination event occurred with the frequency of 5.0 ± 4.0 
x 10-5, resulting in chromosomal translocation. The chromosome derived as a 
result of this translocation contained the functional neoMycin 
phosphotransferase gene. The translocation frequency was scored by counting 
the number of resistant colonies following neoMycin selection and dividing the 
colony count by the total number of cells seeded (Elliott et al., 2005). So what 
effect would demethylation of these Alu elements have on translocation 
frequency? 
 
Figure 5.1: Schematic – Translocation assay 
Homologous Alu elements (blue boxes) from the human MLL gene are inserted on chromosomes 
17 and 14 in mouse ES cells (Hom6.9 cells). These homologous Alu elements are 3' and 5' of the 
splice donor and splice acceptor portions of neoMycin resistance gene (neoSD and neoSA, yellow 
boxes). Double strand breaks (DSB) are generated by the I-SceI endonuclease. Erroneous repair 
can give rise to chromosomal translocations, where the derivative chromosome causes the cells to 
become neoMycin resistant. The frequency of this event was quantified to be 5.0 ± 4.0 
translocations/105 cells. (Elliott et al., 2005). 
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5.2 Results 
5.2.1 Ectopic Alus in mouse ES cells are methylated and sensitive 
to 5-azacytidine 
In order to investigate the effect of DNA methylation on translocation frequency 
at the Alu(MLL) element in the Hom6.9 cell line, it was first necessary to 
determine the DNA methylation status of these Alu sequences. The data in 
previous chapters show that the MBP enrichment at Alu elements is a clear 
indication of their DNA methylation status. Thus, in order to establish the 
methylation status of Alu(MLL), Hom6.9 cells were subject to ChIP assay with 
antibodies against MBD2 and MeCP2 (Figure 5.2). The polymerase occupancy at 
these ectopic Alu loci was also investigated using an antibody against the RPC155 
subunit of Pol III. Beads-only and TAFI48 antibody provide the negative controls. 
The pol II-transcribed p21 gene promoter provides the positive control for MBP 
occupancy (Cherrier et al., 2009) and negative control for Pol III occupancy, 
whereas, the tRNALeu gene provides the reverse control. 
PCR with primers recognising both the ectopic Alu(MLL) sequences shows the 
clear presence of MBD2 and MeCP2, indicating that these sequences are 
methylated. Higher enrichment of MeCP2 is observed at Alu(MLL) loci compared 
to MBD2, which is in agreement with the previous findings at endogenous Alu 
sites in human cells. Moreover, Pol III occupancy is also observed; however 
Alu(MLL) shows considerably less Pol III occupancy compared to tRNALeu gene 
(Note: The Pol III band in the tRNALeu PCR is overexposed).   
Treatment of Hom6.9 cells for 16hrs with 5-azacytidine is able to demethylate 
their genomes and cause considerable reduction in MBP enrichment at B1 and B2 
SINEs (Figure 3.13). Clear eviction of MBPs from Alu(MLL) loci is also observed, 
however, 5-azacytidine does not cause an increase in Pol III occupancy at SINEs. 
These results confirm that Alu(MLL) behaves in a manner similar to Alu 
sequences within human cells, and DNA methylation alongside Pol III occupancy 
are inherent features of SINEs. Moreover, these data suggest that any findings 
using this artificial system can be extrapolated to Alu sequences in human cells. 
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Figure 5.2: Ectopic Alus in the mouse genome behave similarly to Alus in the human 
genome 
ChIP assay in Hom6.9 cells with antibodies against MBD2, MeCP2 and RPC155 at Alu(MLL) 
sequences on chromosomes 17 and 14. ChIPs with beads only and TAFI48 antibody provide the 
negative controls. tRNAleu and p21 promoter, respectively, provide the positive and negative 
controls for polymerase occupancy and visa versa for MBP occupancy. Serial dilutions of the inputs 
show the quantitative nature of the PCR. 
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5.2.2 DNA methylation suppresses rearrangement at SINEs 
The translocation assay was performed on Hom6.9 cells as described in Elliot et 
al, 2005 (Figure 5.4). Cells were allowed to recover for 10hrs following 
electroporation with I-SceI vector (pCBAS) and then were treated with 5-
azacytidine for 16 hours . This duration of treatment is sufficient to demethylate 
Alu(MLL) sequences as it leads to clear eviction of MBPs (Figure3.14). However, 
any alterations observed in the translocation frequency could result from the 
cytotoxic effects of 5-azacytidine (Juttermann et al., 1994; Murakami et al., 
1995). To rule out this possibility, cells were alternatively treated with 
bleoMycin, an agent that causes double strand breaks. Cells treated with 5-
azacytidine and bleoMycin showed the presence of γ-H2Ax foci as viewed by 
immunofluorescence (data not shown). 
Negative control cells electroporated with pTK hyg plasmid do not survive 
selection with neoMycin, since there is no targeted DSB at the Alu(MLL) loci. 
Moreover, 5-azacytidine or bleoMycin treatments do not alter this result. These 
data indicate that the drug treatment on its own is not sufficient to cause the 
translocation event and that the number of colonies obtained in the 
translocation experiment reflects the frequency of erroneous repair at the 
Alu(MLL) loci. 
The untreated cells electroporated with pCBAS (I-SceI) show the clear presence 
of colonies following 8-10 day selection with neoMycin. This indicates that the 
translocation assay was successful and, unlike pTK hyg, pCBAS can lead to 
targeted DSB at Alu(MLL) loci which can then be subjected to erroneous repair. 
The translocation frequency is calculated to be 3.5 ± 2 translocations/105 cells, 
which is similar to what was previously reported by Elliot et al. 5-azacytidine 
treatment leads to a small but insignificant increase in the total number of 
colonies observed following neoMycin selection. On the other hand, a dramatic 
reduction in the total colony count is observed following bleoMycin treatment.  
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Figure 5.3: Translocation assay following 5-azacytidine and bleoMycin treatments 
Translocation assay was performed in Hom6.9 cells with 25µg of I-SceI plasmid (pCBAS) and 
negative control plasmid (pTK hyg). The cells were then treated with 4µM 5-azacytidine and 5µg/ml 
bleoMycin for 16hours. To obtain resistant colonies, selection for 8 to 10 days with 200µg/ml 
neoMycin was performed. Colony counts were performed following GIEMSA staining. 
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However, the total colony count is not a true reflection of the translocation 
frequency following drug treatment, since both the drugs are cytotoxic and lead 
to a substantial reduction in cell numbers on control plates not selected with 
neoMycin. 5-azacytidine and bleoMycin cause ~65% and ~85% loss in cell viability 
respectively. Therefore, the colony counts must be normalised to this loss in cell 
viability. 
Once normalised, the translocation frequency was plotted relative to the 
translocation frequency observed in control cells (Figure 5.4). 5-azacytidine 
shows a significant elevation in chromosomal translocation frequency compared 
to untreated control cells (p<0.01), whereas bleoMycin is unable to cause any 
alteration. These data indicate that the increased translocation is due to the 
demethylating property of 5-azacytidine and not its cytotoxicity. Moreover, an 
overall elevation in cellular DNA repair following bleoMycin treatment does not 
lead to an increase in erroneous repair at Alu(MLL). 
Therefore, it can be concluded that DNA methylation inhibits erroneous repair at 
SINEs, thus contributing to genomic stability. 
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Figure 5.4: Loss of DNA methylation elevates the rate of recombination at SINEs 
Relative incidence of translocation between homologous Alu elements in Hom6.9 cells was 
calculated by counting the number of neoMycin resistant colonies. The count was obtained from 
three independent biological repeats each performed in triplicates. This count was first normalised 
to the average loss of cell viability following drug treatment and then to the average number of 
colonies on the untreated plates. 
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As previously stated, Alu sequences provide prime targets for SSA-mediated 
mutagenesis. Elliot et al had previously reported that Hom6.9 cells undergo 
chromosomal translocation via the SSA repair pathway (Elliott et al., 2005). 
However, the dramatic increase in translocation frequency following the loss of 
DNA methylation could be due to an alteration in the repair pathway used.  
In order to investigate this, seven clones were picked from the control and 5-
azacytidine-treated Hom6.9 plates. The genomic DNA from these clones was 
subjected to PCR with primers flanking the Alu(MLL) sequences on different 
chromosomes (Figure 5.5). Since SSA would lead to the loss of one of the 
Alu(MLL) allele and NHEJ will not, the size of the PCR product obtained would be 
different depending on the repair pathway used for the translocation. Alus 
recombined as a result of SSA would be expected to give a 1kb PCR product, 
whereas Alus recombined as a result of NHEJ would result in a 1.3kb PCR 
product. DNA from Hom6.9 cells not subjected to the translocation protocol 
provides the negative control and demonstrates the specificity of the PCR 
reaction. 
A 1kb product is obtained from the PCR reaction on DNA from all the untreated 
clones, indicating that SSA is the repair pathway that causes the translocation. 
Moreover, 5-azacytine treated clones show no deviation from this pattern, 
indicating that a loss of DNA methylation does not lead to alteration in the 
repair pathway responsible for the erroneous repair. It is possible that the 
observed increase in translocation frequency is due to an increase in the kinetics 
of SSA repair. However, the details of how DNA methylation represses SSA repair 
are still unclear. 
Thus, DNA methylation serves to suppress erroneous repair at SINEs, possibly by 
suppressing error-prone repair pathways like SSA. 
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Figure 5.5: Increased recombination in the absence of DNA methylation is not due to a 
change in the repair pathway used 
PCR on DNA from clones picked following translocation assay in Hom6.9 cells with or without 5-
azacytidine treatment. The schematic on top depicts the location of the primer pair used (black 
arrows) and the different possible PCR product sizes depending on the repair pathway. Neg lane 
shows the PCR reaction on DNA from Hom6.9 cells that did not undergo the translocation protocol. 
M lanes are 1kb and 100bp DNA ladders. 
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5.3 Discussion 
Repetitive elements comprise at least 45% of the human genome and present 
ample opportunity for genomic recombination. With 1 million copies, Alu 
elements are the most abundant repeats in the human genome. Since Alus are 
spread throughout the protein-coding regions, rearrangements due to Alus can 
have devastating effects on genomic stability and have been implicated in many 
human diseases (Deininger et al., 2003; Konkel and Batzer, 2011; Lander et al., 
2001). 
Using a model for rearrangements driven by identical Alu elements, this chapter 
has shown that DNA methylation significantly suppresses interchromosomal 
translocation between identical Alu SINEs (p<0.01). It has been previously 
reported that translocations between identical Alu elements arise due to 
erroneous SSA repair (Elliott et al., 2005). A loss of DNA methylation does not 
lead to an alteration in the repair pathway used, but causes an increase in the 
translocation frequency. However, the reason for elevated SSA at the Alu(MLL) 
loci in the absence of DNA methylation is still unclear. 
RPA32 is a component of the replication protein A (RPA) complex, which binds 
single-stranded DNA obtained following strand resection. RPA binding is thought 
to facilitate single-strand annealing and thus promote SSA (Helleday et al., 
2007). Preliminary ChIP experiments on HeLa cells with an antibody against 
RPA32 show that 5-azacytidine treated Alus are more abundantly bound by this 
ssDNA-binding protein compared to untreated or bleoMycin-treated Alus (data 
not shown). These data, although preliminary, suggest that a loss of DNA 
methylation may lead to increased amounts of RPA-bound ssDNA within the cell. 
Thus DNA methylation may either inhibit the strand-resection kinetics or RPA-
binding to ssDNA. 
The interplay between DNA methylation and repair is not a new finding. DNMT1 
is recruited to sites of DSB repair via its interaction with PCNA and DMAP1 (Lee 
et al., 2010; Mortusewicz et al., 2005). This is thought to cause de novo 
methylation at recombined loci and silence them (Cuozzo et al., 2007). 
However, depletion of DMAP1 leads to elevated levels of HR, suggesting that the 
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recruitment of DNMT1 to the sites of DSB repair may somehow throttle the 
repair process (Lee et al., 2010). 
As previously mentioned, DNA hypomethylation has been correlated with CIN in 
multiple human diseases. Dnmt1-null cells show a high amount of chromosomal 
translocations as seen by chromosome painting (Karpf and Matsui, 2005). 
Demethylation by 5-azacytidine has also been shown to induce sister chromatid 
exchange in vitro and in vivo. This effect of 5-azacytidine has been shown to be 
due to its demethylating activity rather than the associated cytotoxicity 
(Albanesi et al., 1999; Morales-Ramirez et al., 2007). The data presented in this 
chapter demonstrate that Alu sequences may contribute to the genomic 
instability observed in the absence of DNA methylation.  
5-azacytidine and its analogues are FDA-approved treatments for 
myelodysplastic syndrome and other leukemias, where demethylation is thought 
to reactivate repressed tumour suppressor genes and cause tumour regression 
(Christman, 2002). Clinical trials with 5-azacytidine in patients with melanoma 
and renal cell carcinoma have also been reported (Gollob et al., 2006). 
However, 5-azacytidine treatment has also been associated with genome-wide 
DNA damage, CIN and reversal of differentiation in ES cells (Christman, 2002; 
Tsuji-Takayama et al., 2004). CIN caused by DNA demethylation could lead to 
multi-drug resistance and tumour relapse by causing tumour heterogeneity (Lee 
et al., 2011; Sotillo et al., 2010). In addition to these existing studies, the data 
obtained in this chapter would advise a careful review of the use of DNA 
demethylating agents in therapy. 
It must be noted that a 20% sequence divergence between Alu sequences causes 
a shift from SSA to NHEJ as the preferred mode of repair. This, however, does 
not lead to any alterations in the overall translocation frequency (Elliott et al., 
2005). The effects of DNA demethylation on NHEJ may not be similar to its 
effects on SSA. Crucially, NHEJ does not require the strand resection step 
(Helleday et al., 2007), which, according to preliminary data, seems to be the 
process influenced by DNA methylation. 
Since different Alu sequences show ~14% sequence divergence from the Alu 
consensus sequence (Deininger and Daniels, 1986), it is likely that the majority 
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of recombination events between Alus in vivo result from NHEJ as opposed to 
SSA. Elliot et al have also designed a system to study chromosomal translocation 
events between heterologous Alu elements. Initial attempts to use this Het-Alu 
system were unsuccessful due to extremely high cell death following 
electroporation. However, the effect of DNA demethylation on the translocation 
frequency in the Het-Alu cell line must be analysed in order to fully understand 
the mechanisms of erroneous repair. 
The Alu(MLL) elements used in the translocation assay in the Hom6.9 cells are 
occupied by  Pol III. This indicates that, even in this artificial system, the 
recruitment of Pol III is an inherent feature of SINEs. Moreover, these ectopic 
Alus show the same preference for MeCP2 binding over MBD2 binding that is seen 
at endogenous Alus in the human genome. Thus, this ectopic Alu sequence seems 
to behave in a manner very similar to endogenous SINEs. So is its transcription 
inhibited by H3K9me3? What effects would treatments with chaetocin or TSA 
have on the translocation frequency at these ectopic Alus? In addition to this, 
does the Pol III machinery interfere with the translocation event? Would B-block 
mutations or knockdown of TFIIIC elevate the translocation frequency by making 
more of the DNA available for erroneous repair? All these questions still remain 
to be answered.  
From the data obtained so far, it is clear that DNA methylation negatively 
regulates erroneous repair at homologous Alu elements and protects the genome 
from instability. But how this is achieved is still an unanswered question. 
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Chapter 6 Chromatin remodelling and Pol III 
transcription 
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6.1 Introduction 
Pol III transcriptional output is of vital importance for cellular growth and 
proliferation, and therefore, is subjected to tight regulation (see section 1.1.4). 
The previous chapters reveal that transcription of mammalian SINE sequences by 
Pol III is inhibited by H3K9 trimethylation. The first identified example of 
regulation of Pol III transcription by chromatin comes from the Xenopus 5S rRNA 
genes. The oocyte 5S genes show lower affinity for TFIIIA compared to the 
somatic 5S genes, and therefore less stable transcription complexes are formed. 
Following mid-blastula transition (MBT), the cellular levels of TFIIIA drop and the 
oocyte genes lose their expression due to their lower TFIIIA affinity. Introduction 
of excess TFIIIA is able to raise repression of oocyte 5S genes, but this effect is 
transient. The organisation of the oocyte 5S genes into compact chromatin by 
histone H1 is thought to contribute significantly to their silencing following MBT 
(Wolffe and Brown, 1988). 
Indeed, a positioned nucleosome near the 5S ICR was found to inhibit 
transcription initiation and downstream nucleosomes were shown to block 
elongation in an oocyte nuclear extract (Morse, 1989). Multiple other studies 
have shown that repressive chromatin structure, once formed over the 5S gene, 
can inhibit the binding of TFIIIA and inhibit transcription (White, 2002). 
However, TFIIIA can easily bind 5S ICR upon removal or acetylation of histone 
tails, suggesting that post-translational histone modifications play a decisive role 
in Pol III transcriptional regulation (Lee et al., 1993). A positioned nucleosome is 
also thought to be required to juxtapose PSE and DSE within the U6 promoter in 
order to facilitate the Oct-1 and SNAPc interaction (Stunkel et al., 1997). Alu 
sequences have been shown to be able to position nucleosomes, where a 
positioned nucleosome is able to repress Pol III-dependent Alu transcription 
(Englander and Howard, 1995). 
In contrast, the literature suggests that tRNA transcription is not influenced by 
chromatin (White, 2002). Manipulating the levels of histone H1 in Xenopus 
oocytes causes alterations in 5S rRNA expression, but tRNA expression is 
unaffected (Bouvet et al., 1994). Moreover, Drosophila tRNA genes were found 
to have increased sensitivity to micrococcal nuclease (MNase) and DNaseI 
digestion, indicating that tRNA genes are distinctly devoid of nucleosomes 
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(DeLotto and Schedl, 1984). tRNA genes are found to be transcriptionally active 
in hepatocytes and inactive in erythrocytes. Here, the correspondence between 
chromatin accessibility and transcription seems to break down, since tRNA genes 
show similar DNaseI sensitivity in both these cell types (Coveney and Woodland, 
1982).  
This insensitivity of tRNA loci to chromatin regulation has been attributed to the 
intrinsic HAT activity of TFIIIC. Immunopurified TFIIIC was found to be able to 
bind A- and B-block sequences and initiate transcription of a tRNA gene within 
an in vitro reconstituted chromatin template. Two TFIIIC subunits, TFIIIC90 and 
TFIIIC110 were found to have intrinsic HAT activity, where the former 
preferentially acetylates H3K14 residue and the latter acetylates H3, H4 and H2B 
(Hsieh et al., 1999a; Kundu et al., 1999). In addition to this the small size of 
tRNA genes could also account for their insensitivity to chromatin-mediated 
transcriptional inhibition. PIC assembly is thought to be the major rate-limiting 
step in Pol III transcription, and, once the PIC is in place, the small size of the 
tRNA gene means that transcriptional elongation is not a substantial hurdle 
(White, 2002). Pol II transcription can be repressed by chromatin during the 
elongation step, whereas Pol III may be able to escape this repression due to the 
relatively short elongation step. Thus, the ability of TFIIIC to form a PIC in a 
repressive chromatin environment and the relatively short size of tRNA genes 
may explain their insensitivity to chromatin-mediated transcriptional repression. 
Contrary to what a substantial amount of literature suggested at the time, tRNA 
genes were found to be incorporated into inactive chromatin in chick embryos 
and tRNA gene transcription was found to be influenced by nucleosome 
positioning. It was also shown that when a tRNA gene is located at the edge of a 
nucleosome, its transcription is drastically repressed. Intriguingly, when the 
tRNA gene is positioned in the middle or close to the dyad axis, transcription is 
elevated 30-fold (Wittig and Wittig, 1982). These data suggest that nucleosome 
positioning may play an important role in tRNA gene transcription. In addition to 
this, a yeast tRNA gene was also found to be repressed when inserted into the 
silent HMR mating-type locus (Schnell and Rine, 1986). 
More recently, various other studies have also indicated that chromatin may in 
fact influence the transcription of tRNA genes. Different tRNA genes in the 
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mulberry silkworm Bombyx mori were found to be occupied by a nucleosome 
within the 5'-upstream region and this nucleosome occupancy correlated with 
poor expression. The positioned nucleosome was found to impair TFIIIB 
recruitment and the addition of excess TFIIIC with intrinsic HAT activity was able 
to relieve transcription. Moreover, deletion of the upstream sequence also led to 
the loss of transcriptional repression. This suggests that, despite the similarity of 
their ICR sequences, differential expression of tRNA isoacceptor genes in cells 
may be achieved by their unique flanking sequences and associated chromatin 
(Parthasarthy and Gopinathan, 2005). 
c-MYC was found to induce tRNA expression by inducing Gcn5-mediated histone 
acetylation. Once it is recruited to the promoters, potentially through its binding 
with TFIIIC (unpublished data, Kirsteen Campbell), c-MYC was found to recruit 
Gcn5 via its interaction with TRRAP. Gcn5 acetylates histone H3 and promotes 
transcription at tRNA genes by promoting TFIIIB and Pol III recruitment. Histone 
H4 acetylation and TFIIIC enrichment does not change in response to c-MYC, 
indicating that TFIIIC may be able to occupy tRNA genes within a repressive 
chromatin environment, potentially by acetylating H4. However, TFIIIC 
occupancy on its own may not be sufficient for optimal PIC formation in a 
repressive chromatin environment (Kenneth et al., 2007). The initial evidence 
for TFIIIC itself having HAT activity was weak and it has now been shown that 
TFIIIC directly interacts with p300 and recruits it to tRNA genes. The recruitment 
of p300 not only acetylates the histones, but also stabilizes the binding of TFIIIC 
to the core promoter elements (Mertens and Roeder, 2008).  
The mammalian histone chaperone FACT (facilitates chromatin transcription) 
subunit SSRP1 was found to associate with tRNA, 5S rRNA and 7SL loci. 
Knockdown of SSRP1 leads to a reduction in tRNA and 7SL rRNA expression, 
indicating that FACT facilitates Pol III transcription (Birch et al., 2009). Loss of 
Sth1, the ATPase subunit of the yeast RSC complex, was also found to cause a 
reduction in Pol III transcriptional output. This is accompanied by a loss of Pol III 
loading and an elevation in nucleosome density (Parnell et al., 2008). Recently, 
FACT and RSC complexes were shown to regulate the transcription of a yeast 
tRNATyr gene by specific deposition of H2A.Z-containing nucleosomes that flank 
the transcribed region (Mahapatra et al., 2011).  
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In addition to these studies, recent ChIP-seq and RNA-seq analyses have revealed 
that active tRNA genes are marked by histone modifications associated with 
active transcription of Pol II-transcribed genes. Active tRNA loci are enriched for 
histone acetylation, H3K4me1/2/3 and H2A.Z, whereas inactive tRNA genes show 
inactive chromatin marks such as H3K9me3 and H3K27me2/3 (Barski et al., 
2010). 
Thus, it seems that tRNA genes are not exempt from chromatin-mediated 
regulation. However, the effects of chromatin on tRNA transcription are still 
poorly understood and there is a distinct lack of studies that look at these. 
Regulation by chromatin may contribute significantly to defining Pol III 
transcriptional output and understanding these regulatory mechanisms may be of 
vital importance. 
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6.2 Results 
6.2.1 A defined chromatin structure and SWI-SNF chromatin 
remodelling complex at Pol III-transcribed genes 
Before chromatin-mediated transcriptional regulation could be studied, it was 
necessary to define the chromatin structure of a Pol III-transcribed gene. This 
has been done in yeast, however a mammalian locus has not been investigated 
so far. The small size of tRNA genes makes it difficult to perform a detailed 
analysis of the chromatin structure and associated histone marks. However, the 
7SL locus is 300bp long and can be utilised for such analysis. ChIP assays in 
conjunction with mapping PCRs were used to map the location of the Pol III 
transcription apparatus, nucleosomes and histone modifications. Such an 
approach has been previously used to map Maf1 localisation on the 7SL gene 
locus (Goodfellow et al., 2008). 
HeLa chromatin was subjected to ChIP assays with antibodies against RPC155, 
BRF1 and TFIIIC. Antibodies against core histones H2A, H2B and H3 were used to 
map the nucleosome occupancy. Active chromatin marks acetyl-H3 and H3K4 
trimethylation were also investigated in order to gain an idea about the state of 
the chromatin. Beads-only and TAFI48 antibody provided the negative controls 
for each ChIP. The mapping primers amplify five different regions within and 
around the 7SL locus (Figure 6.1). 
Pol III and TFIIIB occupancy peaks at the beginning of the gene (primer set 2), 
whereas the TFIIIC is more evenly distributed across the locus. This is in 
agreement with the known model for the PIC formation on type II promoters 
(Figure 1.2) and with what was observed previously (Goodfellow et al., 2008). 
The 7SL promoter region shows a distinct decrease in core histone occupancy 
and an increase in the acetyl-H3 and H3K4me3. 
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Figure 6.1: Chromatin structure of a Pol III-transcribed 7SL locus 
ChIP in HeLa cells with antibodies against RPC155, BRF1, TFIIIC220; core histones H2A, H2B, 
H3; activating histone modifications acetyl-histone H3 and lysine4 trimethyl-histone H3. PCRs 
performed with mapping primers (top schematic) at 7SL locus. ChIPs with beads only and TAFI48 
antibodies provide the negative controls. The plotted values were calculated using the following 
equation y=[(IP/Input)-(Avg. Neg. IP/Input)] and highest y=1. ChIP values for histone modifications 
were further normalised to total histone H3 levels. 
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These data show that the 7SL locus has a well-defined chromatin structure with 
a nucleosome-free region over the transcribed sequence. MNase digestions 
coupled with scanning PCRs also confirmed these findings, where the DNA 
amplified by the 7SL set2 primers was found to be hypersensitive to digestion 
(data not shown). Thus, the 7SL gene seems to have a chromatin structure 
similar to the tRNA genes in this respect and can be used as a model (Barski et 
al., 2010). 
The presence of such defined chromatin structure could be a result of active 
transcription and highly organised transcription apparatus. However, the 
presence of acetyl-H3 and H3K4me3 marks suggest that some degree of 
chromatin remodelling may be involved. In addition to this, there was previous 
evidence in the lab to suggest the presence of SWI/SNF chromatin remodelling 
complex at tRNA genes (Niall Kenneth, unpublished data). The presence of such 
a remodelling complex could explain the highly ordered chromatin structure 
observed on the 7SL gene. 
Chromatin from A31 mouse fibroblasts was subjected to ChIP assays with 
antibodies against SNF5, BRG1 and BRM subunits of the SWI/SNF complex (Figure 
6.2). Beads only (Mock) and TAFI48 antibodies provide the negative controls, 
whereas, a Pol III antibody provides the positive control. The Pol II-transcribed 
ARPP P0 locus provides the negative control PCR. All three SWI/SNF subunits 
were found to occupy multiple tRNA and 5S rRNA genes. BRG1 and BRM ATPase 
subunits do not show considerable differences in enrichment levels.  
A literature search revealed that SWI/SNF occupancy on tRNA genes has also 
been observed in ChIP-seq experiments on HeLa chromatin (Euskirchen et al., 
2011). Further data mining revealed that 33.5% of all annotated tRNA genes 
were occupied by at least one SWI/SNF subunit (Figure 6.3). Core subunits 
BAF155 and BAF170 were found to be enriched on 146 and 193 tRNA loci, 
respectively. SNF5 was found to occupy 150 tRNA loci, whereas BRG1 was seen 
to occupy 55 tRNA genes. This relatively low gene count for BRG1 occupancy 
could be due to lower antibody efficiency or the presence of BRM as the ATPase 
subunit at many loci. BRM ChIP-seq. was not performed by the authors. Thus, 
the core subunits of the SWI/SNF chromatin remodelling complex are present at 
multiple tRNA genes and may have a role in their transcriptional regulation. 
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Figure 6.2: SWI/SNF subunits occupy Pol III-transcribed genes 
ChIP in A31 mouse fibroblasts with antibodies against SNF5, BRG1 and BRM at tRNA and 5S 
rRNA loci. ChIPs with beads only and TAFI48 antibodies provide the negative controls, whereas 
ChIP with RPC155 antibody provides the positive control. ARPP P0 gene provides the negative 
control for the ChIP. Serial dilutions of inputs show the quantitative nature of the PCR. 
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Figure 6.3: Considerable proportion of human tRNA loci are occupied by SWI/SNF subunits 
Venn diagrams with ChIP sequencing data for SNF5, BRG1, BAF155 and BAF170 subunits  at 
tRNA loci annotated in hg18 human genomic database (data mined from (Euskirchen et al., 2011) 
by Ann Hedley]. 
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6.2.2 SWI/SNF directly represses transcription at tRNA and 5S 
rRNA genes 
Since a substantial number of tRNA genes are enriched for the SWI/SNF complex, 
one can predict that this complex may play a role in their transcriptional 
regulation. SWI/SNF has been implicated in the etiology of many human cancers 
(see section 1.3.4). The core SWI/SNF subunit SNF5 is a bona fide tumour 
suppressor (Versteege et al., 1998), whereas other SWI/SNF subunits are also 
lost or silenced in multiple tumours (Reisman et al., 2009). Pol III transcription is 
also found to be elevated through various mechanisms in many human tumours. 
The regulation of Pol III transcriptional output is of high importance for cell 
growth and proliferation (see section 1.1.5). Therefore, studying the regulation 
of Pol III transcription by the SWI/SNF chromatin remodelling complex may be of 
therapeutic importance. 
SNF5 is one of the core SWI/SNF subunits that is essential for the chromatin 
remodelling activity (Phelan et al., 1999). SNF5 is thought to contribute to 
SWI/SNF recruitment to its target loci, and once recruited it also makes contacts 
with the histone core of the nucleosome (Dechassa et al., 2008; Geng et al., 
2001). Homozygous loss of SNF5 has been shown to cause preimplantation 
embryonic lethality in mice (Guidi et al., 2001). Thus, in order to investigate the 
role of SWI/SNF in Pol III transcriptional regulation, this essential subunit was 
knocked-down using RNAi in A31 mouse fibroblasts. 
Western blots were performed on protein extracts from A31 cells 72 hours 
following transient transfection with scrambled siRNA (sc siRNA) and SNF5 siRNA 
(Figure 6.4a). A substantial reduction in SNF5 protein levels is observed. TFIIB 
and actin provide the loading controls. The SNF5 antibody recognises a doublet 
in the Western blot since SNF5 has two splice variants, which result from 
alternative splicing at the end of exon 2 (Bruder et al., 1999). The functional 
differences between the splice variants are not known, but both the splice 
variants are knocked-down with the siRNA. The RNA from these cells was 
subjected to RT-PCR analysis (Figure 6.4b). ARPP P0 mRNA provides the negative 
control, since microarray data from SNF5 null MEFs did not show alteration in 
ARPP P0 transcript levels (Isakoff et al., 2005). SNF5 mRNA levels show a 
considerable decrease following the knockdown.  
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Figure 6.4: SNF5 knockdown elevates tRNA and 5S rRNA expression 
a) Analysis of SNF5 protein levels by Western blot in A31 mouse fibroblasts following transient 
transfections with 10nM scrambled (sc) siRNA or SNF5 siRNA for 72hrs. TFIIB and actin serve as 
loading controls. b) Analysis by RT-PCR of pre-tRNA and 5S rRNA levels following knockdown of 
SNF5 protein. SNF5 mRNA demonstrates the knockdown and ARPP P0 mRNA serves as loading 
control. c) Analysis by qRT- PCR of pre-tRNAleu and 5S rRNA expression levels. The expression 
was normalised to ARPP P0 mRNA levels. 
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Primers designed within the tRNA introns specifically amplify unprocessed pre-
tRNA molecules. Since the half-life of rat liver tRNAs was estimated to be 5 days 
(Hanoune and Agarwal, 1970), specific amplification of pre-tRNA molecules 
provides a better estimate of the current rate of transcription. Interestingly, 
various pre-tRNA and 5S rRNA transcripts show a three to four fold elevation in 
expression following SNf5 knockdown. It must be noted that the primers against 
5S rRNA detect the steady state levels. This elevation in expression was also 
confirmed using real-time RT-PCR (Figure 6.4c). 
An Rsc4 mutant yeast strain shows a two-fold increase in tRNA expression 
compared to wild-type (Mahapatra et al., 2011). However, the authors were 
looking at steady-state tRNA levels and may have underestimated the increase. 
Nonetheless, just like the yeast RSC complex, the mammalian SWI/SNF complex 
seems to be repressing Pol III transcription. A knockdown of SNF5 in HeLa cells is 
associated with transcriptional upregulation of p21 causing cell cycle arrest and 
apoptosis (Kato et al., 2007). In contrast, I observed no evidence of cell cycle 
arrest or apoptosis upon SNF5 knockdown in A31 cells. A31 cells have been 
shown to illicit a normal p53 and p21 response to γ-irradiation (Nozaki et al., 
1997). The data here would argue that the previous observations are cell type-
specific.  
However, the data obtained from RNAi-mediated knockdown of SNF5 must be 
treated with caution, since the biggest drawbacks of this technology are its off-
target effects [reviewed in (Echeverri and Perrimon, 2006)]. In order to 
ascertain the specificity of the observed results, two alternative siRNA 
sequences targeting SNF5 were used alongside the siRNA previously used. 
Variable levels of SNF5 knockdown were achieved with the three different 
siRNAs. A dose-dependent increase in pre-tRNALeu expression is observed, such 
that the siRNA showing the highest level of knockdown shows the greatest 
elevation in tRNA expression (Figure 6.5). These data indicate that the increase 
in Pol III transcriptional output due to SNF5 knockdown is not due to off-target 
effects, but is target-specific.  
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Figure 6.5: SNF5 knockdowns with multiple siRNAs elevate tRNA expression 
a) Analysis by Western blot of SNF5 protein levels in A31 mouse fibroblasts following transient 
transfections with 10nM sc siRNA or three different SNF5 siRNAs for 72hrs. Actin provides the 
loading control b) Analysis by qRT-PCR of pre-tRNATyr expression levels. Data were normalised to 
ARPP P0 mRNA levels. 
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From the ChIP data, it is clear that the SWI/SNF complex occupies tRNA loci. 
Therefore, one can assume that the effect of SNF5 knockdown on tRNA 
expression is direct. However, the interaction between SWI/SNF and Rb is well 
established. Loss of SNF5 directly or indirectly causes hyperphosphorylation of 
Rb, thus inactivating it (Oruetxebarria et al., 2004). Since Rb represses Pol III 
transcription, its inactivation could in turn cause elevation in tRNA expression 
(Larminie et al., 1997). Therefore, increased tRNA expression following SNF5 
knockdown could be Rb-mediated and not direct. 
The simian virus 40 oncoprotein large T antigen can bind and neutralise Rb 
protein. Cell lines transformed with the large T antigen show elevated tRNA 
expression compared to control cells (Felton-Edkins and White, 2002). Cl38 is 
one such SV40-transformed A31 mouse fibroblast cell line, which can be used to 
investigate the involvement of the Rb pathway in SWI/SNF-mediated repression 
of Pol III transcription. 
SNF5 protein was knocked-down in Cl38 cells using two different siRNAs (Figure 
6.6).  Whole cell extracts from cells transfected with sc siRNA and SNF5 siRNAs 
were subjected to Western blot analysis. A subsantial decrease in SNF5 protein 
levels is observed 72hrs post transfection. α-Tubulin and actin provide the 
loading controls. Total RNA from the control and knockdown cells was then 
subjected to RT-PCR analysis. ARPP P0 provides the loading control. Similar to 
A31 fibroblasts, Cl38 cells show elevated expression of pre-tRNAs and 5S rRNA 
following SNF5 knockdown. 
Despite the inactivation of Rb in Cl38 cells, loss of SNF5 still causes a substantial 
increase in the expression of Pol III products. These data suggest that the 
inhibition of Pol III transcription by SWI/SNF is independent of the Rb pathway. 
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Figure 6.6: SNF5 knockdown elevates tRNA and 5S rRNA expression in SV40-transformed 
cells 
a) Analysis by Western blot of SNF5 protein levels in SV40-transformed Cl38 mouse fibroblasts 
following transient transfections with 10nM sc siRNA or two different SNF5 siRNAs for 72hrs. α-
Tubulin and actin provide the loading controls. b) Analysis by RT-PCR of pre-tRNA and 5S rRNA 
levels following SNF5 knockdown in Cl38 mouse fibroblasts. SNF5 mRNA demonstrates the 
knockdown and ARPP P0 mRNA provides the loading control. 
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SWI/SNF is considered a master regulator of gene transcription and shows 
functional interactions with many other transcriptional regulators, including c-
MYC (see section 1.3.3). c-MYC may influence the expression of BRF1 by binding 
the E-boxes upstream of the BRF1 gene (unpublished data, Lynne Marshall). 
Therefore, the transcriptional regulation by SWI/SNF may be the result of 
altered expression of Pol III or its transcription factors. 
In order to rule out this possibility, levels of various subunits of the Pol III 
transcriptional apparatus were analysed by Western blot and RT-PCR analysis 
following SNF5 knockdown in A31 cells (Figure 6.7). Actin and ARPP P0 provide 
the loading controls for the Western blot and RT-PCR analysis respectively. No 
reproducible differences are observed in the protein or mRNA levels of RPC155, 
BRF1 and TFIIIC110. TBP protein levels do not change either. Even though an 
exhaustive analysis of all the subunits was not performed, the data obtained so 
far from the ChIP and knockdown assays suggest a direct involvement of SWI/SNF 
in regulating transcription at tRNA promoters. 
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Figure 6.7: SNF5 knockdown does not alter levels of Pol III transcription apparatus 
a) Analysis by Western blot of RPC155, TBP, TFIIIC110 and BRF1 protein levels in A31 mouse 
fibroblasts following transient transfections with 10nM sc siRNA or SNF5 siRNA for 72hrs. Actin 
provides the loading control. b) Analysis by RT-PCR of RPC155, BRF1 and TFIIIC110 mRNA 
levels following SNF5 knockdown. ARPP P0 mRNA provides the loading control. 
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6.2.3 BRG1 and BRM are both involved in repressing tRNA 
expression 
An individual SWI/SNF complex can only contain one of the two ATPases, such 
that BRM/BAF complexes are structurally distinct from BRG1/BAF complexes 
(Wang et al., 1996a; Wang et al., 1996b). The ChIP data indicate that both 
BRM/BAF and BRG1/BAF complexes occupy tRNA genes (Figure 6.2). However, 
these two different complex types may have different effects on tRNA 
transcription. Moreover, our conclusion that SWI/SNF represses Pol III 
transcription has been drawn from the knockdown of a single subunit. In yeast, 
the inactivation of any single subunit leads to dissolution and subsequent 
inactivation of the whole complex (Hargreaves and Crabtree, 2011). Therefore, 
would the reduction in the ATPase subunits of the SWI/SNF complex lead to a 
similar increase in tRNA expression, as observed following SNF5 knockdown? 
In order to test this, A31 cells were subjected to RNAi with two different siRNAs 
targeting each ATPase. A substanial decrease in BRG1 protein levels and a 50% 
decrease in BRG1 mRNA levels could be achieved with both the BRG1 siRNAs 
(Figure 6.8). However, BRG1 knockdown results in an elevation of BRM transcript 
levels. A substantial knockdown in BRM protein levels results in a similar 
increase in BRG1 protein and mRNA levels (Figure 6.9). 
A homozygous loss of BRG1 leads to embryonic lethality in mice, whereas BRM 
null mice are viable (Bultman et al., 2000; Reyes et al., 1998). This may reflect 
the important role of BRG1 in the maintenance of the ES cell compartment (Ho 
et al., 2009a; Ho et al., 2009b). However, BRM null mice show an upregulation in 
BRG1 protein levels in a manner similar to what is observed in Figure 6.10 (Reyes 
et al., 1998). Put together, these data indicate that a differentiated cell may 
compensate for the loss of one ATPase by upregulation of the other, although 
the presence of BRG1 is essential for ES cells. 
No elevation in tRNA expression is observed following BRG1 or BRM knockdowns. 
This suggests that the loss of any one ATPase is not sufficient to cause 
transcriptional upregulation at tRNA loci, and that the two ATPases can 
substitute for each other within BAF complexes associated with tRNA genes.  
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Figure 6.8: BRG1 knockdown does not alter tRNA expression 
a) Analysis by Western blot of BRG1 protein levels in A31 mouse fibroblasts following transient 
transfections with 10nM sc siRNA or two different BRG1 siRNAs for 72hrs. α-Tubulin provides the 
loading control. b) Analysis by qRT-PCR of BRM mRNA and pre-tRNA levels following BRG1 
knockdown. BRG1 mRNA demonstrates the knockdown. The data were normalised to ARPP P0 
mRNA levels. 
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Figure 6.9: BRM knockdown does not alter tRNA expression 
a) Analysis by Western blot of BRM or BRG1 protein levels in A31 mouse fibroblasts following 
transient transfections with 10nM sc siRNA and two different BRM siRNAs for 72hrs. α-Tubulin 
provides the loading control. b) Analysis by qRT-PCR of BRG1 mRNA and pre-tRNA levels 
following BRM knockdown. BRM mRNA demonstrates the knockdown. The data were normalised 
to ARPP P0 mRNA levels. 
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Since BRG1 and BRM compensate for each others activity at tRNA genes, a dual-
knockdown is required to investigate the effects of the loss of SWI/SNF ATPase 
subunits. siRNAs targeting both ATPase subunits were used in tandem in order to 
achieve a dual knockdown. However, since single ATPase knockdown upregulates 
the other ATPase subunit, a dual knockdown could not be achieved easily. 
In order to overcome this problem, a pool of two siRNAs against each ATPase was 
used. A31 cells were transfected with sc siRNA, BRG1 siRNA, BRM siRNA or a 
mixture of four different siRNAs, two against each ATPase (Figure 6.10). Even 
though BRG1 siRNA works quite efficiently on its own, the BRG1 siRNA pool is 
only able to reduce BRG1 mRNA and protein levels by 40% when BRM is knocked-
down in tandem. The BRM knockdown on the other hand is more successful and 
80% reduction in BRM protein levels can be observed in the dual-knockdown 
sample. 
Despite the poor knockdown of BRG1 protein, a two-fold increase in pre-tRNA 
and 5S rRNA expression can be seen following the dual-knockdown. These results 
indicate that BRM/BAF and BRG1/BAF complexes at tRNA genes are functionally 
equivalent and consolidate the hypothesis that SWI/SNF represses Pol III 
transcription. Moreover, the ATPase subunits are required for SWI/SNF-mediated 
repression of Pol III transcription and, therefore, this repression may be achieved 
through ATPase-dependent chromatin remodelling. 
 
 164 
 
 
 
 
 
Figure 6.10: BRG1 and BRM dual-knockdown elevates tRNA expression 
a) Analysis by Western blot of BRG1 and BRM protein levels in A31 mouse fibroblasts 72hrs 
following transient transfections with 10nM sc siRNA, BRG1 siRNA, BRM siRNA or 5nm BRG1 
siRNA pool mixed with 5nM BRM siRNA pool. Actin provides the loading control. b) Analysis by 
qRT-PCR of BRG1 mRNA, BRM mRNA, pre-tRNA and 5S rRNA levels following BRG1, BRM and 
dual knockdowns. The data were normalised to ARPP P0 mRNA levels. 
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6.2.4 SWI/SNF subunits interact and co-localise with TFIIIC 
A reduction in the cellular SNF5 protein level causes an increase in Pol III 
transcription. The loss of SNF5 may either lead to the dissociation of the whole 
complex or reduce the specific targeting of the SWI/SNF complex to tRNA and 5S 
rRNA loci. However, SNF5 may just be a bystander in regulating Pol III 
transcription, and other subunits of the SWI/SNF complex may be responsible for 
its targeting. 
In order to investigate the specific role of SNF5 in the repression of SWI/SNF 
complex, a vector constitutively expressing HA-tagged SNF5 from a CMV 
promoter was transiently transfected into A31 cells (Figure 6.11). Western blots 
on protein extracts indicate a mere 25% increase in SNF5 protein levels in the 
pCDNA3HA.SNF5 transfected cells compared to the empty vector controls. HA-
SNF5 migrates as a third (higher) band on the SNF5 blot due to the presence of 
the three N-terminal HA moieties. The HA blot confirms the identity of this third 
band as HA-SNF5. TFIIB serves as a loading control.  
Despite this modest elevation in cellular SNF5 levels, RT-PCR expression analysis 
reveals a dramatic reduction in pre-tRNA and 5S rRNA expression. ARPP P0 serves 
as a loading control. A substantial increase in SNF5 mRNA is also observed, but 
the cells do not express such high amounts of SNF5 protein. This may be because 
the cells that express higher amounts of SNF5 do not survive the drastic 
reduction in Pol III products. 
Reintroduction of SNF5 into malignant rhabdoid tumour (MRT) cells causes an 
upregulation of p16 causing cellular senescence (Oruetxebarria et al., 2004), 
whereas overexpression of SNF5 in A31 cells did not show changes in the p16 
transcript levels. However, this experiment was performed over a relatively 
short time frame of 72hrs and maybe a longer time is required for SNF5 to 
trigger the senescence program. Moreover, the effects observed in the MRT cells 
may be specific to cells which lack SNF5 and may not apply to cells with 
endogenous SNF5.  
The data obtained by this experiment show that a modest increase in SNF5 
protein levels is sufficient to suppress Pol III transcriptional output. 
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Figure 6.11: SNF5 overexpression represses tRNA and 5S rRNA expression 
a) Analysis by Western blot of HA and SNF5 protein levels in A31 mouse fibroblasts following 
transient transfections with 5µg empty vector or pCDNA3HA.SNF5 for 72hrs. TFIIB provides the 
loading control. b) Analysis by RT-PCR of pre-tRNA and 5S rRNA levels following SNF5 
overexpression. SNF5 mRNA demonstrates the successful overexpression. ARPP P0 mRNA 
provides the loading control. 
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The data obtained so far indicate that SWI/SNF complex specifically represses 
tRNA expression. But how this is achieved is still unclear. c-MYC has been shown 
to upregulate tRNA expression by the recruitment of Gcn5 and histone 
acetylation. Myc-mediated induction leads to a change in the chromatin 
environment of tRNA genes (Kenneth et al., 2007). Moreover, SWI/SNF has been 
linked to Myc-mediated transcriptional transactivation (Cheng et al., 1999). 
However, in the case of tRNA transcription, Myc and SWI/SNF seem to have 
contradictory effects. 
In order to resolve the interplay between c-MYC and SWI/SNF at tRNA loci, c-
MYC wild-type and c-MYC null rat fibroblasts were subjected to ChIP assays with 
antibodies against SWI/SNF subunits. Myc-/- cells show a dramatic drop in the 
protein levels of Myc, as seen by Western blot (Figure 6.12a). However, a faint 
band can be observed in the blot, but the reason for this is unknown. But, since 
the wild-type and null cells have drastic differences in the cellular c-MYC levels, 
the system can still be used to investigate the influence of c-MYC on SWI/SNF 
occupancy at tRNA genes. 
Pol III ChIP was also performed in order to confirm the induction of transcription 
at the tRNA genes by c-MYC. TAFI48 antibody provided the negative control for 
the ChIP and the data were normalised to serial input dilutions. c-MYC wild-type 
cells show 2-3 fold increase in Pol III enrichment at tRNALeu and tRNATyr genes 
compared to null cells (Figure 6.12b). It must be noted that each tRNA primer 
set detects multiple genes coding for that tRNA isotype. This agrees with the 
published observation that c-MYC induces Pol III recruitment at tRNA genes 
(Kenneth et al., 2007). 
The transcriptional induction by c-MYC is accompanied by an eviction of SWI/SNF 
subunits from tRNA genes. Considerable reduction in SNF5, BRG1 and BRM 
enrichment at tRNALeu and tRNATyr genes is observed in c-myc+/+ cells compared 
to c-myc-/- cells. These data indicate that the eviction of SWI/SNF complex by c-
MYC may be necessary in order to overcome the transcriptional repression. A 
recent study has shown that Gcn5 can also acetylate Swi2/Snf2 subunit of the 
SWI/SNF complex (Kim et al., 2010). This acetylation was found to cause the 
dissociation of SWI/SNF complex from the chromatin and could be the 
mechanism by which c-MYC evicts the SWI/SNF complex from tRNA loci.  
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Figure 6.12: Myc evicts SWI/SNF subunits from Pol III transcribed loci 
a) Analysis by Western blot of c-MYC protein levels in c-myc+/+ and c-myc-/- rat fibroblasts. TFIIB 
provides the loading control. b) ChIP assay in c-myc+/+ and c-myc-/- rat fibroblasts with antibodies 
against SNF5, BRG1 and BRM at tRNA loci. ChIP with RPC155 antibody provides the positive 
control. ChIP with TAFI48 provided the negative control. 
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c-MYC was reported to cause elevated TFIIIB and Pol III occupancy at tRNA 
genes. However, no differences in the TFIIIC enrichment could be detected in 
response to Myc (Kenneth et al., 2007). TFIIIC, due to its associated HAT 
activity, is thought to be capable of penetrating repressive chromatin structures 
and binding its target sequences (Hsieh et al., 1999a; Kundu et al., 1999; 
Mertens and Roeder, 2008). Despite this, the binding of TFIIIC on its own may 
not be sufficient for optimal TFIIIB and Pol III recruitment, since Myc can readily 
open up the chromatin structure further to elevate TFIIIB and Pol III occupancy 
(Kenneth et al., 2007).  This suggests that TFIIIC may occupy Pol III transcribed 
genes within repressed chromatin and prime them for transcriptional activation 
by proteins like Myc. This is reflected in the ChIP-seq analysis, where less than 
50% of TFIIIC occupied sites are occupied by Pol III and BRF1 (Oler et al., 2010). 
Since SWI/SNF represses transcription in the absence of Myc, and TFIIIC is 
present prior to induction by Myc, is there a correlation between their 
enrichment at tRNA genes? Analysis performed on the existing ChIP-seq data sets 
for TFIIIC (Oler et al., 2010) and SWI/SNF subunits (Euskirchen et al., 2011) 
reveal a striking correlation between their occupancy at tRNA genes (Figure 
6.13). All but 12 tRNA loci enriched for at least one SWI/SNF subunit are also 
enriched for TFIIIC. Moreover, SNF5 occupies 145 of the 249 tRNA genes occupied 
by TFIIIC. The 12 tRNA genes which show SWI/SNF occupancy and no TFIIIC may 
be artefacts due to epitope masking during the immunoprecipitation. Thus, the 
majority of tRNA genes repressed by the SWI/SNF chromatin remodelling 
complex seem to be occupied by TFIIIC. 
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Figure 6.13: SWI/SNF occupancy on tRNA genes is highly correlative with TFIIIC occupancy 
Venn diagrams with ChIP sequencing data for SWI/SNF subunits (SNF5, BRG1, BAF155 and 
BAF170) mined from (Euskirchen et al., 2011) and TFIIIC63 data mined from (Oler et al., 2010)  at 
tRNA loci annotated in hg18 human genomic library. SWI/SNF (blue circle) indicates tRNAs 
occupied by one or more of the SWI/SNF subunits (data mined by Ann Hedley). 
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Since there is a significant correlation between TFIIIC and SWI/SNF occupancy at 
tRNA genes, it is fair to ask the question whether TFIIIC may be involved in 
SWI/SNF recruitment. In order to address this issue, co-immunoprecipitation (co-
IP) assays were performed on protein extracts from A31 fibroblasts. In the 
forward reaction, IP was performed with antibodies against the SWI/SNF subunits 
and the Western blot was performed with antibody against TFIIIC220 subunit 
(Figure 6.14). The IP samples are resolved next to 20% input and rabbit IgG, 
where the latter provides the negative control IP. IPs against all three SWI/SNF 
subunits successfully co-IP TFIIIC220 and the signals obtained were consistently 
above background. The BRM antibody shows the best co-IP with TFIIIC220; 
however this may not mean that BRM is responsible for complex recruitment. 
The better quality of the BRM co-IP may just be due to better antibody affinity 
or its better suitability for the assay. 
The reverse IP reaction was performed with an antibody against an alternative 
TFIIIC subunit, TFIIIC110. Since BRM provided the best co-IP for the forward 
reaction, the Western blot for the reverse reaction was performed against BRM. 
A clear co-IP of BRM with TFIIIC110 is observed in the reverse reaction. Thus, 
SWI/SNF and TFIIIC can be co-immunoprecipitated with antibodies against 
different subunits in both directions, indicating that these two multisubunit 
complexes interact with each other. 
However, this interaction may be mediated by DNA, where both the complexes 
are recruited to the same DNA sequence, but do not physically interact. In order 
to rule out this possibility, co-IP was performed in the absence and presence of 
DNaseI (Figure 6.14). DNaseI would digest any common DNA that may be holding 
the two complexes together. TFIIIC220 antibody was used for the co-IP, where 
rabbit IgGs and an alternative BRM antibody provide the negative and positive 
control IPs respectively. The addition of DNaseI does not abolish the co-IP of BRM 
with TFIIIC220, however it does cause a small reduction in the co-IP signal. This 
suggests that TFIIIC and SWI/SNF complexes primarily interact with each other 
independently of DNA; however the presence of DNA may promote the 
interaction slightly. The data together indicate that TFIIIC and SWI/SNF may co-
occupy tRNA genes, where the former may recruit the latter through protein-
protein interactions. Thus, TFIIIC may not only be priming tRNA genes for 
induction, but also keeping them repressed by recruiting the SWI/SNF complex. 
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Figure 6.14: SWI/SNF subunits co-immunoprecipitate with TFIIIC 
a) Analysis by Western blot for co-immunoprecipitation of SNF5, BRG1 and BRM with TFIIIC220 in 
A31 total cell extracts. The reverse co-immunoprecipitation of TFIIIC110 with BRM is shown in the 
bottom panel. IgG and TAFI48 serve as negative controls. b) Analysis of Western blot for co-
immunoprecipitation of TFIIIC220 with BRM in A31 total cell extract following overnight treatment 
with DNase. IgG and a second BRM antibody provide the negative and positive controls 
respectively. 
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6.2.5 SWI/SNF co-localises with Pol III and limits tRNA 
transcription 
The data obtained so far indicate that the SWI/SNF complex is recruited by 
TFIIIC and inhibits tRNA gene transcription. The polymerase loading on tRNA 
genes is generally considered to be a reliable surrogate measure for their 
transcriptional output. Since SNF5 knockdown leads to a drastic upregulation of 
tRNA expression, it may also be expected to cause increased Pol III loading at 
tRNA genes. Moreover, since SWI/SNF is a chromatin remodelling complex, an 
alteration in core histone occupancy at tRNA genes may also be expected upon 
reduction in SNF5. 
In order to study the effects of SNF5 knockdown upon Pol III transcription factor 
and histone occupancies at tRNA genes, A31 cells were subjected to ChIP assays 
following transfection with scrambled and SNF5 siRNAs. The knockdown of SNF5 
was verified by Western blot for each ChIP repeat, an example of which is shown 
in Figure 6.15a. ChIP for SWI/SNF subunits reveals a drop in SNF5, BRG1 and BRM 
occupancy at tRNALeu and tRNATyr genes following SNF5 knockdown. This 
indicates that a reduction in SNF5 leads to the loss of the entire SWI/SNF 
complex from tRNA genes. This may either be due to dissolution of the entire 
complex or just its dissociation from TFIIIC. Variability in the levels of 
knockdown obtained by transient transfections led to relatively large error bars. 
This may have resulted in the higher than expected BRG1 and BRM enrichment in 
the absence of SNF5 on the tRNALeu genes.  
In order to circumvent this problem, stable cell lines expressing multiple short-
hairpins against SNF5 were constructed. However, despite showing 50% reduction 
in SNF5 mRNA level, the cells did not show any reduction in SNF5 protein levels 
(data not shown). Therefore, these cell lines could not be used for further 
experiments. G401 cells containing an inducible SNF5 expression system in a 
SNF5 null background were also obtained (Oruetxebarria et al., 2004). However, 
these cells failed to show any Pol III transcriptional response to SNF5 induction 
(data not shown). Since these cells are obtained from an MRT cancer cell line, it 
is possible that the lack of Pol III response to SNF5 induction is due to some 
unknown genetic alterations. Therefore, this cell line could not be used for 
further experiments either. 
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Figure 6.15: SNF5 knockdown does not significantly alter histone levels or transcription 
apparatus occupancy at tRNA genes 
a) Analysis by Western blot of SNF5 protein levels in A31 mouse fibroblasts following transient 
transfections with 10nM sc siRNA and SNF5 siRNA for 72hrs. TFIIB provides the loading control. 
b) ChIP assay in A31 mouse fibroblasts following SNF5 knockdown with antibodies against histone 
H3, RPC155, BRF1 and TFIIIC220 at tRNA loci. ChIPs with SNF5, BRG1 and BRM antibodies 
provide the controls for the knockdown. ChIP with TAFI48 antibody provided the negative control. 
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Thus, the best system available was the transient transfection system. tRNALeu 
genes show considerable reduction in histone H3 occupancy following SNF5 
knockdown, whereas this reduction is less apparent at tRNATyr loci. However, the 
reduction in histone occupancy is consistently seen over multiple experiments 
Further experimentation is required to consolidate these data. 
 Surprisingly, despite the dramatic elevation in tRNALeu and tRNATyr expression 
following SNF5 knockdown, no increase in the loading of Pol III transcription 
factors at the respective genes is observed. This was an unexpected result since 
Pol III occupancy is generally concordant with tRNA expression, for example in 
response to c-MYC (Figure 6.12) and (Kenneth et al., 2007). The same 
experiment was performed with lower antibody concentration, reduced 
crosslinking and increased sonication in order to improve sensitivity, but the 
results remained unchanged. This could be a short-coming of the transient 
transfection system, as previously mentioned; however, this result prompted 
further analysis of the available ChIP-seq datasets (Figure 6.16). 
Surprisingly, there is a high degree of correlation between the ChIP-seq datasets 
for SWI/SNF subunits and Pol III. A vast majority of the tRNA genes occupied by 
SWI/SNF subunits are also utilised by Pol III. Thus, SWI/SNF seems to localise to 
genes that are likely to be transcribed. These data, contradict the repressive 
role of SWI/SNF complex revealed by SNF5 and BRG1+BRM knockdown, as well as 
the SNF5 overexpression experiments.  
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Figure 6.16: SWI/SNF occupancy at tRNA genes correlates well with polymerase loading 
Venn diagrams with ChIP sequencing data for SWI/SNF subunits (SNF5, BRG1, BAF155 and 
BAF170) mined from (Euskirchen et al., 2011), TFIIIC63 and RPC32 data mined from (Oler et al., 
2010) at tRNA loci annotated in hg18 human genomic library (data mined by Ann Hedley). 
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 In yeast, Rsc reduces the production of spurious transcripts from the SUP4 tRNA 
gene by defining the chromatin structure around the tRNA locus and providing a 
defined area for transcription. A nucleosome positioned downstream of the tRNA 
gene is also thought to throttle transcription, possibly by repressing efficient 
termination and facilitated recycling of the polymerase (Mahapatra et al., 2011). 
A similar situation may also exist in mammalian cells.  
In order to test this, locus specific primers were designed against a sequence 
200bp downstream of an actively transcribed tRNALeu gene which is occupied by 
SWI/SNF. Since the resolution of a ChIP assay is higher than 200bp, these primers 
will detect differences in the polymerase enrichment toward the end of the 
tRNA gene. Thus the ChIP signal obtained by PCR with these primers is likely to 
represent the polymerase molecules that are successful in transcriptional 
elongation. A significant increase in Pol III enrichment is detected by these 
primers following SNF5 knockdown, suggesting an elevation in transcriptional 
elongation (Figure 6.17).  
The data put together suggest that, even though SWI/SNF does not inhibit the 
overall Pol III loading at tRNA genes, it spatially limits the area bound by Pol III. 
The elevation in Pol III downstream of the tRNA locus also suggests that, 
SWI/SNF may repress tRNA transcription by inhibiting elongation or efficient 
termination by Pol III. Thus, SWI/SNF may be toning down transcription of active 
tRNA genes to maintain it at homeostatic levels.  
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Figure 6.17: SNF5 knockdown causes increased Pol III occupancy towards the end of a 
tRNA locus 
ChIP assay in A31 mouse fibroblasts following SNF5 knockdown with antibody against RPC155 at 
tRNALeu 200bp downstream sequence. TAFI48 provided the negative control (not shown). The 
plotted values were calculated using the % Input values for Pol III ChIP. 
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6.3 Discussion 
The SWI/SNF chromatin remodelling complex is found to be deregulated in many 
human cancers. SNF5 and many other SWI/SNF subunits are considered to be 
tumour suppressors and are lost in multiple tumour types. Despite this, the 
molecular mechanisms which cause cellular transformation in the absence of 
SWI/SNF are still not clear (Reisman et al., 2009). SWI/SNF regulates the cell 
cycle through its physical and functional interactions with proteins like Rb, p53 
and c-MYC, and these interactions may be crucial for its tumour suppressor 
activity (Cheng et al., 1999; Isakoff et al., 2005; Kato et al., 2007).  
Elevated Pol III transcription is also a characteristic of cancers. In addition to 
this, a modest increase in Pol III transcriptional output, by itself, can be 
tumorigenic (Marshall et al., 2008). Thus, the discovery that SWI/SNF inhibits Pol 
III transcription may be of considerable therapeutic significance. The loss of 
SWI/SNF in human cancers could lead to elevated Pol III transcriptional output, 
which in turn can promote cellular transformation. Thus, regulation of Pol III 
transcription may provide another dimension to SWI/SNF’s tumour suppressor 
potential. However, there are no published data studying the levels of Pol III 
transcription in tumours lacking SWI/SNF subunits. This is required in order to 
fathom the full implications of the findings in this chapter. Moreover, further 
experiments are required to ascertain whether elevated Pol III transcription is an 
integral part of the tumorigenic response in the absence of SWI/SNF. 
SWI/SNF is known to be required for Rb and p53-mediated tumour suppression 
and both these proteins also inhibit Pol III transcription (Felton-Edkins et al., 
2003b; Kato et al., 2007; Versteege et al., 2002). However, the effect of 
SWI/SNF on Pol III transcription seems independent of these two pathways, since 
cells transformed with the SV40 large T antigen still show elevated tRNA 
expression upon SNF5 knockdown. Thus, cells seem to employ multiple 
redundant pathways in order to keep the Pol III transcriptional output in check, 
SWI/SNF being one of them. 
SWI/SNF was found to be required for activation by c-MYC, since dominant-
negative mutants of SNF5 and BRG1 inhibit c-MYC-mediated transactivation 
(Cheng et al., 1999). However, c-MYC and SWI/SNF seem to have opposing 
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activities at tRNA genes, where transcriptional induction by c-MYC leads to 
eviction of SWI/SNF. c-MYC has been shown to recruit Gcn5 via its interaction 
with TRRAP at Pol III-transcribed genes. It has been recently shown that Gcn5 
acetylates Snf2 at two lysine residues, which upon acetylation interact with the 
Snf2 bromodomain and cause its eviction from the nucleosome (Kim et al., 
2010). This may be the mechanism by which Myc evicts the SWI/SNF complex 
from tRNA genes. Thus, SWI/SNF may play a role in counteracting the oncogenic 
effects of c-MYC, at least as far as Pol III transcription is concerned.  
Mice with single copy loss of different SWI/SNF subunits become tumour-prone. 
SNF5+/- mice acquire lymphomas and rhabdoid tumours with extremely high 
penetrance within 10 weeks, whereas BRG1+/- mice develop mammary tumours 
within a year (Roberts et al., 2002). But BRG1+/- tumours are not similar in 
morphology to the SNF5+/- tumours. Firstly, they are carcinomas and not 
sarcomas. Secondly, they arise due to haploinsufficiency of BRG1, rather than 
the loss of heterozygosity as seen in SNF5+/- tumours. In addition to this, BRG1+/-   
BRM-/- double mutant mice do not develop tumours similar to Snf+/- mice either. 
This suggests that the observed phenotypic differences are not simply due to the 
fact that BRG1 has a closely related paralog, whereas, SNF5 does not (Bultman 
et al., 2008). BRM null mice do not develop tumours spontaneously, but BRM loss 
does sensitise them to carcinogens (Glaros et al., 2007). Therefore mice lacking 
different SWI/SNF subunits show differing phenotypes, and accordingly, it has 
been suggested that there are functional differences between the tumour 
suppression properties of these proteins.  
However, as far as Pol III transcription is concerned, BRG1 and BRM can 
compensate for the loss of each other and the BRG1/BRM dual-knockdown 
produces the same effect as SNF5 knockdown. Therefore, both the BRG1/BAF 
and BRM/BAF complexes seem to behave in a similar manner. Moreover, the 
reduction in BRM leads to the upregulation of BRG1, and vice versa. This 
phenomenon was previously observed in MEFs obtained from BRM-/- mice; 
however, the upregulation of BRM mRNA following BRG1 reduction has not been 
previously reported (Glaros et al., 2007). This compensatory feedback loop 
depicts the importance of these ATPases for cellular homeostasis; however the 
mechanisms of this feedback loop still remain unclear. 
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The recruitment of the SWI/SNF complex to tRNA genes seems to occur via its 
interaction with TFIIIC. Not only is there a high degree of correlation between 
their enrichment at tRNA genes, but SWI/SNF subunits also co-IP with more than 
one TFIIIC subunit. Attempts to co-IP BRF1 and SWI/SNF were unsuccessful. 
Moreover, c-MYC does not alter the TFIIIC occupancy at tRNA genes, but it evicts 
SWI/SNF and causes the recruitment of TFIIIB and Pol III. This inverse correlation 
consolidates the hypothesis that SWI/SNF is recruited by TFIIIC, and not by TFIIIB 
or Pol III. It is still unclear which SWI/SNF subunit is responsible for its 
interaction with TFIIIC or if the presence of the whole complex is required. 
There is a considerable degree of overlap between the ChIP-seq enrichment for 
all the four subunits tested at tRNA genes, suggesting that the presence of the 
whole complex may be required for recruitment. Pull-down assays with SNF5 and 
BRG1 dominant negative mutants defective for complex formation may provide 
further insights into the role of particular subunits in SWI/SNF at tRNA genes (de 
La Serna et al., 2000; Geng et al., 2001). 
In yeast, the loss of RSC was initially found to cause an increase in nucleosome 
density at tRNA genes (Parnell et al., 2008). This suggests that RSC may be an 
activator of Pol III transcription. However, recent experiments have shown that 
a knockdown of RSC causes elevated tRNA expression. RSC deposits nucleosomes 
containing H2A.Z flanking the yeast SUP4 tRNA gene. The nucleosome positioned 
downstream of the transcribed region represses Pol III transcription, possibly by 
inhibiting facilitated polymerase recycling. This was proposed to help tone down 
transcription levels to maintain a balanced output (Mahapatra et al., 2011). The 
ChIP-seq data from HeLa cells indicate that SWI/SNF may occupy actively 
transcribed tRNA loci. In addition to this, no elevation in Pol III occupancy at 
tRNA genes is observed following SNF5 knockdown. Therefore, SWI/SNF may not 
behave like conventional inhibitors that repress the recruitment of the 
polymerase, but instead may somehow modulate transcription of active tRNA 
genes. Loss of SNF5 leads to elevated Pol III occupancy at the end of a tRNA 
gene, indicating that there may be increased transcriptional elongation. As 
observed previously, when a tRNA gene is located at the edge of a nucleosome, 
it transcription is dramatically reduced (Wittig and Wittig, 1982). One can 
envisage that SWI/SNF may achieve transcriptional repression via a nucleosome 
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positioned towards the end of tRNA genes, as is observed for the yeast SUP4 
gene.  
Therefore, SWI/SNF inhibits Pol III transcription, however, detailed analysis of 
nucleosome positioning, along with promoter and terminator accessibility assays, 
are required in order to ascertain its precise mechanisms. The role of Pol III 
transcription in formation of tumours following loss of SWI/SNF subunits also 
needs to be examined further. 
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Chapter 7 Final Discussion 
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SINE transcription can put a tremendous load on cellular metabolism by engaging 
a large fraction of the available Pol III transcriptional apparatus. Moreover, an 
abundance of SINE transcripts may impede essential cellular process like protein 
translation and may also be toxic to the cell (Hasler and Strub, 2006; Kaneko et 
al., 2011). Thus, it is important for the cell to silence SINE transcription and this 
has been thought to be achieved via DNA methylation (Liu et al., 1994; Liu and 
Schmid, 1993; Schmid, 1991). Contrary to expectations and common belief, this 
study finds the presence of Pol III transcriptional machinery at SINE loci enriched 
for DNA methylation and MBPs. Methylation of A- and B- block promoter 
sequences is found not to impede Pol III recruitment to SINEs. 
From the data presented, it is clear that silencing at SINEs is achieved by H3K9 
trimethylation and SUV39H1. However, it is still unclear how this is targeted to 
SINEs, especially in the absence of DNA methylation. HP1 is thought to be 
recruited to its target sequences via the RNAi machinery (Pal-Bhadra et al., 
2004) and an RNA component is required for HP1 localisation (Kwon and 
Workman, 2010). Alu transcripts have recently been shown to be targets of RNA 
processing by DICER1 (Kaneko et al., 2011). I have preliminary data to suggest 
that knockdown of DICER1 leads to elevated Pol III occupancy at Alu loci. Thus, 
it can be hypothesised that SINE RNA, once processed by the RNAi machinery, is 
responsible for targeting HP1 to SINE sequences. HP1, once recruited at SINEs, 
establishes H3K9 methylation and repressive chromatin via recruitment of 
SUV39H1. DNMTs are then recruited to fill in the last piece of the puzzle and 
lock down SINE transcription (Figure 7.1). The basal level of Pol III found at SINEs 
may be required to produce sufficient transcripts in order to maintain the 
hypothesised RNA-directed transcriptional repression. 
The RITS (RNA-induced transcriptional gene silencing) complex is thought to be 
vital for the establishment of RNA-directed transcriptional repression. RITS 
comprises of Argonaute (Ago1) protein, a chromodomain protein Chp1 and a 
novel protein Tas3. The slicer activity of Ago1 is thought to be crucial for siRNA 
processing, whereas Chp1 contributes to the H3K9me-binding ability of RITS 
(Grewal and Jia, 2007). RITS also recruits the RNA-directed RNA polymerase 
complex (RDRC), which is responsible for the production of dsRNA molecules that 
can be processed by DICER (Sugiyama et al., 2005). The involvement of RITS and 
RDRC in SINE transcriptional silencing is still unexplored. However, the 
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secondary structure of SINE RNA contains dsRNA regions that can be processed by 
DICER. Thus, RDRC may not be required for RNA-directed SINE transcriptional 
repression. 
Younger AluY elements, which are closer to the Alu consensus sequence, show 
higher levels of DNA methylation compared to their older AluJ and AluS 
counterparts. This could be due to such RNA-directed active targeting of DNA 
methylation via HP1, since the younger elements have higher sequence similarity 
to the consensus Alu sequence. However, the mechanism for the recruitment of 
DNMTs is still unclear from the data available and the methylation status of 
SINEs in SUV39H1h2 knockout cells needs to be analysed. 
The data obtained in chapters 3 and 4 suggest the following model for SINE 
transcriptional repression. In the presence of DNA methylation, transcription is 
repressed by HP1, H3K9 methylation, MBPs and HDACs. Transcription is sensitive 
to TSA since HDACs contribute to both MBP and SUV39H1-dependent repression. 
In the absence of DNA methylation, a loss of MBP and HDACs is observed, 
however HP1 and H3K9 methylation can still keep transcription repressed. Here 
the repression is insensitive to TSA treatment due to the reduced HDAC 
occupancy and a switch away from HDAC-dependent repression. Moreover, when 
control cells are treated with chaetocin, HDAC-dependent silencing only allows 
for a modest increase in transcription. But when DNA methylation and HDACs are 
lost in Dnmt1-/- cells, SINEs become more sensitive to chaetocin treatment.  
Further work is required to fully establish this as a model for SINE transcriptional 
repression. It may be necessary to detect micro- and pi-RNA derivatives of SINE 
RNA in cellular extracts and their association with RITS complex. The effects of 
DICER1-knockdown on SINEs also need to be studied thoroughly, including 
changes in HP1, SUV39H1 and H3K9me3 enrichments. Antisense oligonucleotides 
targeting SINE RNA may also be able to alleviate RNA-directed transcriptional 
repression and cause increased Pol III occupancy at SINEs.  
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Figure 7.1: Model for SINE transcriptional repression. 
a) Hypothetical HP1 targeting by processed SINE RNA b) HP1 recruits SUV39H1 and H3K9me3. 
c) DNMTs, MBPs and HDACs are then recruited. 
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HP1α isoform associates with heterochromatic regions and promotes gene 
silencing, whereas HP1γ associates with euchromatin and is thought to be 
involved in gene activation. In Drosophila, HP1c associates with heat-shock 
induced genes, where it colocalises with elongating Pol II and histone chaperone 
FACT (Kwon and Workman, 2010). SINEs are heat-shock induced genes, and 
therefore HP1 isoform switching may be involved in SINE transcriptional 
regulation. The presence of limiting levels of Pol III at suppressed SINE loci 
indicates that these sites are poised for transcriptional activation. However, the 
involvement of HP1 isoforms in the rapid transcriptional activation of SINEs 
following heat-shock still needs to be investigated. 
Repetitive elements provide ample opportunity for erroneous recombination 
events and these, if left unchecked, can threaten genomic stability. 
Recombination between SINEs can be particularly deleterious, since these 
elements populate the gene-rich regions of the genome (Konkel and Batzer, 
2011). The Alu consensus sequence contains 24 CpG sites and Alus account for up 
to one-third of all CpG sites within the human genome. In most normal tissues, 
these Alu CpGs are found to be methylated (Rubin et al., 1994; Schmid, 1991). 
From the data obtained during this study, it seems that the purpose of DNA 
methylation at SINEs is to ensure genomic stability by suppressing erroneous 
recombination between these sequences. Moreover, the data also imply that 
SINEs may contribute to the hypomethylation-associated genomic instability 
observed in many human diseases (Ehrlich, 2005).  
LINE transcription and retrotransposition has previously been shown to be 
suppressed either directly by DNA methylation or by MeCP2 overexpression (Yu 
et al., 2001). Since SINE retrotransposition depends on LINE proteins, by 
suppressing LINE transcription, DNA methylation may be able to suppress SINE 
transposition and further ensure genomic stability (Schmid, 2003). 
The mechanism by which DNA methylation suppresses recombination is not yet 
understood. Preliminary data suggest that DNA methylation may somehow 
reduce the amount of ssDNA generated in the cell following DNA damage. 
However, these data were obtained from 5-azacytidine treated HeLa cells, 
where damage may be being specifically targeted to methylated sequences, for 
example Alus. This experiment must be repeated in the Dnmt1-/- and wild-type 
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MEFs in order to consolidate the findings. Further work is also required to fully 
understand how DNA methylation can affect the availability of ssDNA and the 
kinetics of repair. Moreover, would NHEJ-mediated repair be affected by DNA 
methylation as is observed for SSA-mediated repair at SINEs? 
Recent publication of ChIP-seq analysis at Pol III-transcribed genes has revealed 
that tRNA genes may be subject to the same chromatin-mediated transcriptional 
control as is observed for Pol II-transcribed genes (White, 2011). However, it is 
still unclear whether tRNA loci have the permissive chromatin due to their 
proximity to Pol II-transcribed genes and enhancer elements, or whether the Pol 
III transcription apparatus establishes the permissive chromatin environment 
(Oler et al., 2010).  
However, the presence of SWI/SNF at tRNA loci was found not to correlate with 
the presence of Pol II (Euskirchen et al., 2011). In contrast, SWI/SNF and Pol III 
transcription apparatus occupancy at tRNA genes is highly correlative, suggesting 
that the former may be recruited by the latter. In addition to this, multiple 
SWI/SNF subunits co-IP with more than one TFIIIC subunit, suggesting there is 
direct interaction with the transcription complex. 
SWI/SNF is found to suppress Pol III transcription, where both BRG1/BAF and 
BRM/BAF complexes have similar activities. Despite this, no elevation in the 
enrichment for Pol III transcriptional apparatus is observed on tRNA loci 
following SNF5 knockdown. However, SNF5 knockdown does lead to an elevation 
in Pol III occupancy downstream of a tRNA locus. In addition to this, 
transcriptional activation by c-MYC leads to eviction of the SWI/SNF complex 
from the tRNA loci. These two observations consolidate the hypothesis that 
SWI/SNF directly represses transcription at tRNA loci, but it is still unclear how 
this is achieved. It may be achieved by limiting the space available to the 
transcriptional apparatus, possibly through positioned nucleosomes. Since there 
is more polymerase present downstream in the absence of SNF5, the presence of 
SWI/SNF may impede transcript elongation, efficient termination or facilitated 
recycling. Changes in DNA accessibility following SNF5 knockdown must be 
analysed by MNase/DNaseI digestion. Fine mapping the changes in the 
positioning of nucleosomes and Pol III transcriptional machinery following the 
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knockdown of SWI/SNF subunits will be required to resolve the mechanistic 
details of this repression. 
43% of SWI/SNF-enriched loci are found to correspond to enhancer regions and 
17% correspond to CTCF sites (Euskirchen et al., 2011). TFIIIC binding sites, 
especially ETC loci, are also found to localise near CTCF binding sites (Carriere 
et al., 2011; Moqtaderi et al., 2010). In addition to this, Pol III-occupied loci, 
when not near Pol II promoters, also have enhancer-like chromatin (Oler et al., 
2010). The correlation between TFIIIC, CTCF and SWI/SNF suggests a functional 
link between these complexes. 
Recent ChIP-seq analysis in 6 different species has revealed that, despite 
differences at individual tRNA genes, Pol III loading is highly conserved among 
amino acid isotypes, i.e. the total Pol III loading at the members of a particular 
tRNA isotype is highly conserved between species (Kutter et al., 2011). This 
observation suggests that higher order 3D organisation between tRNA isotype 
genes may be involved in the regulation of Pol III loading at individual tRNA loci. 
Moreover, this also indicates that there is a requirement to modulate individual 
tRNA gene expression in order to regulate overall cellular availability of each 
tRNA isotype. SWI/SNF may be involved in such 3D organisation and fine-tuning.  
The Pol III loading at tRNA isotypes was also found to correlate with the codon 
usage by the cellular transcriptome, i.e. the Pol III loading at a less-used isotype 
was lower and vice-versa (Kutter et al., 2011). H3K9me3 is found to negatively 
correlate with Pol III loading at tRNA genes (Barski et al., 2010). Thus, RNA-
directed transcriptional silencing may also be involved in the overall regulation 
of Pol III loading at tRNAs. One can envisage the scenario where, tRNA isotypes 
not used by the translational apparatus accumulate in the cell and feed back 
into the RNAi machinery and repress expression from their parent genes through 
the HP1-H3K9me3 pathway. 
Thus, the regulation of Pol III transcription is more complex than previously 
thought and a considerable amount of work is still required to fully understand 
it. 
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